data_2lq2_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lq2 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.834 0.35 . . . . 74.420000000000002 110.874 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.42 -35.88 90.77 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.762 -0.732 . . . . 74.530000000000001 112.543 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.15 -40.17 86.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.767 0.318 . . . . 75.329999999999998 110.844 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.414 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 1.6 tt -85.52 -19.74 8.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 71.25 111.126 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -68.77 -36.15 77.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.143 -0.481 . . . . 70.019999999999996 110.872 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.546 ' N ' ' HD2' ' A' ' 8' ' ' PRO . . . -59.2 -56.41 36.3 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.644 0.735 . . . . 73.150000000000006 111.144 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 7' ' ' ALA . 53.5 Cg_endo -69.82 -29.48 23.51 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.663 2.242 . . . . 72.319999999999993 112.316 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -80.43 -17.24 52.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.435 . . . . 73.0 110.862 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.572 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.87 -54.8 51.68 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.632 0.729 . . . . 75.200000000000003 110.894 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.9 Cg_endo -69.75 -27.78 26.08 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.695 2.263 . . . . 71.25 112.344 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.03 -18.0 44.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.441 . . . . 73.329999999999998 110.879 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.614 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -57.79 -52.72 72.35 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.696 0.76 . . . . 75.209999999999994 110.861 -179.823 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.6 Cg_endo -69.76 -24.5 29.6 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.691 2.261 . . . . 70.129999999999995 112.344 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.32 -40.85 25.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 74.530000000000001 111.068 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 23.9 mm -72.19 -40.44 65.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 75.519999999999996 111.132 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.4 mt -71.9 -30.23 65.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.469 . . . . 74.439999999999998 110.923 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.44 -30.29 37.34 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.712 -0.756 . . . . 51.439999999999998 112.493 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.09 -32.65 39.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.811 0.338 . . . . 72.540000000000006 110.882 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.65 -33.19 74.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.251 -0.432 . . . . 73.230000000000004 111.113 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.18 -40.49 67.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 72.540000000000006 111.122 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.1 t -80.79 -23.3 39.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 61.329999999999998 111.154 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -74.63 -38.55 62.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 75.349999999999994 110.911 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 94.4 t -71.99 -35.1 52.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 74.340000000000003 111.159 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 96.5 t -69.85 -36.88 71.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 74.430000000000007 111.091 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.23 -32.92 38.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 64.030000000000001 111.105 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 61.350000000000001 111.115 179.889 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.07 0 CA-C-O 120.888 0.375 . . . . 75.230000000000004 110.91 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.42 -35.86 90.74 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.784 -0.722 . . . . 74.420000000000002 112.474 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -67.27 -40.08 86.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.759 0.314 . . . . 74.430000000000007 110.875 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.416 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 4.0 tt -85.61 -19.62 8.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.2 -0.454 . . . . 75.030000000000001 111.105 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -68.76 -36.4 78.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 74.049999999999997 110.85 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.536 ' N ' ' HD2' ' A' ' 8' ' ' PRO . . . -59.14 -56.49 35.53 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.567 0.699 . . . . 74.540000000000006 111.077 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 7' ' ' ALA . 53.9 Cg_endo -69.75 -29.35 24.04 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.715 2.277 . . . . 61.32 112.34 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -80.44 -17.35 52.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.258 -0.428 . . . . 72.519999999999996 110.894 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.581 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.93 -54.67 53.1 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.628 0.728 . . . . 75.239999999999995 110.902 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.8 Cg_endo -69.74 -27.9 26.01 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.705 2.27 . . . . 64.129999999999995 112.357 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.96 -18.09 44.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.436 . . . . 71.420000000000002 110.84 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.61 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -57.73 -52.83 71.49 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.66 0.743 . . . . 74.109999999999999 110.794 -179.755 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.6 Cg_endo -69.73 -24.39 29.88 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.717 2.278 . . . . 74.430000000000007 112.336 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.22 -40.53 26.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 51.299999999999997 111.085 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 54.8 mt -73.25 -39.88 56.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 71.120000000000005 111.122 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.23 -29.65 62.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 74.25 110.921 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.84 -30.46 35.4 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.763 -0.732 . . . . 75.150000000000006 112.473 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 50.8 pttt -80.8 -31.9 35.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.797 0.332 . . . . 73.129999999999995 110.916 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.89 -33.44 74.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 74.219999999999999 111.141 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.05 -40.43 68.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 74.040000000000006 111.063 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.0 t -80.78 -23.34 39.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 74.439999999999998 111.104 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -74.68 -38.51 62.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 73.140000000000001 110.874 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.6 t -72.03 -35.12 52.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 75.519999999999996 111.123 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 95.2 t -69.81 -36.86 71.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 74.239999999999995 111.11 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.17 -32.96 38.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 73.439999999999998 111.111 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 75.329999999999998 111.085 179.935 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.861 0.363 . . . . 74.099999999999994 110.923 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.42 -35.89 90.77 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.761 -0.733 . . . . 60.509999999999998 112.499 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 11.6 mtm180 -67.24 -40.09 86.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.788 0.328 . . . . 73.530000000000001 110.903 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.409 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 4.7 tt -85.59 -19.65 8.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 74.340000000000003 111.087 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -68.7 -36.47 78.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 73.329999999999998 110.88 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.545 ' N ' ' HD2' ' A' ' 8' ' ' PRO . . . -59.06 -56.48 35.73 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.567 0.699 . . . . 62.549999999999997 111.124 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 7' ' ' ALA . 53.5 Cg_endo -69.83 -29.33 23.71 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.653 2.235 . . . . 70.519999999999996 112.319 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -80.46 -17.31 52.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 74.340000000000003 110.805 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.576 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.91 -54.76 52.06 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.664 0.745 . . . . 74.230000000000004 110.862 -179.87 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.8 Cg_endo -69.71 -27.82 26.23 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.71 2.273 . . . . 74.430000000000007 112.363 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.9 m -82.01 -18.03 44.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 75.140000000000001 110.857 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.621 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -57.84 -52.69 72.54 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.617 0.722 . . . . 71.230000000000004 110.848 -179.769 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 13' ' ' SER . 54.4 Cg_endo -69.75 -24.54 29.61 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.624 2.216 . . . . 75.439999999999998 112.378 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.26 -40.63 26.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 72.239999999999995 111.092 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 24.1 mm -72.53 -40.24 62.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 75.430000000000007 111.151 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.9 tp -71.47 -32.12 67.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.21 -0.45 . . . . 75.549999999999997 110.916 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.56 -28.97 41.27 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.712 -0.756 . . . . 52.030000000000001 112.458 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 26.0 mttm -80.17 -31.53 38.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.774 0.321 . . . . 74.219999999999999 110.886 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.11 -33.42 74.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 75.219999999999999 111.116 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.09 -40.4 68.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 71.230000000000004 111.064 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.2 t -80.77 -23.28 39.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.209 -0.451 . . . . 72.120000000000005 111.181 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -74.98 -38.07 61.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 62.409999999999997 110.899 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 85.2 t -72.36 -35.14 51.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 73.0 111.164 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 94.8 t -69.83 -36.83 71.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 74.109999999999999 111.14 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.24 -32.84 38.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 61.009999999999998 111.102 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 74.530000000000001 111.119 179.946 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.05 0 CA-C-O 120.793 0.33 . . . . 74.129999999999995 110.914 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -65.34 -35.66 91.74 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.74 -0.743 . . . . 72.109999999999999 112.491 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.2 mmm-85 -67.32 -40.21 85.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.777 0.322 . . . . 64.239999999999995 110.882 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.414 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 1.3 tt -85.68 -19.64 8.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 74.420000000000002 111.125 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -68.69 -36.34 78.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 72.239999999999995 110.882 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.543 ' N ' ' HD2' ' A' ' 8' ' ' PRO . . . -59.23 -56.47 35.72 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.589 0.709 . . . . 70.340000000000003 111.099 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 7' ' ' ALA . 54.5 Cg_endo -69.72 -29.4 24.13 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.691 2.26 . . . . 61.32 112.35 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -80.48 -17.27 52.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 74.040000000000006 110.87 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.576 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.91 -54.75 52.18 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.622 0.725 . . . . 72.400000000000006 110.864 -179.919 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 54.3 Cg_endo -69.74 -27.8 26.13 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.677 2.251 . . . . 75.109999999999999 112.361 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.7 m -82.05 -18.0 44.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 71.230000000000004 110.828 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.613 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -57.79 -52.69 72.56 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.69 0.757 . . . . 74.140000000000001 110.871 -179.816 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.7 Cg_endo -69.8 -24.56 29.34 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.697 2.265 . . . . 73.030000000000001 112.313 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.24 -40.66 26.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 74.319999999999993 111.124 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 15.8 mt -72.51 -40.27 63.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 73.030000000000001 111.134 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.6 tt -71.41 -32.15 68.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 75.420000000000002 110.989 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.55 -28.93 41.43 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.72 -0.752 . . . . 73.319999999999993 112.508 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.2 mttm -80.16 -31.53 38.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.835 0.35 . . . . 74.030000000000001 110.889 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.07 -33.57 74.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.44 . . . . 71.530000000000001 111.083 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.95 -40.42 68.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.438 . . . . 73.140000000000001 111.061 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.2 t -80.76 -23.33 39.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.264 -0.425 . . . . 74.129999999999995 111.126 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.68 -38.56 62.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.461 . . . . 75.430000000000007 110.879 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 94.2 t -71.96 -35.19 53.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.174 -0.467 . . . . 74.219999999999999 111.146 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 95.8 t -69.78 -36.84 71.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.485 . . . . 75.239999999999995 111.119 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.22 -33.0 38.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 75.5 111.079 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.434 . . . . 74.150000000000006 111.125 179.919 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.817 0.341 . . . . 75.129999999999995 110.884 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.44 -35.87 90.74 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.77 -0.729 . . . . 63.549999999999997 112.47 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -67.22 -40.18 86.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.847 0.356 . . . . 70.430000000000007 110.859 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.41 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 4.7 tt -85.54 -19.68 8.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 74.209999999999994 111.125 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -68.6 -36.5 78.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 75.030000000000001 110.868 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.545 ' N ' ' HD2' ' A' ' 8' ' ' PRO . . . -59.1 -56.48 35.7 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.606 0.717 . . . . 72.409999999999997 111.114 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 7' ' ' ALA . 54.2 Cg_endo -69.74 -29.39 24.03 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.679 2.253 . . . . 73.439999999999998 112.334 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -80.38 -17.37 52.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 61.119999999999997 110.91 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.576 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.86 -54.75 52.2 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.655 0.74 . . . . 74.420000000000002 110.891 -179.919 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 54.0 Cg_endo -69.7 -27.53 26.66 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.691 2.26 . . . . 74.129999999999995 112.324 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.23 -18.33 42.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 75.010000000000005 110.898 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.626 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -57.84 -52.34 75.14 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.659 0.742 . . . . 71.230000000000004 110.827 -179.827 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.626 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.5 Cg_endo -69.69 -24.81 29.56 Favored 'Trans proline' 0 N--CA 1.465 -0.178 0 C-N-CA 122.723 2.282 . . . . 73.430000000000007 112.365 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.23 -40.55 26.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 72.239999999999995 111.158 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.6 mt -72.43 -40.23 63.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 72.329999999999998 111.132 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.54 -32.06 67.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 74.129999999999995 110.915 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.54 -28.89 41.67 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.74 -0.743 . . . . 55.149999999999999 112.509 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.2 mttm -80.06 -31.94 39.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.825 0.345 . . . . 75.010000000000005 110.951 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.87 -36.74 83.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 73.25 111.11 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.41 -39.0 74.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 53.340000000000003 111.147 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.8 m -80.37 -24.06 40.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.237 -0.438 . . . . 64.540000000000006 111.144 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -75.5 -38.67 59.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 75.340000000000003 110.842 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.2 t -70.94 -35.46 59.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.194 -0.457 . . . . 72.25 111.127 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 96.3 t -70.7 -38.57 73.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 72.450000000000003 111.112 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.25 -27.44 38.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 73.340000000000003 111.129 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 72.340000000000003 111.092 179.927 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.766 0.317 . . . . 74.310000000000002 110.877 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.42 -35.9 90.81 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.787 -0.72 . . . . 70.400000000000006 112.474 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 32.3 mmt-85 -67.19 -40.17 86.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.819 0.343 . . . . 72.329999999999998 110.888 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.417 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 6.5 tt -85.53 -19.65 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 74.519999999999996 111.176 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -68.68 -36.49 78.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 75.230000000000004 110.846 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.54 ' N ' ' HD2' ' A' ' 8' ' ' PRO . . . -59.05 -56.53 35.19 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.565 0.697 . . . . 71.019999999999996 111.074 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 7' ' ' ALA . 53.7 Cg_endo -69.75 -29.34 24.08 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.709 2.273 . . . . 72.140000000000001 112.337 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -80.49 -17.35 51.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 74.329999999999998 110.825 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.584 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -57.92 -54.71 52.62 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.666 0.746 . . . . 75.219999999999999 110.909 -179.909 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.8 Cg_endo -69.75 -27.73 26.18 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.676 2.251 . . . . 63.240000000000002 112.398 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.4 t -82.11 -18.03 44.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 74.310000000000002 110.871 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.617 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -57.75 -52.63 72.95 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.673 0.749 . . . . 61.140000000000001 110.88 -179.838 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.617 ' HD2' ' N ' ' A' ' 13' ' ' SER . 54.1 Cg_endo -69.72 -23.82 30.56 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.686 2.257 . . . . 73.120000000000005 112.382 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.68 -42.09 22.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 74.230000000000004 111.129 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 10.2 tp -74.75 -34.25 33.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 73.450000000000003 111.12 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.79 -32.74 60.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 74.239999999999995 110.9 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.11 -28.57 40.62 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.771 -0.728 . . . . 50.119999999999997 112.535 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.4 mmtt -80.12 -30.82 39.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.783 0.325 . . . . 75.310000000000002 110.922 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.3 -33.79 74.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 75.209999999999994 111.098 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.85 -40.34 69.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 60.32 111.079 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.2 t -80.7 -23.43 39.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.254 -0.43 . . . . 70.439999999999998 111.114 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -74.69 -38.48 62.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 71.450000000000003 110.859 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.0 t -72.1 -35.1 52.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 74.209999999999994 111.108 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 95.4 t -69.79 -36.89 71.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 75.109999999999999 111.14 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.17 -32.93 38.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 63.130000000000003 111.12 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 74.349999999999994 111.119 179.903 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.859 0.361 . . . . 75.230000000000004 110.928 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.42 -35.93 90.83 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.747 -0.74 . . . . 55.32 112.47 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -67.23 -40.11 86.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.764 0.316 . . . . 74.319999999999993 110.847 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.414 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 1.2 tt -85.51 -19.67 8.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 70.299999999999997 111.151 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -68.69 -36.48 78.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 72.049999999999997 110.869 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.54 ' N ' ' HD2' ' A' ' 8' ' ' PRO . . . -59.1 -56.53 35.17 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.534 0.683 . . . . 73.340000000000003 111.075 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 7' ' ' ALA . 53.9 Cg_endo -69.69 -29.39 24.26 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.657 2.238 . . . . 74.239999999999995 112.385 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -80.4 -17.36 52.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 72.109999999999999 110.859 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.574 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.87 -54.73 52.38 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.683 0.754 . . . . 75.030000000000001 110.901 -179.917 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 54.0 Cg_endo -69.81 -27.72 25.91 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.668 2.245 . . . . 72.230000000000004 112.348 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.4 m -82.09 -18.04 44.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 74.25 110.828 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.621 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -57.75 -52.61 73.07 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.649 0.737 . . . . 73.400000000000006 110.869 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.5 Cg_endo -69.75 -23.85 30.4 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.693 2.262 . . . . 72.150000000000006 112.345 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.68 -42.08 22.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 75.209999999999994 111.125 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 11.2 tp -74.8 -34.25 33.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.435 . . . . 65.120000000000005 111.117 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.7 mt -75.62 -32.82 60.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 75.549999999999997 110.956 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.17 -28.54 40.5 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.744 -0.741 . . . . 64.540000000000006 112.484 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -80.12 -30.83 39.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.803 0.335 . . . . 75.430000000000007 110.943 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.32 -33.77 74.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 74.5 111.075 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.83 -40.38 69.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.263 -0.426 . . . . 72.319999999999993 111.076 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.2 t -80.77 -23.26 39.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 62.32 111.136 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -74.78 -38.53 62.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 71.230000000000004 110.831 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.2 t -71.81 -35.8 56.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 74.120000000000005 111.129 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 90.5 t -70.22 -36.96 69.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 65.040000000000006 111.11 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.17 -30.83 38.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 65.230000000000004 111.107 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.216 -0.447 . . . . 65.439999999999998 111.083 179.983 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.782 0.325 . . . . 75.430000000000007 110.839 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.44 -35.88 90.75 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.779 -0.724 . . . . 72.420000000000002 112.503 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 13.0 mmt85 -67.24 -40.16 86.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.817 0.341 . . . . 70.420000000000002 110.853 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.416 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 2.4 tt -85.57 -19.61 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.452 . . . . 72.239999999999995 111.133 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -68.67 -36.41 78.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 64.409999999999997 110.898 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.539 ' N ' ' HD2' ' A' ' 8' ' ' PRO . . . -59.12 -56.49 35.59 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.63 0.729 . . . . 72.25 111.121 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 7' ' ' ALA . 53.5 Cg_endo -69.77 -29.37 23.94 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.659 2.24 . . . . 73.299999999999997 112.338 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -80.39 -17.39 52.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 74.540000000000006 110.851 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.575 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -57.81 -54.77 51.86 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.679 0.752 . . . . 70.109999999999999 110.88 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.4 Cg_endo -69.77 -27.42 26.45 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.67 2.247 . . . . 74.230000000000004 112.341 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.0 m -82.25 -18.33 42.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 73.439999999999998 110.92 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.628 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -57.84 -52.25 75.82 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.683 0.754 . . . . 72.549999999999997 110.837 -179.812 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.628 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.8 Cg_endo -69.76 -23.97 30.18 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.674 2.249 . . . . 74.319999999999993 112.378 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.73 -42.04 22.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 70.239999999999995 111.068 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.7 tp -74.61 -34.22 34.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 72.519999999999996 111.189 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.3 tt -75.84 -32.67 59.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 73.310000000000002 110.919 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.19 -28.42 40.92 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.719 -0.753 . . . . 72.540000000000006 112.506 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.1 mmtp -80.08 -31.28 39.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.78 0.324 . . . . 72.430000000000007 110.879 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.04 -36.93 83.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 62.530000000000001 111.097 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.24 -39.16 75.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 73.109999999999999 111.101 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 85.8 m -80.25 -24.15 40.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.439 . . . . 74.519999999999996 111.134 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -75.44 -38.68 59.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 73.219999999999999 110.832 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.7 t -70.9 -35.42 59.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 73.430000000000007 111.151 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 94.9 t -70.37 -37.06 69.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 64.430000000000007 111.165 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.24 -30.73 38.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 60.32 111.072 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 73.409999999999997 111.116 179.936 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.046 0 CA-C-O 120.838 0.352 . . . . 73.010000000000005 110.88 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -65.0 -34.34 89.63 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.734 -0.746 . . . . 72.430000000000007 112.482 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.51 -39.73 81.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.779 0.323 . . . . 73.209999999999994 110.873 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.416 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 1.1 tt -85.7 -20.02 8.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 71.420000000000002 111.15 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.58 -36.4 78.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 54.229999999999997 110.87 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.539 ' N ' ' HD2' ' A' ' 8' ' ' PRO . . . -59.1 -56.58 34.71 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.557 0.694 . . . . 73.310000000000002 111.077 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 7' ' ' ALA . 54.2 Cg_endo -69.7 -29.39 24.21 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.704 2.269 . . . . 75.510000000000005 112.327 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -80.37 -17.35 52.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.229 -0.441 . . . . 64.010000000000005 110.893 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.578 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.92 -54.72 52.49 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.664 0.745 . . . . 74.239999999999995 110.9 -179.897 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.6 Cg_endo -69.74 -27.74 26.22 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.656 2.237 . . . . 75.310000000000002 112.367 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.15 -18.07 44.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 61.130000000000003 110.821 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.61 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -57.67 -52.65 72.81 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.635 0.731 . . . . 62.329999999999998 110.847 -179.831 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.6 Cg_endo -69.75 -23.23 31.07 Favored 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.724 2.283 . . . . 73.200000000000003 112.351 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.06 -42.13 21.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 64.310000000000002 111.102 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.8 tp -74.43 -34.86 37.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 71.299999999999997 111.127 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.43 -32.71 60.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 65.420000000000002 110.924 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.06 -28.4 41.5 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.735 -0.745 . . . . 63.329999999999998 112.492 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.8 mtpt -80.08 -31.53 39.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.728 0.299 . . . . 74.239999999999995 110.847 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.95 -36.74 82.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.257 -0.429 . . . . 61.539999999999999 111.139 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.29 -39.29 74.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 74.120000000000005 111.098 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 93.1 m -80.22 -24.16 40.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 73.420000000000002 111.129 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -75.37 -38.63 59.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 73.549999999999997 110.904 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.4 t -70.66 -34.88 58.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.469 . . . . 75.109999999999999 111.104 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 98.3 t -69.98 -36.81 70.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 64.549999999999997 111.097 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.12 -32.96 38.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 74.310000000000002 111.093 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 75.219999999999999 111.05 -179.989 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.038 0 CA-C-O 120.85 0.357 . . . . 74.340000000000003 110.938 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.39 -35.91 90.85 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.73 -0.748 . . . . 72.230000000000004 112.517 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 -67.19 -40.14 86.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.803 0.335 . . . . 73.019999999999996 110.876 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.418 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 20.2 pt -85.55 -19.72 8.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 75.329999999999998 111.154 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -68.75 -36.17 78.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 72.010000000000005 110.909 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.542 ' N ' ' HD2' ' A' ' 8' ' ' PRO . . . -59.17 -56.44 36.05 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.563 0.697 . . . . 74.129999999999995 111.124 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 7' ' ' ALA . 53.6 Cg_endo -69.78 -29.56 23.56 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.676 2.251 . . . . 71.209999999999994 112.347 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -80.29 -17.41 52.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.46 . . . . 74.120000000000005 110.817 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.575 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.79 -54.89 50.63 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.624 0.725 . . . . 74.0 110.898 -179.869 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 54.2 Cg_endo -69.78 -26.2 27.75 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.658 2.239 . . . . 75.519999999999996 112.338 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.79 -19.16 38.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 73.420000000000002 110.859 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.621 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 1.9 t -57.64 -52.14 76.51 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.688 0.756 . . . . 72.239999999999995 110.851 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 13' ' ' SER . 54.3 Cg_endo -69.64 -24.81 29.79 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.7 2.267 . . . . 74.430000000000007 112.364 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.3 -40.62 26.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 74.549999999999997 111.091 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 70.4 mt -72.31 -40.25 64.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 75.299999999999997 111.186 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.1 tt -71.47 -32.21 68.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 73.430000000000007 110.931 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.46 -28.87 42.09 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.706 -0.759 . . . . 74.239999999999995 112.524 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -80.05 -31.92 39.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.845 0.355 . . . . 71.409999999999997 110.94 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.92 -36.59 82.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.447 . . . . 72.150000000000006 111.091 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.47 -39.13 74.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 70.420000000000002 111.1 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.9 m -80.26 -24.13 40.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 73.140000000000001 111.185 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -75.39 -38.72 59.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 72.010000000000005 110.853 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 91.7 t -70.63 -35.11 59.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 71.140000000000001 111.099 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 96.9 t -69.86 -36.73 70.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 53.5 111.135 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.18 -32.93 38.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 74.129999999999995 111.083 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 75.219999999999999 111.141 179.905 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.831 0.348 . . . . 72.329999999999998 110.874 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.4 -35.89 90.81 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.712 -0.756 . . . . 64.540000000000006 112.521 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.2 mmm180 -67.2 -40.16 86.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.787 0.327 . . . . 75.209999999999994 110.856 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.417 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 19.9 pt -85.49 -19.74 8.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 74.239999999999995 111.129 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -68.81 -36.1 77.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 75.109999999999999 110.874 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.542 ' N ' ' HD2' ' A' ' 8' ' ' PRO . . . -59.2 -56.46 35.81 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.582 0.706 . . . . 73.25 111.097 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 7' ' ' ALA . 53.7 Cg_endo -69.74 -29.58 23.71 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.705 2.27 . . . . 74.129999999999995 112.333 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -80.27 -17.3 52.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 75.540000000000006 110.941 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.572 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.83 -54.94 50.18 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.69 0.757 . . . . 73.549999999999997 110.882 -179.901 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 54.1 Cg_endo -69.75 -26.14 27.92 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.655 2.237 . . . . 73.239999999999995 112.369 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.1 m -82.82 -19.22 38.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.461 . . . . 73.239999999999995 110.862 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.625 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 1.9 t -57.57 -52.09 76.91 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.673 0.749 . . . . 55.329999999999998 110.889 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.625 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.9 Cg_endo -69.83 -24.67 29.09 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.663 2.242 . . . . 74.209999999999994 112.336 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.32 -40.59 26.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.28 -0.418 . . . . 72.439999999999998 111.081 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 24.0 mm -72.32 -40.3 64.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 72.120000000000005 111.173 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.7 tt -71.44 -32.19 68.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 74.109999999999999 110.909 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.54 -28.83 41.91 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.753 -0.737 . . . . 70.219999999999999 112.472 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.8 mttm -80.08 -31.99 39.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.866 0.365 . . . . 74.409999999999997 110.905 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.86 -36.67 82.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 75.25 111.066 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.44 -39.11 74.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 72.430000000000007 111.101 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.3 m -80.33 -24.09 40.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.204 -0.453 . . . . 74.209999999999994 111.143 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -75.47 -38.63 59.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 65.109999999999999 110.88 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.6 t -70.93 -35.53 60.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 65.409999999999997 111.122 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.5 t -70.34 -37.0 69.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 75.219999999999999 111.13 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.22 -30.74 38.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 72.349999999999994 111.082 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 75.450000000000003 111.132 179.927 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.844 0.354 . . . . 74.219999999999999 110.916 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -65.36 -35.64 91.7 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.77 -0.729 . . . . 70.530000000000001 112.473 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 9.4 mmm-85 -67.36 -40.23 85.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.766 0.317 . . . . 75.200000000000003 110.862 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.416 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 9.1 tt -85.66 -19.64 8.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 74.25 111.144 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -68.71 -36.31 78.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 72.129999999999995 110.876 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.539 ' N ' ' HD2' ' A' ' 8' ' ' PRO . . . -59.17 -56.51 35.31 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.615 0.721 . . . . 51.340000000000003 111.108 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 7' ' ' ALA . 53.3 Cg_endo -69.82 -29.3 23.77 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.632 2.221 . . . . 73.530000000000001 112.339 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -80.43 -17.34 52.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 53.409999999999997 110.871 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.577 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.92 -54.74 52.36 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.605 0.717 . . . . 74.450000000000003 110.855 -179.877 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.8 Cg_endo -69.74 -27.41 26.61 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.714 2.276 . . . . 63.25 112.318 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.6 t -82.3 -18.43 42.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.43 . . . . 60.130000000000003 110.877 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.628 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -57.79 -52.24 75.82 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.662 0.744 . . . . 75.299999999999997 110.858 -179.819 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.628 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.8 Cg_endo -69.73 -24.03 30.26 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.661 2.241 . . . . 55.229999999999997 112.321 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.7 -42.02 22.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 75.510000000000005 111.092 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.6 tp -74.58 -34.29 34.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 73.239999999999995 111.162 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 30.6 mt -75.75 -32.77 60.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.12 -0.491 . . . . 72.200000000000003 110.902 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.1 -28.46 41.08 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.747 -0.739 . . . . 73.319999999999993 112.518 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.4 mttp -80.07 -31.24 39.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.809 0.338 . . . . 73.239999999999995 110.91 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.16 -36.64 82.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 70.450000000000003 111.104 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.37 -39.22 74.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.434 . . . . 72.129999999999995 111.08 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.1 m -80.3 -24.04 40.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 75.25 111.131 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -75.43 -38.58 59.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 72.109999999999999 110.853 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.7 t -71.1 -35.44 58.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.446 . . . . 65.040000000000006 111.106 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 95.9 t -70.37 -37.12 69.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 74.150000000000006 111.11 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.17 -30.69 38.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 70.109999999999999 111.1 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 72.329999999999998 111.042 179.996 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.847 0.355 . . . . 73.340000000000003 110.92 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -65.06 -34.2 89.17 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.706 -0.759 . . . . 74.340000000000003 112.545 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -68.53 -39.81 81.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.82 0.343 . . . . 72.420000000000002 110.876 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.416 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 28.9 pt -85.65 -19.99 8.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 75.549999999999997 111.164 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.6 -36.4 78.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.189 -0.46 . . . . 75.430000000000007 110.878 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.537 ' N ' ' HD2' ' A' ' 8' ' ' PRO . . . -59.09 -56.53 35.22 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.587 0.708 . . . . 61.350000000000001 111.108 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 7' ' ' ALA . 53.9 Cg_endo -69.79 -29.27 23.98 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.661 2.241 . . . . 65.450000000000003 112.389 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -80.45 -17.38 51.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 74.430000000000007 110.859 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.58 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.91 -54.71 52.64 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.664 0.745 . . . . 75.140000000000001 110.918 -179.916 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.4 Cg_endo -69.79 -27.77 25.93 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.69 2.26 . . . . 74.540000000000006 112.332 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.04 -18.09 44.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 74.019999999999996 110.836 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.611 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -57.75 -52.56 73.47 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.676 0.75 . . . . 71.329999999999998 110.885 -179.804 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.611 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.7 Cg_endo -69.76 -23.85 30.34 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.713 2.275 . . . . 74.219999999999999 112.33 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.69 -42.07 22.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 74.420000000000002 111.114 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.6 tp -74.76 -34.3 33.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 75.409999999999997 111.111 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 51.1 tp -75.66 -32.71 60.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 74.239999999999995 110.958 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.22 -28.54 40.3 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.757 -0.735 . . . . 62.140000000000001 112.419 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.9 mtpp -80.12 -30.83 39.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.752 0.31 . . . . 73.299999999999997 110.889 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.28 -33.83 75.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.283 -0.417 . . . . 71.530000000000001 111.071 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.81 -40.41 69.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 63.229999999999997 111.048 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.2 t -80.71 -23.38 39.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 74.340000000000003 111.111 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -74.72 -38.49 62.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 62.509999999999998 110.87 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 94.2 t -71.94 -35.12 53.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 62.140000000000001 111.151 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 96.1 t -69.79 -36.86 71.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 73.340000000000003 111.125 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.22 -32.9 38.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 71.409999999999997 111.128 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 72.230000000000004 111.127 179.905 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.822 0.344 . . . . 71.439999999999998 110.902 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.4 -35.95 90.9 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.794 -0.717 . . . . 64.340000000000003 112.473 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 79.8 mtt180 -67.16 -40.15 86.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.758 0.313 . . . . 74.349999999999994 110.853 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.417 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 14.7 tt -85.49 -19.75 8.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 75.540000000000006 111.138 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -68.75 -36.15 78.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 73.420000000000002 110.823 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.542 ' N ' ' HD2' ' A' ' 8' ' ' PRO . . . -59.24 -56.47 35.74 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.604 0.716 . . . . 75.099999999999994 111.101 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 7' ' ' ALA . 53.9 Cg_endo -69.75 -29.39 24.01 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.676 2.25 . . . . 73.25 112.371 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -80.54 -17.22 52.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 74.109999999999999 110.89 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.581 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -58.02 -54.45 55.46 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.659 0.742 . . . . 62.109999999999999 110.887 -179.883 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.8 Cg_endo -69.74 -27.35 26.69 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.7 2.266 . . . . 73.209999999999994 112.321 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.42 -19.1 39.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 74.099999999999994 110.865 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.635 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -56.09 -52.07 75.66 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.633 0.73 . . . . 72.329999999999998 110.83 -179.778 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.635 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.5 Cg_endo -69.78 -20.24 35.0 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.675 2.25 . . . . 71.109999999999999 112.36 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.9 -42.54 19.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.434 . . . . 75.530000000000001 111.089 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 22.2 pt -74.29 -35.91 41.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 74.019999999999996 111.099 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -74.32 -32.81 62.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 72.219999999999999 110.901 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.04 -28.64 40.66 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.743 -0.741 . . . . 72.040000000000006 112.489 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.0 mtpt -80.19 -30.44 38.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.762 0.315 . . . . 73.150000000000006 110.838 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.49 -34.48 75.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.284 -0.416 . . . . 74.340000000000003 111.089 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.61 -40.24 69.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 64.209999999999994 111.073 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.3 t -80.75 -22.59 40.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 60.439999999999998 111.148 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -75.76 -38.53 58.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 73.310000000000002 110.903 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 96.3 t -67.83 -40.34 83.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 74.409999999999997 111.146 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.2 p -69.56 -34.28 60.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 74.329999999999998 111.171 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.25 -29.13 38.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.126 -0.488 . . . . 53.030000000000001 111.133 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 54.140000000000001 111.109 179.94 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.852 0.358 . . . . 73.340000000000003 110.895 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.42 -35.89 90.78 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.705 -0.759 . . . . 74.319999999999993 112.499 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 26.4 mmt85 -67.17 -40.2 86.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.813 0.339 . . . . 73.510000000000005 110.84 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.418 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 31.4 pt -85.5 -19.69 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 73.540000000000006 111.137 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -68.81 -36.12 77.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.458 . . . . 64.219999999999999 110.887 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.538 ' N ' ' HD2' ' A' ' 8' ' ' PRO . . . -59.21 -56.47 35.72 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.599 0.714 . . . . 74.310000000000002 111.113 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 7' ' ' ALA . 54.4 Cg_endo -69.71 -29.56 23.92 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.714 2.276 . . . . 73.349999999999994 112.395 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -80.34 -17.3 52.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 71.129999999999995 110.897 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.578 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.82 -54.95 50.07 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.632 0.73 . . . . 75.319999999999993 110.884 -179.906 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.7 Cg_endo -69.7 -26.17 28.11 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.716 2.277 . . . . 73.239999999999995 112.363 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.7 t -82.88 -19.14 37.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 62.109999999999999 110.857 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.627 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 2.0 t -57.63 -51.96 77.88 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.665 0.745 . . . . 74.420000000000002 110.886 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 13' ' ' SER . 54.0 Cg_endo -69.77 -24.08 30.03 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.693 2.262 . . . . 71.540000000000006 112.387 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.67 -42.02 22.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 64.0 111.101 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 12.4 tt -74.62 -34.29 34.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 62.119999999999997 111.083 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.9 tp -75.74 -32.75 60.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 73.129999999999995 110.899 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.19 -28.36 41.11 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.695 -0.764 . . . . 61.310000000000002 112.462 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.8 mttt -80.11 -31.29 39.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.752 0.311 . . . . 75.400000000000006 110.882 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.76 -39.97 88.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 73.439999999999998 111.133 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.24 -37.07 77.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 74.219999999999999 111.084 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.0 m -80.32 -24.74 39.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.25 -0.432 . . . . 51.450000000000003 111.161 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -77.39 -37.49 51.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 72.040000000000006 110.882 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 91.5 t -71.08 -40.1 75.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.448 . . . . 74.310000000000002 111.184 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.0 p -68.67 -33.82 61.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 71.0 111.105 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.29 -32.56 38.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 74.140000000000001 111.028 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 43.329999999999998 111.051 179.993 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.8 pptp? . . . . . 0 C--O 1.23 0.041 0 CA-C-O 120.829 0.347 . . . . 75.25 110.891 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -65.02 -34.36 89.65 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.719 -0.753 . . . . 74.340000000000003 112.472 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 -68.48 -39.76 81.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.766 0.317 . . . . 75.120000000000005 110.866 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.416 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 29.4 pt -85.68 -19.99 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 73.409999999999997 111.102 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.64 -36.31 78.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 71.25 110.905 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.54 ' N ' ' HD2' ' A' ' 8' ' ' PRO . . . -59.11 -56.58 34.63 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.613 0.72 . . . . 72.420000000000002 111.068 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 7' ' ' ALA . 53.7 Cg_endo -69.78 -29.34 23.92 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.687 2.258 . . . . 74.310000000000002 112.313 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -80.4 -17.28 52.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.221 -0.445 . . . . 74.230000000000004 110.922 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.579 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.95 -54.75 52.27 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.634 0.731 . . . . 72.349999999999994 110.851 -179.918 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.8 Cg_endo -69.78 -27.71 26.07 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.741 2.294 . . . . 61.240000000000002 112.33 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.3 m -82.19 -17.99 44.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 63.439999999999998 110.844 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.625 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.2 OUTLIER -57.78 -52.62 73.08 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.68 0.752 . . . . 73.25 110.842 -179.838 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.625 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.7 Cg_endo -69.75 -23.85 30.39 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.73 2.287 . . . . 72.409999999999997 112.341 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.7 -41.99 22.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 64.109999999999999 111.153 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 15.4 tt -74.76 -34.33 33.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 71.519999999999996 111.125 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.66 -32.73 60.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 74.200000000000003 110.893 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.24 -28.52 40.31 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.792 -0.718 . . . . 73.150000000000006 112.434 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -80.2 -30.84 38.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.74 0.305 . . . . 73.510000000000005 110.873 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.34 -33.69 74.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 62.130000000000003 111.134 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.88 -40.37 68.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 74.019999999999996 111.099 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.3 t -80.65 -23.4 39.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 72.150000000000006 111.188 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -75.18 -37.82 61.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 74.25 110.881 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 85.7 t -72.77 -35.7 50.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.228 -0.442 . . . . 74.299999999999997 111.125 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 95.9 t -70.17 -37.3 71.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 72.109999999999999 111.137 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.23 -30.57 38.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 74.209999999999994 111.073 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 60.240000000000002 111.104 179.944 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.058 0 CA-C-O 120.81 0.338 . . . . 75.340000000000003 110.878 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.42 -35.89 90.78 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.688 -0.768 . . . . 70.420000000000002 112.537 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.3 mtt180 -67.15 -40.11 86.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.853 0.359 . . . . 74.409999999999997 110.891 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.413 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 10.7 tp -85.55 -19.81 8.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 73.530000000000001 111.167 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -68.55 -36.43 78.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 74.420000000000002 110.86 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.541 ' N ' ' HD2' ' A' ' 8' ' ' PRO . . . -59.06 -56.62 34.32 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.581 0.705 . . . . 73.25 111.089 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 7' ' ' ALA . 53.3 Cg_endo -69.74 -29.27 24.22 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.696 2.264 . . . . 64.010000000000005 112.326 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -80.54 -17.32 51.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 74.519999999999996 110.806 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.577 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.93 -54.67 53.02 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.696 0.76 . . . . 72.329999999999998 110.866 -179.884 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.8 Cg_endo -69.69 -27.71 26.45 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.705 2.27 . . . . 71.129999999999995 112.386 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m -82.16 -18.34 43.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.46 . . . . 71.010000000000005 110.872 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.625 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -57.2 -52.55 73.32 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.667 0.746 . . . . 75.209999999999994 110.88 -179.823 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.625 ' HD2' ' N ' ' A' ' 13' ' ' SER . 54.0 Cg_endo -69.76 -23.48 30.77 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.659 2.24 . . . . 74.340000000000003 112.3 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.56 -41.67 23.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.26 -0.427 . . . . 63.549999999999997 111.091 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 33.6 mm -72.41 -40.07 63.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.462 . . . . 74.219999999999999 111.16 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -71.83 -31.87 66.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 72.530000000000001 110.911 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.61 -28.93 41.21 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.715 -0.755 . . . . 62.329999999999998 112.534 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.8 mtpp -80.05 -32.17 39.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.731 0.301 . . . . 75.219999999999999 110.881 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.83 -36.64 82.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 72.109999999999999 111.134 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.42 -39.09 74.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 64.400000000000006 111.122 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.9 m -80.31 -24.11 40.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 71.25 111.163 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -75.38 -38.94 59.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 74.329999999999998 110.802 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.6 t -70.35 -35.02 60.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 75.409999999999997 111.167 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 96.7 t -69.94 -36.7 70.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 72.230000000000004 111.123 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.21 -32.81 38.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.481 . . . . 71.109999999999999 111.093 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.271 -0.422 . . . . 72.239999999999995 111.105 179.946 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.789 0.328 . . . . 74.5 110.882 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -67.37 -34.34 84.74 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.725 -0.75 . . . . 64.319999999999993 112.508 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -69.99 -37.59 75.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.815 0.34 . . . . 74.519999999999996 110.826 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.408 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 11.6 tt -87.09 -19.88 7.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 73.510000000000005 111.149 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -69.47 -36.57 76.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 64.040000000000006 110.854 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.548 ' N ' ' HD2' ' A' ' 8' ' ' PRO . . . -59.09 -56.2 38.6 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.557 0.694 . . . . 61.340000000000003 111.068 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 7' ' ' ALA . 53.8 Cg_endo -69.76 -29.56 23.66 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.69 2.26 . . . . 74.400000000000006 112.346 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -80.4 -17.31 52.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 74.349999999999994 110.896 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.586 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -57.83 -54.81 51.51 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.648 0.737 . . . . 75.109999999999999 110.876 -179.901 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 54.2 Cg_endo -69.71 -27.76 26.3 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.73 2.287 . . . . 73.430000000000007 112.324 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.1 -18.04 44.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 73.25 110.856 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.619 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -57.75 -52.59 73.23 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.657 0.741 . . . . 55.25 110.869 -179.832 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.5 Cg_endo -69.8 -23.79 30.21 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.664 2.243 . . . . 63.130000000000003 112.351 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.75 -41.98 22.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.227 -0.442 . . . . 62.439999999999998 111.086 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 11.2 tp -74.82 -34.24 32.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 72.319999999999993 111.113 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.3 tp -75.86 -32.6 59.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 74.239999999999995 110.925 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.21 -28.43 40.8 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.708 -0.758 . . . . 74.239999999999995 112.526 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.3 mttt -80.0 -31.36 39.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.823 0.344 . . . . 74.0 110.938 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.05 -36.65 82.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 73.450000000000003 111.089 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.29 -39.4 74.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.244 -0.434 . . . . 63.009999999999998 111.081 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.4 m -80.27 -24.0 40.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 63.310000000000002 111.14 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -75.39 -38.63 59.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.438 . . . . 65.310000000000002 110.857 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.8 t -70.83 -35.14 58.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.202 -0.454 . . . . 73.239999999999995 111.142 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 96.2 t -69.87 -36.67 70.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 70.219999999999999 111.141 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.17 -32.91 38.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.465 . . . . 74.219999999999999 111.111 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 75.420000000000002 111.087 179.972 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.823 0.344 . . . . 73.310000000000002 110.876 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.29 -35.94 91.0 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.742 -0.742 . . . . 73.430000000000007 112.51 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 44.5 mmm-85 -67.19 -40.16 86.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.777 0.323 . . . . 73.299999999999997 110.866 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.42 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 0.8 OUTLIER -85.52 -19.75 8.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.46 . . . . 65.409999999999997 111.107 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -68.77 -36.17 77.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.46 . . . . 72.019999999999996 110.831 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.537 ' N ' ' HD2' ' A' ' 8' ' ' PRO . . . -59.16 -56.52 35.25 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.607 0.718 . . . . 71.299999999999997 111.083 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 7' ' ' ALA . 53.4 Cg_endo -69.78 -29.46 23.72 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.665 2.243 . . . . 73.129999999999995 112.345 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -80.36 -17.34 52.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 71.409999999999997 110.864 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.581 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.89 -54.72 52.52 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.668 0.747 . . . . 74.530000000000001 110.883 -179.866 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.6 Cg_endo -69.79 -27.77 25.92 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.732 2.288 . . . . 73.340000000000003 112.298 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.1 -18.0 44.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.272 -0.422 . . . . 72.349999999999994 110.9 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.613 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -57.85 -52.58 73.34 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.638 0.732 . . . . 73.340000000000003 110.811 -179.806 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.9 Cg_endo -69.75 -23.79 30.46 Favored 'Trans proline' 0 C--N 1.341 0.132 0 C-N-CA 122.682 2.255 . . . . 75.099999999999994 112.367 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.78 -41.98 22.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 74.129999999999995 111.095 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.1 tp -74.82 -34.25 32.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.431 . . . . 74.540000000000006 111.111 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.7 tp -75.74 -32.7 60.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.461 . . . . 74.430000000000007 110.933 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.22 -28.49 40.5 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.746 -0.74 . . . . 54.119999999999997 112.481 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -80.04 -31.1 39.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.841 0.353 . . . . 75.209999999999994 110.931 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.95 -40.08 87.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 72.409999999999997 111.07 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.48 -37.44 77.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 70.219999999999999 111.131 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.6 m -80.46 -23.27 40.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 74.230000000000004 111.166 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -77.92 -38.86 44.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 74.400000000000006 110.905 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 99.3 t -66.19 -40.31 86.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 74.510000000000005 111.133 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.5 m -68.92 -31.91 52.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 74.230000000000004 111.094 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.48 -34.18 36.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 54.509999999999998 111.105 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 74.450000000000003 111.081 179.956 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.839 0.352 . . . . 74.540000000000006 110.906 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.46 -35.98 90.87 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.726 -0.749 . . . . 75.140000000000001 112.459 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.7 mmt-85 -67.05 -40.14 87.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.773 0.321 . . . . 65.5 110.915 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.42 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 1.1 tt -85.55 -19.73 8.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 72.439999999999998 111.084 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -68.74 -36.15 78.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.207 -0.451 . . . . 75.010000000000005 110.86 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.542 ' N ' ' HD2' ' A' ' 8' ' ' PRO . . . -59.23 -56.47 35.7 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.572 0.701 . . . . 73.430000000000007 111.126 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 7' ' ' ALA . 54.0 Cg_endo -69.75 -29.4 24.0 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.705 2.27 . . . . 64.340000000000003 112.342 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -80.54 -17.26 52.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.242 -0.436 . . . . 70.140000000000001 110.866 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.587 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.98 -54.44 55.52 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.646 0.736 . . . . 75.230000000000004 110.941 -179.928 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.8 Cg_endo -69.77 -27.31 26.56 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.661 2.241 . . . . 65.109999999999999 112.342 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.46 -19.11 39.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 73.530000000000001 110.802 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.634 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.2 OUTLIER -55.99 -52.14 74.91 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.689 0.757 . . . . 73.209999999999994 110.874 -179.83 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.634 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.6 Cg_endo -69.79 -20.58 34.49 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.687 2.258 . . . . 73.530000000000001 112.302 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.42 -42.38 20.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.283 -0.417 . . . . 71.430000000000007 111.08 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.1 pt -75.73 -35.17 30.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 71.450000000000003 111.115 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.55 -30.57 57.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 74.200000000000003 110.947 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.54 -29.78 35.04 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.706 -0.759 . . . . 71.200000000000003 112.467 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.9 -31.28 35.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.786 0.327 . . . . 72.209999999999994 110.884 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.12 -33.75 75.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 64.340000000000003 111.081 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.86 -40.37 69.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 74.230000000000004 111.117 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.2 t -80.77 -23.33 39.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.215 -0.448 . . . . 63.420000000000002 111.121 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -74.7 -38.51 62.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.24 -0.436 . . . . 65.420000000000002 110.863 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.1 t -72.02 -35.06 52.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 74.329999999999998 111.121 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 95.9 t -69.82 -36.85 71.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.46 . . . . 73.530000000000001 111.157 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.19 -32.95 38.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 74.120000000000005 111.11 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 75.420000000000002 111.112 179.927 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 16.8 m . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.904 0.383 . . . . 64.530000000000001 111.101 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.13 -19.46 47.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 74.420000000000002 110.874 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.42 -35.88 90.77 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.762 -0.732 . . . . 74.530000000000001 112.543 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.15 -40.17 86.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.767 0.318 . . . . 75.329999999999998 110.844 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.414 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 1.6 tt -85.52 -19.74 8.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 71.25 111.126 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -68.77 -36.15 77.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.143 -0.481 . . . . 70.019999999999996 110.872 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.546 ' N ' ' HD2' ' A' ' 8' ' ' PRO . . . -59.2 -56.41 36.3 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.644 0.735 . . . . 73.150000000000006 111.144 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 7' ' ' ALA . 53.5 Cg_endo -69.82 -29.48 23.51 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.663 2.242 . . . . 72.319999999999993 112.316 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -80.43 -17.24 52.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.435 . . . . 73.0 110.862 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.572 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.87 -54.8 51.68 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.632 0.729 . . . . 75.200000000000003 110.894 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.9 Cg_endo -69.75 -27.78 26.08 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.695 2.263 . . . . 71.25 112.344 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.03 -18.0 44.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.441 . . . . 73.329999999999998 110.879 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.614 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -57.79 -52.72 72.35 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.696 0.76 . . . . 75.209999999999994 110.861 -179.823 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.6 Cg_endo -69.76 -24.5 29.6 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.691 2.261 . . . . 70.129999999999995 112.344 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.32 -40.85 25.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 74.530000000000001 111.068 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 23.9 mm -72.19 -40.44 65.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 75.519999999999996 111.132 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.4 mt -71.9 -30.23 65.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.469 . . . . 74.439999999999998 110.923 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.44 -30.29 37.34 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.712 -0.756 . . . . 51.439999999999998 112.493 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.09 -32.65 39.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.811 0.338 . . . . 72.540000000000006 110.882 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.65 -33.19 74.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.251 -0.432 . . . . 73.230000000000004 111.113 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.18 -40.49 67.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 72.540000000000006 111.122 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.1 t -80.79 -23.3 39.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 61.329999999999998 111.154 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -74.63 -38.55 62.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 75.349999999999994 110.911 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 94.4 t -71.99 -35.1 52.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 74.340000000000003 111.159 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 96.5 t -69.85 -36.88 71.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 74.430000000000007 111.091 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.23 -32.92 38.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 64.030000000000001 111.105 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.91 -19.97 54.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 61.350000000000001 111.115 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -59.94 -25.97 65.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.206 -0.452 . . . . 74.209999999999994 110.902 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.7 ptmm? -73.64 -32.57 64.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 74.450000000000003 110.884 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.0 m . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 65.340000000000003 110.806 -179.87 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 6.7 m . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.886 0.374 . . . . 72.420000000000002 111.102 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.12 -19.43 47.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 75.230000000000004 110.91 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.42 -35.86 90.74 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.784 -0.722 . . . . 74.420000000000002 112.474 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -67.27 -40.08 86.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.759 0.314 . . . . 74.430000000000007 110.875 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.416 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 4.0 tt -85.61 -19.62 8.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.2 -0.454 . . . . 75.030000000000001 111.105 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -68.76 -36.4 78.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 74.049999999999997 110.85 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.536 ' N ' ' HD2' ' A' ' 8' ' ' PRO . . . -59.14 -56.49 35.53 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.567 0.699 . . . . 74.540000000000006 111.077 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 7' ' ' ALA . 53.9 Cg_endo -69.75 -29.35 24.04 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.715 2.277 . . . . 61.32 112.34 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -80.44 -17.35 52.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.258 -0.428 . . . . 72.519999999999996 110.894 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.581 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.93 -54.67 53.1 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.628 0.728 . . . . 75.239999999999995 110.902 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.8 Cg_endo -69.74 -27.9 26.01 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.705 2.27 . . . . 64.129999999999995 112.357 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.96 -18.09 44.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.436 . . . . 71.420000000000002 110.84 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.61 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -57.73 -52.83 71.49 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.66 0.743 . . . . 74.109999999999999 110.794 -179.755 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.6 Cg_endo -69.73 -24.39 29.88 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.717 2.278 . . . . 74.430000000000007 112.336 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.22 -40.53 26.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 51.299999999999997 111.085 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 54.8 mt -73.25 -39.88 56.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 71.120000000000005 111.122 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.23 -29.65 62.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 74.25 110.921 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.84 -30.46 35.4 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.763 -0.732 . . . . 75.150000000000006 112.473 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 50.8 pttt -80.8 -31.9 35.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.797 0.332 . . . . 73.129999999999995 110.916 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.89 -33.44 74.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 74.219999999999999 111.141 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.05 -40.43 68.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 74.040000000000006 111.063 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.0 t -80.78 -23.34 39.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 74.439999999999998 111.104 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -74.68 -38.51 62.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 73.140000000000001 110.874 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.6 t -72.03 -35.12 52.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 75.519999999999996 111.123 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 95.2 t -69.81 -36.86 71.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 74.239999999999995 111.11 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.17 -32.96 38.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 73.439999999999998 111.111 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.92 -20.03 55.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 75.329999999999998 111.085 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -59.87 -25.94 65.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.201 -0.454 . . . . 75.0 110.923 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.62 -32.62 64.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 73.099999999999994 110.844 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 36.6 t . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.289 -0.414 . . . . 75.129999999999995 110.899 -179.919 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.5 t . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.884 0.374 . . . . 72.319999999999993 111.11 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.06 -19.45 47.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 74.099999999999994 110.923 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.42 -35.89 90.77 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.761 -0.733 . . . . 60.509999999999998 112.499 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 11.6 mtm180 -67.24 -40.09 86.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.788 0.328 . . . . 73.530000000000001 110.903 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.409 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 4.7 tt -85.59 -19.65 8.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 74.340000000000003 111.087 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -68.7 -36.47 78.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 73.329999999999998 110.88 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.545 ' N ' ' HD2' ' A' ' 8' ' ' PRO . . . -59.06 -56.48 35.73 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.567 0.699 . . . . 62.549999999999997 111.124 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 7' ' ' ALA . 53.5 Cg_endo -69.83 -29.33 23.71 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.653 2.235 . . . . 70.519999999999996 112.319 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -80.46 -17.31 52.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 74.340000000000003 110.805 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.576 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.91 -54.76 52.06 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.664 0.745 . . . . 74.230000000000004 110.862 -179.87 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.8 Cg_endo -69.71 -27.82 26.23 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.71 2.273 . . . . 74.430000000000007 112.363 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.9 m -82.01 -18.03 44.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 75.140000000000001 110.857 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.621 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -57.84 -52.69 72.54 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.617 0.722 . . . . 71.230000000000004 110.848 -179.769 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 13' ' ' SER . 54.4 Cg_endo -69.75 -24.54 29.61 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.624 2.216 . . . . 75.439999999999998 112.378 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.26 -40.63 26.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 72.239999999999995 111.092 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 24.1 mm -72.53 -40.24 62.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 75.430000000000007 111.151 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.9 tp -71.47 -32.12 67.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.21 -0.45 . . . . 75.549999999999997 110.916 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.56 -28.97 41.27 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.712 -0.756 . . . . 52.030000000000001 112.458 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 26.0 mttm -80.17 -31.53 38.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.774 0.321 . . . . 74.219999999999999 110.886 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.11 -33.42 74.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 75.219999999999999 111.116 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.09 -40.4 68.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 71.230000000000004 111.064 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.2 t -80.77 -23.28 39.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.209 -0.451 . . . . 72.120000000000005 111.181 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -74.98 -38.07 61.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 62.409999999999997 110.899 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 85.2 t -72.36 -35.14 51.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 73.0 111.164 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 94.8 t -69.83 -36.83 71.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 74.109999999999999 111.14 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.24 -32.84 38.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 61.009999999999998 111.102 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -80.11 -19.92 46.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 74.530000000000001 111.119 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -59.97 -34.01 72.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.476 . . . . 75.420000000000002 110.897 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -71.03 -32.3 69.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.272 -0.422 . . . . 75.140000000000001 110.94 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.6 t . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 74.319999999999993 110.838 -179.901 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.1 m . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.92 0.39 . . . . 74.420000000000002 111.112 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.22 -19.23 47.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.133 -0.485 . . . . 74.129999999999995 110.914 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -65.34 -35.66 91.74 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.74 -0.743 . . . . 72.109999999999999 112.491 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.2 mmm-85 -67.32 -40.21 85.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.777 0.322 . . . . 64.239999999999995 110.882 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.414 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 1.3 tt -85.68 -19.64 8.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 74.420000000000002 111.125 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -68.69 -36.34 78.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 72.239999999999995 110.882 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.543 ' N ' ' HD2' ' A' ' 8' ' ' PRO . . . -59.23 -56.47 35.72 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.589 0.709 . . . . 70.340000000000003 111.099 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 7' ' ' ALA . 54.5 Cg_endo -69.72 -29.4 24.13 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.691 2.26 . . . . 61.32 112.35 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -80.48 -17.27 52.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 74.040000000000006 110.87 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.576 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.91 -54.75 52.18 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.622 0.725 . . . . 72.400000000000006 110.864 -179.919 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 54.3 Cg_endo -69.74 -27.8 26.13 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.677 2.251 . . . . 75.109999999999999 112.361 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.7 m -82.05 -18.0 44.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 71.230000000000004 110.828 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.613 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -57.79 -52.69 72.56 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.69 0.757 . . . . 74.140000000000001 110.871 -179.816 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.7 Cg_endo -69.8 -24.56 29.34 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.697 2.265 . . . . 73.030000000000001 112.313 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.24 -40.66 26.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 74.319999999999993 111.124 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 15.8 mt -72.51 -40.27 63.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 73.030000000000001 111.134 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.6 tt -71.41 -32.15 68.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 75.420000000000002 110.989 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.55 -28.93 41.43 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.72 -0.752 . . . . 73.319999999999993 112.508 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.2 mttm -80.16 -31.53 38.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.835 0.35 . . . . 74.030000000000001 110.889 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.07 -33.57 74.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.44 . . . . 71.530000000000001 111.083 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.95 -40.42 68.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.438 . . . . 73.140000000000001 111.061 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.2 t -80.76 -23.33 39.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.264 -0.425 . . . . 74.129999999999995 111.126 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.68 -38.56 62.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.461 . . . . 75.430000000000007 110.879 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 94.2 t -71.96 -35.19 53.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.174 -0.467 . . . . 74.219999999999999 111.146 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 95.8 t -69.78 -36.84 71.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.485 . . . . 75.239999999999995 111.119 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.22 -33.0 38.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 75.5 111.079 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.95 -20.0 55.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.434 . . . . 74.150000000000006 111.125 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -59.93 -25.95 65.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 75.239999999999995 110.9 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.49 -32.63 64.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.253 -0.431 . . . . 72.120000000000005 110.929 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 75.349999999999994 110.827 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.925 0.393 . . . . 75.349999999999994 111.132 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.13 -19.43 47.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 75.129999999999995 110.884 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.44 -35.87 90.74 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.77 -0.729 . . . . 63.549999999999997 112.47 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -67.22 -40.18 86.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.847 0.356 . . . . 70.430000000000007 110.859 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.41 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 4.7 tt -85.54 -19.68 8.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 74.209999999999994 111.125 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -68.6 -36.5 78.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 75.030000000000001 110.868 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.545 ' N ' ' HD2' ' A' ' 8' ' ' PRO . . . -59.1 -56.48 35.7 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.606 0.717 . . . . 72.409999999999997 111.114 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 7' ' ' ALA . 54.2 Cg_endo -69.74 -29.39 24.03 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.679 2.253 . . . . 73.439999999999998 112.334 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -80.38 -17.37 52.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 61.119999999999997 110.91 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.576 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.86 -54.75 52.2 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.655 0.74 . . . . 74.420000000000002 110.891 -179.919 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 54.0 Cg_endo -69.7 -27.53 26.66 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.691 2.26 . . . . 74.129999999999995 112.324 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.23 -18.33 42.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 75.010000000000005 110.898 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.626 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -57.84 -52.34 75.14 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.659 0.742 . . . . 71.230000000000004 110.827 -179.827 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.626 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.5 Cg_endo -69.69 -24.81 29.56 Favored 'Trans proline' 0 N--CA 1.465 -0.178 0 C-N-CA 122.723 2.282 . . . . 73.430000000000007 112.365 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.23 -40.55 26.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 72.239999999999995 111.158 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.6 mt -72.43 -40.23 63.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 72.329999999999998 111.132 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.54 -32.06 67.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 74.129999999999995 110.915 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.54 -28.89 41.67 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.74 -0.743 . . . . 55.149999999999999 112.509 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.2 mttm -80.06 -31.94 39.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.825 0.345 . . . . 75.010000000000005 110.951 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.87 -36.74 83.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 73.25 111.11 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.41 -39.0 74.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 53.340000000000003 111.147 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.8 m -80.37 -24.06 40.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.237 -0.438 . . . . 64.540000000000006 111.144 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -75.5 -38.67 59.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 75.340000000000003 110.842 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.2 t -70.94 -35.46 59.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.194 -0.457 . . . . 72.25 111.127 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 96.3 t -70.7 -38.57 73.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 72.450000000000003 111.112 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.25 -27.44 38.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 73.340000000000003 111.129 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -80.49 -34.66 35.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 72.340000000000003 111.092 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 62.6 t-105 -69.93 -40.17 75.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.232 -0.44 . . . . 73.140000000000001 110.917 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.05 -27.99 60.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 74.310000000000002 110.915 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.197 -0.456 . . . . 65.530000000000001 110.844 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 24.5 m . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.873 0.368 . . . . 72.120000000000005 111.161 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.06 -19.44 47.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 74.310000000000002 110.877 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.42 -35.9 90.81 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.787 -0.72 . . . . 70.400000000000006 112.474 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 32.3 mmt-85 -67.19 -40.17 86.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.819 0.343 . . . . 72.329999999999998 110.888 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.417 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 6.5 tt -85.53 -19.65 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 74.519999999999996 111.176 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -68.68 -36.49 78.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 75.230000000000004 110.846 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.54 ' N ' ' HD2' ' A' ' 8' ' ' PRO . . . -59.05 -56.53 35.19 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.565 0.697 . . . . 71.019999999999996 111.074 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 7' ' ' ALA . 53.7 Cg_endo -69.75 -29.34 24.08 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.709 2.273 . . . . 72.140000000000001 112.337 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -80.49 -17.35 51.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 74.329999999999998 110.825 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.584 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -57.92 -54.71 52.62 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.666 0.746 . . . . 75.219999999999999 110.909 -179.909 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.8 Cg_endo -69.75 -27.73 26.18 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.676 2.251 . . . . 63.240000000000002 112.398 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.4 t -82.11 -18.03 44.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 74.310000000000002 110.871 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.617 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -57.75 -52.63 72.95 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.673 0.749 . . . . 61.140000000000001 110.88 -179.838 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.617 ' HD2' ' N ' ' A' ' 13' ' ' SER . 54.1 Cg_endo -69.72 -23.82 30.56 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.686 2.257 . . . . 73.120000000000005 112.382 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.68 -42.09 22.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 74.230000000000004 111.129 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 10.2 tp -74.75 -34.25 33.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 73.450000000000003 111.12 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.79 -32.74 60.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 74.239999999999995 110.9 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.11 -28.57 40.62 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.771 -0.728 . . . . 50.119999999999997 112.535 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.4 mmtt -80.12 -30.82 39.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.783 0.325 . . . . 75.310000000000002 110.922 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.3 -33.79 74.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 75.209999999999994 111.098 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.85 -40.34 69.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 60.32 111.079 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.2 t -80.7 -23.43 39.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.254 -0.43 . . . . 70.439999999999998 111.114 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -74.69 -38.48 62.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 71.450000000000003 110.859 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.0 t -72.1 -35.1 52.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 74.209999999999994 111.108 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 95.4 t -69.79 -36.89 71.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 75.109999999999999 111.14 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.17 -32.93 38.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 63.130000000000003 111.12 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.03 -19.79 54.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 74.349999999999994 111.119 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -59.74 -20.94 59.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.215 -0.448 . . . . 74.239999999999995 110.913 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.91 -33.41 73.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 73.319999999999993 110.878 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 73.030000000000001 110.858 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.8 m . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.843 0.354 . . . . 64.109999999999999 111.139 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.07 -19.44 47.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.469 . . . . 75.230000000000004 110.928 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.42 -35.93 90.83 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.747 -0.74 . . . . 55.32 112.47 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -67.23 -40.11 86.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.764 0.316 . . . . 74.319999999999993 110.847 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.414 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 1.2 tt -85.51 -19.67 8.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 70.299999999999997 111.151 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -68.69 -36.48 78.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 72.049999999999997 110.869 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.54 ' N ' ' HD2' ' A' ' 8' ' ' PRO . . . -59.1 -56.53 35.17 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.534 0.683 . . . . 73.340000000000003 111.075 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 7' ' ' ALA . 53.9 Cg_endo -69.69 -29.39 24.26 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.657 2.238 . . . . 74.239999999999995 112.385 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -80.4 -17.36 52.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 72.109999999999999 110.859 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.574 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.87 -54.73 52.38 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.683 0.754 . . . . 75.030000000000001 110.901 -179.917 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 54.0 Cg_endo -69.81 -27.72 25.91 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.668 2.245 . . . . 72.230000000000004 112.348 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.4 m -82.09 -18.04 44.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 74.25 110.828 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.621 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -57.75 -52.61 73.07 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.649 0.737 . . . . 73.400000000000006 110.869 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.5 Cg_endo -69.75 -23.85 30.4 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.693 2.262 . . . . 72.150000000000006 112.345 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.68 -42.08 22.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 75.209999999999994 111.125 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 11.2 tp -74.8 -34.25 33.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.435 . . . . 65.120000000000005 111.117 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.7 mt -75.62 -32.82 60.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 75.549999999999997 110.956 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.17 -28.54 40.5 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.744 -0.741 . . . . 64.540000000000006 112.484 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -80.12 -30.83 39.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.803 0.335 . . . . 75.430000000000007 110.943 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.32 -33.77 74.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 74.5 111.075 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.83 -40.38 69.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.263 -0.426 . . . . 72.319999999999993 111.076 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.2 t -80.77 -23.26 39.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 62.32 111.136 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -74.78 -38.53 62.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 71.230000000000004 110.831 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.2 t -71.81 -35.8 56.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 74.120000000000005 111.129 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 90.5 t -70.22 -36.96 69.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 65.040000000000006 111.11 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.17 -30.83 38.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 65.230000000000004 111.107 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -80.4 -36.49 33.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.216 -0.447 . . . . 65.439999999999998 111.083 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 90.0 t90 -68.05 -40.09 82.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 71.299999999999997 110.968 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.92 -29.36 63.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 74.519999999999996 110.902 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.4 t . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 65.310000000000002 110.888 -179.894 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 6.9 m . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.864 0.364 . . . . 74.25 111.103 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.19 -19.38 47.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.148 -0.478 . . . . 75.430000000000007 110.839 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.44 -35.88 90.75 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.779 -0.724 . . . . 72.420000000000002 112.503 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 13.0 mmt85 -67.24 -40.16 86.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.817 0.341 . . . . 70.420000000000002 110.853 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.416 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 2.4 tt -85.57 -19.61 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.452 . . . . 72.239999999999995 111.133 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -68.67 -36.41 78.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 64.409999999999997 110.898 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.539 ' N ' ' HD2' ' A' ' 8' ' ' PRO . . . -59.12 -56.49 35.59 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.63 0.729 . . . . 72.25 111.121 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 7' ' ' ALA . 53.5 Cg_endo -69.77 -29.37 23.94 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.659 2.24 . . . . 73.299999999999997 112.338 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -80.39 -17.39 52.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 74.540000000000006 110.851 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.575 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -57.81 -54.77 51.86 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.679 0.752 . . . . 70.109999999999999 110.88 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.4 Cg_endo -69.77 -27.42 26.45 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.67 2.247 . . . . 74.230000000000004 112.341 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.0 m -82.25 -18.33 42.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 73.439999999999998 110.92 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.628 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -57.84 -52.25 75.82 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.683 0.754 . . . . 72.549999999999997 110.837 -179.812 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.628 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.8 Cg_endo -69.76 -23.97 30.18 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.674 2.249 . . . . 74.319999999999993 112.378 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.73 -42.04 22.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 70.239999999999995 111.068 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.7 tp -74.61 -34.22 34.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 72.519999999999996 111.189 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.3 tt -75.84 -32.67 59.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 73.310000000000002 110.919 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.19 -28.42 40.92 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.719 -0.753 . . . . 72.540000000000006 112.506 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.1 mmtp -80.08 -31.28 39.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.78 0.324 . . . . 72.430000000000007 110.879 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.04 -36.93 83.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 62.530000000000001 111.097 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.24 -39.16 75.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 73.109999999999999 111.101 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 85.8 m -80.25 -24.15 40.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.439 . . . . 74.519999999999996 111.134 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -75.44 -38.68 59.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 73.219999999999999 110.832 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.7 t -70.9 -35.42 59.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 73.430000000000007 111.151 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 94.9 t -70.37 -37.06 69.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 64.430000000000007 111.165 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.24 -30.73 38.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 60.32 111.072 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -80.34 -36.62 33.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 73.409999999999997 111.116 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 86.9 t90 -67.98 -40.15 83.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.183 -0.462 . . . . 75.140000000000001 110.908 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.92 -29.33 63.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 75.230000000000004 110.858 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.432 . . . . 72.230000000000004 110.845 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 31.4 m . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.894 0.378 . . . . 73.430000000000007 111.137 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.15 -19.62 46.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 73.010000000000005 110.88 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -65.0 -34.34 89.63 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.734 -0.746 . . . . 72.430000000000007 112.482 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.51 -39.73 81.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.779 0.323 . . . . 73.209999999999994 110.873 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.416 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 1.1 tt -85.7 -20.02 8.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 71.420000000000002 111.15 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.58 -36.4 78.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 54.229999999999997 110.87 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.539 ' N ' ' HD2' ' A' ' 8' ' ' PRO . . . -59.1 -56.58 34.71 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.557 0.694 . . . . 73.310000000000002 111.077 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 7' ' ' ALA . 54.2 Cg_endo -69.7 -29.39 24.21 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.704 2.269 . . . . 75.510000000000005 112.327 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -80.37 -17.35 52.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.229 -0.441 . . . . 64.010000000000005 110.893 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.578 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.92 -54.72 52.49 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.664 0.745 . . . . 74.239999999999995 110.9 -179.897 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.6 Cg_endo -69.74 -27.74 26.22 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.656 2.237 . . . . 75.310000000000002 112.367 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.15 -18.07 44.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 61.130000000000003 110.821 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.61 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -57.67 -52.65 72.81 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.635 0.731 . . . . 62.329999999999998 110.847 -179.831 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.6 Cg_endo -69.75 -23.23 31.07 Favored 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.724 2.283 . . . . 73.200000000000003 112.351 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.06 -42.13 21.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 64.310000000000002 111.102 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.8 tp -74.43 -34.86 37.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 71.299999999999997 111.127 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.43 -32.71 60.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 65.420000000000002 110.924 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.06 -28.4 41.5 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.735 -0.745 . . . . 63.329999999999998 112.492 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.8 mtpt -80.08 -31.53 39.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.728 0.299 . . . . 74.239999999999995 110.847 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.95 -36.74 82.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.257 -0.429 . . . . 61.539999999999999 111.139 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.29 -39.29 74.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 74.120000000000005 111.098 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 93.1 m -80.22 -24.16 40.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 73.420000000000002 111.129 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -75.37 -38.63 59.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 73.549999999999997 110.904 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.4 t -70.66 -34.88 58.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.469 . . . . 75.109999999999999 111.104 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 98.3 t -69.98 -36.81 70.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 64.549999999999997 111.097 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.12 -32.96 38.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 74.310000000000002 111.093 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.97 -20.03 55.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 75.219999999999999 111.05 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -59.84 -25.97 65.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.251 -0.431 . . . . 75.409999999999997 110.961 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -73.62 -32.59 64.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 72.439999999999998 110.878 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 28.5 t . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 72.319999999999993 110.85 -179.879 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 18.1 m . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.929 0.395 . . . . 74.010000000000005 111.137 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.09 -19.42 47.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.475 . . . . 74.340000000000003 110.938 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.39 -35.91 90.85 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.73 -0.748 . . . . 72.230000000000004 112.517 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 -67.19 -40.14 86.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.803 0.335 . . . . 73.019999999999996 110.876 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.418 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 20.2 pt -85.55 -19.72 8.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 75.329999999999998 111.154 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -68.75 -36.17 78.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 72.010000000000005 110.909 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.542 ' N ' ' HD2' ' A' ' 8' ' ' PRO . . . -59.17 -56.44 36.05 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.563 0.697 . . . . 74.129999999999995 111.124 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 7' ' ' ALA . 53.6 Cg_endo -69.78 -29.56 23.56 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.676 2.251 . . . . 71.209999999999994 112.347 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -80.29 -17.41 52.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.46 . . . . 74.120000000000005 110.817 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.575 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.79 -54.89 50.63 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.624 0.725 . . . . 74.0 110.898 -179.869 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 54.2 Cg_endo -69.78 -26.2 27.75 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.658 2.239 . . . . 75.519999999999996 112.338 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.79 -19.16 38.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 73.420000000000002 110.859 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.621 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 1.9 t -57.64 -52.14 76.51 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.688 0.756 . . . . 72.239999999999995 110.851 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 13' ' ' SER . 54.3 Cg_endo -69.64 -24.81 29.79 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.7 2.267 . . . . 74.430000000000007 112.364 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.3 -40.62 26.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 74.549999999999997 111.091 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 70.4 mt -72.31 -40.25 64.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 75.299999999999997 111.186 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.1 tt -71.47 -32.21 68.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 73.430000000000007 110.931 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.46 -28.87 42.09 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.706 -0.759 . . . . 74.239999999999995 112.524 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -80.05 -31.92 39.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.845 0.355 . . . . 71.409999999999997 110.94 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.92 -36.59 82.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.447 . . . . 72.150000000000006 111.091 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.47 -39.13 74.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 70.420000000000002 111.1 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.9 m -80.26 -24.13 40.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 73.140000000000001 111.185 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -75.39 -38.72 59.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 72.010000000000005 110.853 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 91.7 t -70.63 -35.11 59.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 71.140000000000001 111.099 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 96.9 t -69.86 -36.73 70.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 53.5 111.135 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.18 -32.93 38.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 74.129999999999995 111.083 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.94 -20.0 54.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 75.219999999999999 111.141 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -59.88 -26.03 65.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 71.310000000000002 110.914 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.36 -32.7 64.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.254 -0.43 . . . . 75.349999999999994 110.942 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.8 t . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 74.239999999999995 110.907 -179.953 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.8 m . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.889 0.376 . . . . 64.010000000000005 111.142 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.06 -19.5 47.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 72.329999999999998 110.874 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.4 -35.89 90.81 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.712 -0.756 . . . . 64.540000000000006 112.521 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.2 mmm180 -67.2 -40.16 86.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.787 0.327 . . . . 75.209999999999994 110.856 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.417 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 19.9 pt -85.49 -19.74 8.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 74.239999999999995 111.129 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -68.81 -36.1 77.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 75.109999999999999 110.874 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.542 ' N ' ' HD2' ' A' ' 8' ' ' PRO . . . -59.2 -56.46 35.81 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.582 0.706 . . . . 73.25 111.097 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 7' ' ' ALA . 53.7 Cg_endo -69.74 -29.58 23.71 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.705 2.27 . . . . 74.129999999999995 112.333 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -80.27 -17.3 52.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 75.540000000000006 110.941 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.572 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.83 -54.94 50.18 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.69 0.757 . . . . 73.549999999999997 110.882 -179.901 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 54.1 Cg_endo -69.75 -26.14 27.92 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.655 2.237 . . . . 73.239999999999995 112.369 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.1 m -82.82 -19.22 38.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.461 . . . . 73.239999999999995 110.862 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.625 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 1.9 t -57.57 -52.09 76.91 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.673 0.749 . . . . 55.329999999999998 110.889 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.625 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.9 Cg_endo -69.83 -24.67 29.09 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.663 2.242 . . . . 74.209999999999994 112.336 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.32 -40.59 26.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.28 -0.418 . . . . 72.439999999999998 111.081 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 24.0 mm -72.32 -40.3 64.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 72.120000000000005 111.173 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.7 tt -71.44 -32.19 68.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 74.109999999999999 110.909 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.54 -28.83 41.91 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.753 -0.737 . . . . 70.219999999999999 112.472 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.8 mttm -80.08 -31.99 39.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.866 0.365 . . . . 74.409999999999997 110.905 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.86 -36.67 82.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 75.25 111.066 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.44 -39.11 74.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 72.430000000000007 111.101 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.3 m -80.33 -24.09 40.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.204 -0.453 . . . . 74.209999999999994 111.143 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -75.47 -38.63 59.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 65.109999999999999 110.88 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.6 t -70.93 -35.53 60.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 65.409999999999997 111.122 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.5 t -70.34 -37.0 69.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 75.219999999999999 111.13 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.22 -30.74 38.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 72.349999999999994 111.082 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -80.4 -36.53 33.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 75.450000000000003 111.132 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 68.2 t-105 -68.02 -40.13 83.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.451 . . . . 75.329999999999998 110.954 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.92 -29.37 63.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 74.040000000000006 110.895 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 73.230000000000004 110.834 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.7 m . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.888 0.375 . . . . 75.310000000000002 111.179 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.18 -19.21 47.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.453 . . . . 74.219999999999999 110.916 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -65.36 -35.64 91.7 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.77 -0.729 . . . . 70.530000000000001 112.473 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 9.4 mmm-85 -67.36 -40.23 85.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.766 0.317 . . . . 75.200000000000003 110.862 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.416 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 9.1 tt -85.66 -19.64 8.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 74.25 111.144 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -68.71 -36.31 78.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 72.129999999999995 110.876 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.539 ' N ' ' HD2' ' A' ' 8' ' ' PRO . . . -59.17 -56.51 35.31 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.615 0.721 . . . . 51.340000000000003 111.108 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 7' ' ' ALA . 53.3 Cg_endo -69.82 -29.3 23.77 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.632 2.221 . . . . 73.530000000000001 112.339 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -80.43 -17.34 52.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 53.409999999999997 110.871 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.577 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.92 -54.74 52.36 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.605 0.717 . . . . 74.450000000000003 110.855 -179.877 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.8 Cg_endo -69.74 -27.41 26.61 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.714 2.276 . . . . 63.25 112.318 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.6 t -82.3 -18.43 42.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.43 . . . . 60.130000000000003 110.877 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.628 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -57.79 -52.24 75.82 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.662 0.744 . . . . 75.299999999999997 110.858 -179.819 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.628 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.8 Cg_endo -69.73 -24.03 30.26 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.661 2.241 . . . . 55.229999999999997 112.321 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.7 -42.02 22.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 75.510000000000005 111.092 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.6 tp -74.58 -34.29 34.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 73.239999999999995 111.162 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 30.6 mt -75.75 -32.77 60.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.12 -0.491 . . . . 72.200000000000003 110.902 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.1 -28.46 41.08 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.747 -0.739 . . . . 73.319999999999993 112.518 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.4 mttp -80.07 -31.24 39.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.809 0.338 . . . . 73.239999999999995 110.91 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.16 -36.64 82.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 70.450000000000003 111.104 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.37 -39.22 74.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.434 . . . . 72.129999999999995 111.08 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.1 m -80.3 -24.04 40.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 75.25 111.131 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -75.43 -38.58 59.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 72.109999999999999 110.853 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.7 t -71.1 -35.44 58.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.446 . . . . 65.040000000000006 111.106 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 95.9 t -70.37 -37.12 69.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 74.150000000000006 111.11 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.17 -30.69 38.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 70.109999999999999 111.1 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -80.39 -36.69 33.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 72.329999999999998 111.042 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 50.4 t90 -68.0 -40.06 83.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.434 . . . . 74.140000000000001 110.919 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.99 -29.26 62.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.285 -0.416 . . . . 73.099999999999994 110.849 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 10.6 t . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.248 -0.433 . . . . 73.219999999999999 110.833 -179.871 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.5 t . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.861 0.363 . . . . 71.430000000000007 111.096 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.14 -19.59 46.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.457 . . . . 73.340000000000003 110.92 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -65.06 -34.2 89.17 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.706 -0.759 . . . . 74.340000000000003 112.545 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -68.53 -39.81 81.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.82 0.343 . . . . 72.420000000000002 110.876 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.416 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 28.9 pt -85.65 -19.99 8.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 75.549999999999997 111.164 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.6 -36.4 78.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.189 -0.46 . . . . 75.430000000000007 110.878 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.537 ' N ' ' HD2' ' A' ' 8' ' ' PRO . . . -59.09 -56.53 35.22 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.587 0.708 . . . . 61.350000000000001 111.108 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 7' ' ' ALA . 53.9 Cg_endo -69.79 -29.27 23.98 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.661 2.241 . . . . 65.450000000000003 112.389 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -80.45 -17.38 51.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 74.430000000000007 110.859 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.58 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.91 -54.71 52.64 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.664 0.745 . . . . 75.140000000000001 110.918 -179.916 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.4 Cg_endo -69.79 -27.77 25.93 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.69 2.26 . . . . 74.540000000000006 112.332 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.04 -18.09 44.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 74.019999999999996 110.836 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.611 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -57.75 -52.56 73.47 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.676 0.75 . . . . 71.329999999999998 110.885 -179.804 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.611 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.7 Cg_endo -69.76 -23.85 30.34 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.713 2.275 . . . . 74.219999999999999 112.33 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.69 -42.07 22.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 74.420000000000002 111.114 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.6 tp -74.76 -34.3 33.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 75.409999999999997 111.111 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 51.1 tp -75.66 -32.71 60.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 74.239999999999995 110.958 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.22 -28.54 40.3 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.757 -0.735 . . . . 62.140000000000001 112.419 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.9 mtpp -80.12 -30.83 39.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.752 0.31 . . . . 73.299999999999997 110.889 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.28 -33.83 75.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.283 -0.417 . . . . 71.530000000000001 111.071 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.81 -40.41 69.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 63.229999999999997 111.048 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.2 t -80.71 -23.38 39.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 74.340000000000003 111.111 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -74.72 -38.49 62.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 62.509999999999998 110.87 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 94.2 t -71.94 -35.12 53.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 62.140000000000001 111.151 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 96.1 t -69.79 -36.86 71.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 73.340000000000003 111.125 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.22 -32.9 38.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 71.409999999999997 111.128 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.01 -19.83 54.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 72.230000000000004 111.127 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -59.67 -20.99 59.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 73.430000000000007 110.922 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.95 -33.3 73.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 75.430000000000007 110.907 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 75.200000000000003 110.844 -179.916 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.9 m . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.854 0.359 . . . . 74.010000000000005 111.155 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.07 -19.48 47.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 71.439999999999998 110.902 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.4 -35.95 90.9 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.794 -0.717 . . . . 64.340000000000003 112.473 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 79.8 mtt180 -67.16 -40.15 86.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.758 0.313 . . . . 74.349999999999994 110.853 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.417 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 14.7 tt -85.49 -19.75 8.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 75.540000000000006 111.138 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -68.75 -36.15 78.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 73.420000000000002 110.823 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.542 ' N ' ' HD2' ' A' ' 8' ' ' PRO . . . -59.24 -56.47 35.74 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.604 0.716 . . . . 75.099999999999994 111.101 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 7' ' ' ALA . 53.9 Cg_endo -69.75 -29.39 24.01 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.676 2.25 . . . . 73.25 112.371 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -80.54 -17.22 52.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 74.109999999999999 110.89 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.581 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -58.02 -54.45 55.46 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.659 0.742 . . . . 62.109999999999999 110.887 -179.883 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.8 Cg_endo -69.74 -27.35 26.69 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.7 2.266 . . . . 73.209999999999994 112.321 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.42 -19.1 39.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 74.099999999999994 110.865 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.635 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -56.09 -52.07 75.66 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.633 0.73 . . . . 72.329999999999998 110.83 -179.778 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.635 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.5 Cg_endo -69.78 -20.24 35.0 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.675 2.25 . . . . 71.109999999999999 112.36 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.9 -42.54 19.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.434 . . . . 75.530000000000001 111.089 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 22.2 pt -74.29 -35.91 41.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 74.019999999999996 111.099 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -74.32 -32.81 62.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 72.219999999999999 110.901 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.04 -28.64 40.66 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.743 -0.741 . . . . 72.040000000000006 112.489 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.0 mtpt -80.19 -30.44 38.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.762 0.315 . . . . 73.150000000000006 110.838 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.49 -34.48 75.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.284 -0.416 . . . . 74.340000000000003 111.089 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.61 -40.24 69.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 64.209999999999994 111.073 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.3 t -80.75 -22.59 40.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 60.439999999999998 111.148 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -75.76 -38.53 58.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 73.310000000000002 110.903 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 96.3 t -67.83 -40.34 83.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 74.409999999999997 111.146 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.2 p -69.56 -34.28 60.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 74.329999999999998 111.171 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.25 -29.13 38.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.126 -0.488 . . . . 53.030000000000001 111.133 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.98 -19.94 54.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 54.140000000000001 111.109 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 13.0 t-105 -59.95 -28.52 67.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 62.420000000000002 110.934 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.1 ptmt -70.1 -32.57 70.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 75.340000000000003 110.958 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.1 t . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 72.439999999999998 110.864 -179.892 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 31.6 m . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.898 0.38 . . . . 74.219999999999999 111.112 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.14 -19.44 47.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.141 -0.481 . . . . 73.340000000000003 110.895 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.42 -35.89 90.78 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.705 -0.759 . . . . 74.319999999999993 112.499 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 26.4 mmt85 -67.17 -40.2 86.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.813 0.339 . . . . 73.510000000000005 110.84 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.418 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 31.4 pt -85.5 -19.69 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 73.540000000000006 111.137 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -68.81 -36.12 77.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.458 . . . . 64.219999999999999 110.887 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.538 ' N ' ' HD2' ' A' ' 8' ' ' PRO . . . -59.21 -56.47 35.72 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.599 0.714 . . . . 74.310000000000002 111.113 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 7' ' ' ALA . 54.4 Cg_endo -69.71 -29.56 23.92 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.714 2.276 . . . . 73.349999999999994 112.395 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -80.34 -17.3 52.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 71.129999999999995 110.897 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.578 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.82 -54.95 50.07 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.632 0.73 . . . . 75.319999999999993 110.884 -179.906 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.7 Cg_endo -69.7 -26.17 28.11 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.716 2.277 . . . . 73.239999999999995 112.363 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.7 t -82.88 -19.14 37.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 62.109999999999999 110.857 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.627 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 2.0 t -57.63 -51.96 77.88 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.665 0.745 . . . . 74.420000000000002 110.886 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 13' ' ' SER . 54.0 Cg_endo -69.77 -24.08 30.03 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.693 2.262 . . . . 71.540000000000006 112.387 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.67 -42.02 22.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 64.0 111.101 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 12.4 tt -74.62 -34.29 34.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 62.119999999999997 111.083 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.9 tp -75.74 -32.75 60.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 73.129999999999995 110.899 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.19 -28.36 41.11 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.695 -0.764 . . . . 61.310000000000002 112.462 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.8 mttt -80.11 -31.29 39.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.752 0.311 . . . . 75.400000000000006 110.882 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.76 -39.97 88.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 73.439999999999998 111.133 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.24 -37.07 77.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 74.219999999999999 111.084 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.0 m -80.32 -24.74 39.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.25 -0.432 . . . . 51.450000000000003 111.161 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -77.39 -37.49 51.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 72.040000000000006 110.882 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 91.5 t -71.08 -40.1 75.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.448 . . . . 74.310000000000002 111.184 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.0 p -68.67 -33.82 61.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 71.0 111.105 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.29 -32.56 38.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 74.140000000000001 111.028 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.01 -19.94 55.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 43.329999999999998 111.051 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -59.95 -30.72 69.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.245 -0.434 . . . . 74.140000000000001 110.905 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.5 ptmm? -67.36 -32.64 73.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 73.129999999999995 110.921 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.4 p . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.223 -0.444 . . . . 64.340000000000003 110.889 -179.917 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.4 t . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.902 0.382 . . . . 75.549999999999997 111.117 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.8 pptp? -80.18 -19.61 46.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.459 . . . . 75.25 110.891 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -65.02 -34.36 89.65 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.719 -0.753 . . . . 74.340000000000003 112.472 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 -68.48 -39.76 81.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.766 0.317 . . . . 75.120000000000005 110.866 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.416 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 29.4 pt -85.68 -19.99 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 73.409999999999997 111.102 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.64 -36.31 78.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 71.25 110.905 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.54 ' N ' ' HD2' ' A' ' 8' ' ' PRO . . . -59.11 -56.58 34.63 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.613 0.72 . . . . 72.420000000000002 111.068 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 7' ' ' ALA . 53.7 Cg_endo -69.78 -29.34 23.92 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.687 2.258 . . . . 74.310000000000002 112.313 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -80.4 -17.28 52.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.221 -0.445 . . . . 74.230000000000004 110.922 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.579 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.95 -54.75 52.27 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.634 0.731 . . . . 72.349999999999994 110.851 -179.918 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.8 Cg_endo -69.78 -27.71 26.07 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.741 2.294 . . . . 61.240000000000002 112.33 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.3 m -82.19 -17.99 44.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 63.439999999999998 110.844 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.625 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.2 OUTLIER -57.78 -52.62 73.08 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.68 0.752 . . . . 73.25 110.842 -179.838 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.625 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.7 Cg_endo -69.75 -23.85 30.39 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.73 2.287 . . . . 72.409999999999997 112.341 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.7 -41.99 22.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 64.109999999999999 111.153 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 15.4 tt -74.76 -34.33 33.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 71.519999999999996 111.125 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.66 -32.73 60.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 74.200000000000003 110.893 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.24 -28.52 40.31 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.792 -0.718 . . . . 73.150000000000006 112.434 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -80.2 -30.84 38.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.74 0.305 . . . . 73.510000000000005 110.873 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.34 -33.69 74.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 62.130000000000003 111.134 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.88 -40.37 68.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 74.019999999999996 111.099 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.3 t -80.65 -23.4 39.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 72.150000000000006 111.188 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -75.18 -37.82 61.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 74.25 110.881 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 85.7 t -72.77 -35.7 50.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.228 -0.442 . . . . 74.299999999999997 111.125 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 95.9 t -70.17 -37.3 71.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 72.109999999999999 111.137 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.23 -30.57 38.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 74.209999999999994 111.073 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -80.36 -36.79 33.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 60.240000000000002 111.104 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 30.2 t90 -67.91 -40.13 83.44 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.196 -0.456 . . . . 75.219999999999999 110.938 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.89 -29.3 63.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 74.450000000000003 110.92 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.5 m . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.236 -0.438 . . . . 74.310000000000002 110.87 -179.915 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 18.4 m . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.886 0.374 . . . . 74.430000000000007 111.137 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.07 -19.48 47.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 75.340000000000003 110.878 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.42 -35.89 90.78 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.688 -0.768 . . . . 70.420000000000002 112.537 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.3 mtt180 -67.15 -40.11 86.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.853 0.359 . . . . 74.409999999999997 110.891 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.413 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 10.7 tp -85.55 -19.81 8.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 73.530000000000001 111.167 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -68.55 -36.43 78.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 74.420000000000002 110.86 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.541 ' N ' ' HD2' ' A' ' 8' ' ' PRO . . . -59.06 -56.62 34.32 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.581 0.705 . . . . 73.25 111.089 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 7' ' ' ALA . 53.3 Cg_endo -69.74 -29.27 24.22 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.696 2.264 . . . . 64.010000000000005 112.326 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -80.54 -17.32 51.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 74.519999999999996 110.806 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.577 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.93 -54.67 53.02 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.696 0.76 . . . . 72.329999999999998 110.866 -179.884 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.8 Cg_endo -69.69 -27.71 26.45 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.705 2.27 . . . . 71.129999999999995 112.386 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m -82.16 -18.34 43.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.46 . . . . 71.010000000000005 110.872 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.625 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -57.2 -52.55 73.32 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.667 0.746 . . . . 75.209999999999994 110.88 -179.823 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.625 ' HD2' ' N ' ' A' ' 13' ' ' SER . 54.0 Cg_endo -69.76 -23.48 30.77 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.659 2.24 . . . . 74.340000000000003 112.3 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.56 -41.67 23.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.26 -0.427 . . . . 63.549999999999997 111.091 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 33.6 mm -72.41 -40.07 63.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.462 . . . . 74.219999999999999 111.16 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -71.83 -31.87 66.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 72.530000000000001 110.911 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.61 -28.93 41.21 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.715 -0.755 . . . . 62.329999999999998 112.534 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.8 mtpp -80.05 -32.17 39.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.731 0.301 . . . . 75.219999999999999 110.881 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.83 -36.64 82.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 72.109999999999999 111.134 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.42 -39.09 74.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 64.400000000000006 111.122 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.9 m -80.31 -24.11 40.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 71.25 111.163 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -75.38 -38.94 59.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 74.329999999999998 110.802 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.6 t -70.35 -35.02 60.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 75.409999999999997 111.167 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 96.7 t -69.94 -36.7 70.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 72.230000000000004 111.123 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.21 -32.81 38.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.481 . . . . 71.109999999999999 111.093 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.03 -19.96 55.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.271 -0.422 . . . . 72.239999999999995 111.105 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 9.9 t90 -59.93 -27.59 66.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.457 . . . . 73.219999999999999 110.932 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.32 -32.61 68.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 71.25 110.922 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.9 t . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.445 . . . . 73.340000000000003 110.883 -179.917 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 31.1 m . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.865 0.364 . . . . 74.209999999999994 111.168 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.09 -18.72 45.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 74.5 110.882 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -67.37 -34.34 84.74 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.725 -0.75 . . . . 64.319999999999993 112.508 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -69.99 -37.59 75.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.815 0.34 . . . . 74.519999999999996 110.826 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.408 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 11.6 tt -87.09 -19.88 7.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 73.510000000000005 111.149 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -69.47 -36.57 76.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 64.040000000000006 110.854 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.548 ' N ' ' HD2' ' A' ' 8' ' ' PRO . . . -59.09 -56.2 38.6 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.557 0.694 . . . . 61.340000000000003 111.068 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 7' ' ' ALA . 53.8 Cg_endo -69.76 -29.56 23.66 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.69 2.26 . . . . 74.400000000000006 112.346 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -80.4 -17.31 52.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 74.349999999999994 110.896 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.586 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -57.83 -54.81 51.51 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.648 0.737 . . . . 75.109999999999999 110.876 -179.901 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 54.2 Cg_endo -69.71 -27.76 26.3 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.73 2.287 . . . . 73.430000000000007 112.324 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.1 -18.04 44.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 73.25 110.856 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.619 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -57.75 -52.59 73.23 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.657 0.741 . . . . 55.25 110.869 -179.832 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.5 Cg_endo -69.8 -23.79 30.21 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.664 2.243 . . . . 63.130000000000003 112.351 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.75 -41.98 22.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.227 -0.442 . . . . 62.439999999999998 111.086 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 11.2 tp -74.82 -34.24 32.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 72.319999999999993 111.113 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.3 tp -75.86 -32.6 59.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 74.239999999999995 110.925 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.21 -28.43 40.8 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.708 -0.758 . . . . 74.239999999999995 112.526 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.3 mttt -80.0 -31.36 39.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.823 0.344 . . . . 74.0 110.938 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.05 -36.65 82.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 73.450000000000003 111.089 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.29 -39.4 74.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.244 -0.434 . . . . 63.009999999999998 111.081 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.4 m -80.27 -24.0 40.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 63.310000000000002 111.14 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -75.39 -38.63 59.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.438 . . . . 65.310000000000002 110.857 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.8 t -70.83 -35.14 58.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.202 -0.454 . . . . 73.239999999999995 111.142 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 96.2 t -69.87 -36.67 70.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 70.219999999999999 111.141 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.17 -32.91 38.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.465 . . . . 74.219999999999999 111.111 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -80.12 -19.82 46.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 75.420000000000002 111.087 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -59.77 -22.94 62.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 74.040000000000006 110.917 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.34 -33.23 74.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 73.209999999999994 110.922 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 74.420000000000002 110.844 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.8 t . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.9 0.381 . . . . 73.510000000000005 111.114 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.15 -19.61 46.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 73.310000000000002 110.876 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.29 -35.94 91.0 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.742 -0.742 . . . . 73.430000000000007 112.51 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 44.5 mmm-85 -67.19 -40.16 86.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.777 0.323 . . . . 73.299999999999997 110.866 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.42 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 0.8 OUTLIER -85.52 -19.75 8.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.46 . . . . 65.409999999999997 111.107 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -68.77 -36.17 77.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.46 . . . . 72.019999999999996 110.831 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.537 ' N ' ' HD2' ' A' ' 8' ' ' PRO . . . -59.16 -56.52 35.25 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.607 0.718 . . . . 71.299999999999997 111.083 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 7' ' ' ALA . 53.4 Cg_endo -69.78 -29.46 23.72 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.665 2.243 . . . . 73.129999999999995 112.345 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -80.36 -17.34 52.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 71.409999999999997 110.864 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.581 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.89 -54.72 52.52 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.668 0.747 . . . . 74.530000000000001 110.883 -179.866 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.6 Cg_endo -69.79 -27.77 25.92 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.732 2.288 . . . . 73.340000000000003 112.298 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.1 -18.0 44.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.272 -0.422 . . . . 72.349999999999994 110.9 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.613 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -57.85 -52.58 73.34 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.638 0.732 . . . . 73.340000000000003 110.811 -179.806 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.9 Cg_endo -69.75 -23.79 30.46 Favored 'Trans proline' 0 C--N 1.341 0.132 0 C-N-CA 122.682 2.255 . . . . 75.099999999999994 112.367 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.78 -41.98 22.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 74.129999999999995 111.095 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.1 tp -74.82 -34.25 32.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.431 . . . . 74.540000000000006 111.111 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.7 tp -75.74 -32.7 60.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.461 . . . . 74.430000000000007 110.933 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.22 -28.49 40.5 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.746 -0.74 . . . . 54.119999999999997 112.481 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -80.04 -31.1 39.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.841 0.353 . . . . 75.209999999999994 110.931 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.95 -40.08 87.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 72.409999999999997 111.07 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.48 -37.44 77.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 70.219999999999999 111.131 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.6 m -80.46 -23.27 40.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 74.230000000000004 111.166 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -77.92 -38.86 44.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 74.400000000000006 110.905 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 99.3 t -66.19 -40.31 86.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 74.510000000000005 111.133 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.5 m -68.92 -31.91 52.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 74.230000000000004 111.094 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.48 -34.18 36.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 54.509999999999998 111.105 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.0 -19.96 55.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 74.450000000000003 111.081 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -59.9 -25.65 65.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.244 -0.434 . . . . 72.219999999999999 110.907 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.46 -32.82 74.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.252 -0.431 . . . . 74.439999999999998 110.88 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.9 t . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 75.129999999999995 110.833 -179.897 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.3 t . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.875 0.369 . . . . 73.420000000000002 111.139 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.09 -19.44 47.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 74.540000000000006 110.906 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.46 -35.98 90.87 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.726 -0.749 . . . . 75.140000000000001 112.459 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.7 mmt-85 -67.05 -40.14 87.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.773 0.321 . . . . 65.5 110.915 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.42 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 1.1 tt -85.55 -19.73 8.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 72.439999999999998 111.084 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -68.74 -36.15 78.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.207 -0.451 . . . . 75.010000000000005 110.86 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.542 ' N ' ' HD2' ' A' ' 8' ' ' PRO . . . -59.23 -56.47 35.7 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.572 0.701 . . . . 73.430000000000007 111.126 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 7' ' ' ALA . 54.0 Cg_endo -69.75 -29.4 24.0 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.705 2.27 . . . . 64.340000000000003 112.342 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -80.54 -17.26 52.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.242 -0.436 . . . . 70.140000000000001 110.866 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.587 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.98 -54.44 55.52 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.646 0.736 . . . . 75.230000000000004 110.941 -179.928 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.8 Cg_endo -69.77 -27.31 26.56 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.661 2.241 . . . . 65.109999999999999 112.342 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.46 -19.11 39.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 73.530000000000001 110.802 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.634 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.2 OUTLIER -55.99 -52.14 74.91 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.689 0.757 . . . . 73.209999999999994 110.874 -179.83 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.634 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.6 Cg_endo -69.79 -20.58 34.49 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.687 2.258 . . . . 73.530000000000001 112.302 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.42 -42.38 20.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.283 -0.417 . . . . 71.430000000000007 111.08 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.1 pt -75.73 -35.17 30.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 71.450000000000003 111.115 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.55 -30.57 57.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 74.200000000000003 110.947 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.54 -29.78 35.04 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.706 -0.759 . . . . 71.200000000000003 112.467 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.9 -31.28 35.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.786 0.327 . . . . 72.209999999999994 110.884 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.12 -33.75 75.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 64.340000000000003 111.081 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.86 -40.37 69.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 74.230000000000004 111.117 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.2 t -80.77 -23.33 39.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.215 -0.448 . . . . 63.420000000000002 111.121 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -74.7 -38.51 62.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.24 -0.436 . . . . 65.420000000000002 110.863 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.1 t -72.02 -35.06 52.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 74.329999999999998 111.121 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 95.9 t -69.82 -36.85 71.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.46 . . . . 73.530000000000001 111.157 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.19 -32.95 38.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 74.120000000000005 111.11 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.98 -19.94 54.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 75.420000000000002 111.112 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 27.0 t90 -59.95 -26.11 65.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.205 -0.452 . . . . 73.219999999999999 110.885 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.2 ptmt -73.32 -32.62 64.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.279 -0.419 . . . . 75.430000000000007 110.914 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.9 t . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 72.430000000000007 110.862 -179.886 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.834 0.35 . . . . 74.42 110.874 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.42 -35.88 90.77 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.762 -0.732 . . . . 74.53 112.543 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.15 -40.17 86.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.767 0.318 . . . . 72.33 110.844 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.407 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 1.6 tt -85.52 -19.74 8.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 71.25 111.126 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -68.77 -36.15 77.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.143 -0.481 . . . . 70.02 110.872 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.708 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.2 -56.41 36.3 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.644 0.735 . . . . 73.15 111.144 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.708 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 53.5 Cg_endo -69.82 -29.48 23.51 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.663 2.242 . . . . 62.31 112.316 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -80.43 -17.24 52.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.435 . . . . 73.0 110.862 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.586 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.87 -54.8 51.68 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.632 0.729 . . . . 60.11 110.894 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.9 Cg_endo -69.75 -27.78 26.08 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.695 2.263 . . . . 71.12 112.344 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.03 -18.0 44.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.441 . . . . 73.33 110.879 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.62 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -57.79 -52.72 72.35 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.696 0.76 . . . . 75.21 110.861 -179.823 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.62 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.6 Cg_endo -69.76 -24.5 29.6 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.691 2.261 . . . . 70.13 112.344 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.32 -40.85 25.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 74.53 111.068 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 23.9 mm -72.19 -40.44 65.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 75.52 111.132 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.4 mt -71.9 -30.23 65.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.469 . . . . 74.44 110.923 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.44 -30.29 37.34 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.712 -0.756 . . . . 51.44 112.493 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.438 ' HA ' HG22 ' A' ' 22' ' ' THR . 0.0 OUTLIER -80.09 -32.65 39.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.811 0.338 . . . . 72.41 110.882 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.655 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -67.65 -33.19 74.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.251 -0.432 . . . . 54.45 111.113 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.647 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -72.18 -40.49 67.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 72.54 111.122 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.438 HG22 ' HA ' ' A' ' 19' ' ' LYS . 9.1 t -80.79 -23.3 39.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 61.12 111.154 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -74.63 -38.55 62.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 75.35 110.911 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 20' ' ' ALA . 94.4 t -71.99 -35.1 52.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 74.34 111.159 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 21' ' ' ALA . 96.5 t -69.85 -36.88 71.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 74.43 111.091 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.23 -32.92 38.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 64.03 111.105 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 61.35 111.115 179.889 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.07 0 CA-C-O 120.888 0.375 . . . . 75.23 110.91 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.42 -35.86 90.74 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.784 -0.722 . . . . 72.14 112.474 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -67.27 -40.08 86.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.759 0.314 . . . . 74.13 110.875 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.408 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 4.0 tt -85.61 -19.62 8.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.2 -0.454 . . . . 71.51 111.105 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -68.76 -36.4 78.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 74.05 110.85 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.706 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.14 -56.49 35.53 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.567 0.699 . . . . 74.54 111.077 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.706 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 53.9 Cg_endo -69.75 -29.35 24.04 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.715 2.277 . . . . 61.32 112.34 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -80.44 -17.35 52.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.258 -0.428 . . . . 72.52 110.894 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.594 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.93 -54.67 53.1 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.628 0.728 . . . . 75.24 110.902 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.8 Cg_endo -69.74 -27.9 26.01 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.705 2.27 . . . . 64.13 112.357 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.96 -18.09 44.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.436 . . . . 71.42 110.84 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.625 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -57.73 -52.83 71.49 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.66 0.743 . . . . 74.11 110.794 -179.755 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.625 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.6 Cg_endo -69.73 -24.39 29.88 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.717 2.278 . . . . 74.15 112.336 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.22 -40.53 26.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 51.3 111.085 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 54.8 mt -73.25 -39.88 56.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 64.42 111.122 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.23 -29.65 62.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 41.34 110.921 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.84 -30.46 35.4 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.763 -0.732 . . . . 75.15 112.473 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.439 ' HA ' HG22 ' A' ' 22' ' ' THR . 50.8 pttt -80.8 -31.9 35.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.797 0.332 . . . . 73.02 110.916 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.65 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -67.89 -33.44 74.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 73.14 111.141 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.649 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -72.05 -40.43 68.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 74.04 111.063 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.439 HG22 ' HA ' ' A' ' 19' ' ' LYS . 9.0 t -80.78 -23.34 39.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 74.44 111.104 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -74.68 -38.51 62.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 73.14 110.874 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 20' ' ' ALA . 93.6 t -72.03 -35.12 52.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 75.52 111.123 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 21' ' ' ALA . 95.2 t -69.81 -36.86 71.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 70.44 111.11 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.17 -32.96 38.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 73.44 111.111 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 71.21 111.085 179.935 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.861 0.363 . . . . 74.1 110.923 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.42 -35.89 90.77 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.761 -0.733 . . . . 60.51 112.499 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 11.6 mtm180 -67.24 -40.09 86.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.788 0.328 . . . . 71.55 110.903 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.402 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 4.7 tt -85.59 -19.65 8.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 74.34 111.087 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -68.7 -36.47 78.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 73.33 110.88 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.706 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.06 -56.48 35.73 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.567 0.699 . . . . 62.55 111.124 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.706 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 53.5 Cg_endo -69.83 -29.33 23.71 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.653 2.235 . . . . 55.05 112.319 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -80.46 -17.31 52.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 74.34 110.805 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.586 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.91 -54.76 52.06 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.664 0.745 . . . . 64.22 110.862 -179.87 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.8 Cg_endo -69.71 -27.82 26.23 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.71 2.273 . . . . 71.04 112.363 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.9 m -82.01 -18.03 44.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 74.35 110.857 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.629 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -57.84 -52.69 72.54 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.617 0.722 . . . . 55.14 110.848 -179.769 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.629 ' HD2' ' N ' ' A' ' 13' ' ' SER . 54.4 Cg_endo -69.75 -24.54 29.61 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.624 2.216 . . . . 75.43 112.378 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.26 -40.63 26.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 71.34 111.092 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 24.1 mm -72.53 -40.24 62.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 65.11 111.151 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.9 tp -71.47 -32.12 67.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.21 -0.45 . . . . 72.21 110.916 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.56 -28.97 41.27 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.712 -0.756 . . . . 52.03 112.458 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.433 ' HA ' HG22 ' A' ' 22' ' ' THR . 26.0 mttm -80.17 -31.53 38.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.774 0.321 . . . . 74.22 110.886 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.647 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -68.11 -33.42 74.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 75.22 111.116 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.653 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -72.09 -40.4 68.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 64.51 111.064 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.433 HG22 ' HA ' ' A' ' 19' ' ' LYS . 9.2 t -80.77 -23.28 39.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.209 -0.451 . . . . 72.12 111.181 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -74.98 -38.07 61.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 62.41 110.899 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 20' ' ' ALA . 85.2 t -72.36 -35.14 51.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 71.5 111.164 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 21' ' ' ALA . 94.8 t -69.83 -36.83 71.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 64.34 111.14 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.24 -32.84 38.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 54.03 111.102 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 54.43 111.119 179.946 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.05 0 CA-C-O 120.793 0.33 . . . . 74.13 110.914 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -65.34 -35.66 91.74 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.74 -0.743 . . . . 72.11 112.491 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.2 mmm-85 -67.32 -40.21 85.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.777 0.322 . . . . 61.1 110.882 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.406 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 1.3 tt -85.68 -19.64 8.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 54.02 111.125 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -68.69 -36.34 78.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 72.24 110.882 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.71 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.23 -56.47 35.72 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.589 0.709 . . . . 70.34 111.099 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.71 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 54.5 Cg_endo -69.72 -29.4 24.13 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.691 2.26 . . . . 61.32 112.35 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -80.48 -17.27 52.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 74.04 110.87 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.59 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.91 -54.75 52.18 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.622 0.725 . . . . 64.21 110.864 -179.919 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 54.3 Cg_endo -69.74 -27.8 26.13 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.677 2.251 . . . . 74.33 112.361 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.7 m -82.05 -18.0 44.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 52.24 110.828 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.619 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -57.79 -52.69 72.56 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.69 0.757 . . . . 74.14 110.871 -179.816 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.7 Cg_endo -69.8 -24.56 29.34 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.697 2.265 . . . . 63.01 112.313 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.24 -40.66 26.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 72.3 111.124 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 15.8 mt -72.51 -40.27 63.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 54.12 111.134 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.6 tt -71.41 -32.15 68.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 63.33 110.989 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.55 -28.93 41.43 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.72 -0.752 . . . . 73.32 112.508 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.436 ' HA ' HG22 ' A' ' 22' ' ' THR . 9.2 mttm -80.16 -31.53 38.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.835 0.35 . . . . 74.03 110.889 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.654 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -68.07 -33.57 74.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.44 . . . . 71.53 111.083 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.651 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -71.95 -40.42 68.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.438 . . . . 51.43 111.061 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.436 HG22 ' HA ' ' A' ' 19' ' ' LYS . 9.2 t -80.76 -23.33 39.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.264 -0.425 . . . . 74.13 111.126 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.68 -38.56 62.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.461 . . . . 75.43 110.879 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 20' ' ' ALA . 94.2 t -71.96 -35.19 53.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.174 -0.467 . . . . 73.13 111.146 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 21' ' ' ALA . 95.8 t -69.78 -36.84 71.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.485 . . . . 62.11 111.119 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.22 -33.0 38.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 75.5 111.079 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.434 . . . . 53.34 111.125 179.919 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.817 0.341 . . . . 71.42 110.884 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.44 -35.87 90.74 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.77 -0.729 . . . . 62.21 112.47 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -67.22 -40.18 86.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.847 0.356 . . . . 70.43 110.859 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.402 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 4.7 tt -85.54 -19.68 8.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 65.15 111.125 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -68.6 -36.5 78.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 75.03 110.868 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.703 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.1 -56.48 35.7 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.606 0.717 . . . . 72.41 111.114 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.703 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 54.2 Cg_endo -69.74 -29.39 24.03 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.679 2.253 . . . . 73.44 112.334 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -80.38 -17.37 52.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 61.12 110.91 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.585 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.86 -54.75 52.2 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.655 0.74 . . . . 71.54 110.891 -179.919 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 54.0 Cg_endo -69.7 -27.53 26.66 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.691 2.26 . . . . 65.21 112.324 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.23 -18.33 42.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 75.01 110.898 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.635 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -57.84 -52.34 75.14 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.659 0.742 . . . . 71.23 110.827 -179.827 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.635 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.5 Cg_endo -69.69 -24.81 29.56 Favored 'Trans proline' 0 N--CA 1.465 -0.178 0 C-N-CA 122.723 2.282 . . . . 73.43 112.365 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.23 -40.55 26.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 72.24 111.158 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.6 mt -72.43 -40.23 63.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 72.3 111.132 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.54 -32.06 67.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 74.13 110.915 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.54 -28.89 41.67 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.74 -0.743 . . . . 55.15 112.509 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.2 mttm -80.06 -31.94 39.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.825 0.345 . . . . 64.35 110.951 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.666 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -66.87 -36.74 83.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 71.34 111.11 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.644 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -70.41 -39.0 74.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 53.3 111.147 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.8 m -80.37 -24.06 40.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.237 -0.438 . . . . 64.54 111.144 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -75.5 -38.67 59.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 75.34 110.842 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 20' ' ' ALA . 93.2 t -70.94 -35.46 59.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.194 -0.457 . . . . 33.33 111.127 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 21' ' ' ALA . 96.3 t -70.7 -38.57 73.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 72.42 111.112 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.25 -27.44 38.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 23.52 111.129 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 72.34 111.092 179.927 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.766 0.317 . . . . 74.31 110.877 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.42 -35.9 90.81 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.787 -0.72 . . . . 70.4 112.474 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 32.3 mmt-85 -67.19 -40.17 86.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.819 0.343 . . . . 72.33 110.888 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.408 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 6.5 tt -85.53 -19.65 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 74.52 111.176 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -68.68 -36.49 78.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 75.23 110.846 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.704 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.05 -56.53 35.19 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.565 0.697 . . . . 71.02 111.074 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.704 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 53.7 Cg_endo -69.75 -29.34 24.08 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.709 2.273 . . . . 72.14 112.337 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -80.49 -17.35 51.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 74.33 110.825 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.597 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -57.92 -54.71 52.62 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.666 0.746 . . . . 73.51 110.909 -179.909 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.8 Cg_endo -69.75 -27.73 26.18 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.676 2.251 . . . . 63.24 112.398 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.4 t -82.11 -18.03 44.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 33.52 110.871 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.631 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -57.75 -52.63 72.95 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.673 0.749 . . . . 50.11 110.88 -179.838 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 13' ' ' SER . 54.1 Cg_endo -69.72 -23.82 30.56 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.686 2.257 . . . . 73.12 112.382 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.68 -42.09 22.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 64.41 111.129 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 10.2 tp -74.75 -34.25 33.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 70.24 111.12 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.79 -32.74 60.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 74.24 110.9 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.11 -28.57 40.62 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.771 -0.728 . . . . 50.12 112.535 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.44 ' HA ' HG22 ' A' ' 22' ' ' THR . 30.4 mmtt -80.12 -30.82 39.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.783 0.325 . . . . 75.31 110.922 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.647 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -68.3 -33.79 74.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 72.34 111.098 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.648 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -71.85 -40.34 69.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 54.21 111.079 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.44 HG22 ' HA ' ' A' ' 19' ' ' LYS . 9.2 t -80.7 -23.43 39.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.254 -0.43 . . . . 70.44 111.114 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -74.69 -38.48 62.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 71.45 110.859 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 20' ' ' ALA . 93.0 t -72.1 -35.1 52.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 63.41 111.108 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 21' ' ' ALA . 95.4 t -69.79 -36.89 71.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 75.11 111.14 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.17 -32.93 38.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 63.13 111.12 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 33.01 111.119 179.903 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.859 0.361 . . . . 75.23 110.928 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.42 -35.93 90.83 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.747 -0.74 . . . . 55.32 112.47 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -67.23 -40.11 86.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.764 0.316 . . . . 74.32 110.847 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.406 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 1.2 tt -85.51 -19.67 8.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 70.3 111.151 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -68.69 -36.48 78.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 72.05 110.869 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.703 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.1 -56.53 35.17 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.534 0.683 . . . . 73.34 111.075 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.703 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 53.9 Cg_endo -69.69 -29.39 24.26 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.657 2.238 . . . . 74.24 112.385 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -80.4 -17.36 52.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 65.0 110.859 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.587 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.87 -54.73 52.38 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.683 0.754 . . . . 72.25 110.901 -179.917 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 54.0 Cg_endo -69.81 -27.72 25.91 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.668 2.245 . . . . 62.33 112.348 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.4 m -82.09 -18.04 44.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 74.25 110.828 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.629 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -57.75 -52.61 73.07 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.649 0.737 . . . . 73.4 110.869 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.629 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.5 Cg_endo -69.75 -23.85 30.4 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.693 2.262 . . . . 71.42 112.345 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.68 -42.08 22.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 44.51 111.125 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 11.2 tp -74.8 -34.25 33.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.435 . . . . 65.12 111.117 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.513 HD12 ' O ' ' A' ' 13' ' ' SER . 3.7 mt -75.62 -32.82 60.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 74.11 110.956 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.17 -28.54 40.5 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.744 -0.741 . . . . 64.54 112.484 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.436 ' HA ' HG22 ' A' ' 22' ' ' THR . 84.6 mttt -80.12 -30.83 39.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.803 0.335 . . . . 75.43 110.943 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.655 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -68.32 -33.77 74.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 74.13 111.075 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.594 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -71.83 -40.38 69.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.263 -0.426 . . . . 62.43 111.076 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.436 HG22 ' HA ' ' A' ' 19' ' ' LYS . 9.2 t -80.77 -23.26 39.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 62.32 111.136 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -74.78 -38.53 62.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 71.23 110.831 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 20' ' ' ALA . 93.2 t -71.81 -35.8 56.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 71.1 111.129 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 21' ' ' ALA . 90.5 t -70.22 -36.96 69.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 63.25 111.11 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.17 -30.83 38.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 45.21 111.107 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.216 -0.447 . . . . 65.44 111.083 179.983 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.782 0.325 . . . . 75.43 110.839 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.44 -35.88 90.75 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.779 -0.724 . . . . 72.42 112.503 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 13.0 mmt85 -67.24 -40.16 86.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.817 0.341 . . . . 70.42 110.853 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.407 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 2.4 tt -85.57 -19.61 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.452 . . . . 64.31 111.133 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -68.67 -36.41 78.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 64.41 110.898 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.7 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.12 -56.49 35.59 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.63 0.729 . . . . 72.25 111.121 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.7 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 53.5 Cg_endo -69.77 -29.37 23.94 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.659 2.24 . . . . 70.53 112.338 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -80.39 -17.39 52.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 71.22 110.851 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.588 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -57.81 -54.77 51.86 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.679 0.752 . . . . 70.11 110.88 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.588 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.4 Cg_endo -69.77 -27.42 26.45 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.67 2.247 . . . . 74.23 112.341 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.0 m -82.25 -18.33 42.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 55.03 110.92 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.636 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -57.84 -52.25 75.82 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.683 0.754 . . . . 72.55 110.837 -179.812 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.8 Cg_endo -69.76 -23.97 30.18 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.674 2.249 . . . . 74.32 112.378 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.73 -42.04 22.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 45.3 111.068 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.7 tp -74.61 -34.22 34.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 64.42 111.189 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.3 tt -75.84 -32.67 59.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 73.31 110.919 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.19 -28.42 40.92 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.719 -0.753 . . . . 72.54 112.506 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.1 mmtp -80.08 -31.28 39.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.78 0.324 . . . . 62.41 110.879 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.666 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -67.04 -36.93 83.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 40.15 111.097 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.647 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -70.24 -39.16 75.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 73.11 111.101 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 85.8 m -80.25 -24.15 40.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.439 . . . . 71.23 111.134 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -75.44 -38.68 59.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 73.22 110.832 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 20' ' ' ALA . 93.7 t -70.9 -35.42 59.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 73.43 111.151 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 21' ' ' ALA . 94.9 t -70.37 -37.06 69.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 62.33 111.165 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.24 -30.73 38.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 55.13 111.072 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 73.41 111.116 179.936 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.046 0 CA-C-O 120.838 0.352 . . . . 72.22 110.88 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -65.0 -34.34 89.63 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.734 -0.746 . . . . 72.43 112.482 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.51 -39.73 81.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.779 0.323 . . . . 73.21 110.873 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.407 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 1.1 tt -85.7 -20.02 8.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 65.32 111.15 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.58 -36.4 78.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 51.51 110.87 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.709 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.1 -56.58 34.71 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.557 0.694 . . . . 73.31 111.077 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.709 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 54.2 Cg_endo -69.7 -29.39 24.21 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.704 2.269 . . . . 73.03 112.327 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -80.37 -17.35 52.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.229 -0.441 . . . . 62.42 110.893 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.591 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.92 -54.72 52.49 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.664 0.745 . . . . 74.24 110.9 -179.897 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.6 Cg_endo -69.74 -27.74 26.22 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.656 2.237 . . . . 61.3 112.367 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.15 -18.07 44.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 61.13 110.821 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.621 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -57.67 -52.65 72.81 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.635 0.731 . . . . 62.33 110.847 -179.831 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.6 Cg_endo -69.75 -23.23 31.07 Favored 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.724 2.283 . . . . 73.2 112.351 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.06 -42.13 21.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 42.04 111.102 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.8 tp -74.43 -34.86 37.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 63.33 111.127 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.542 HD13 ' O ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -75.43 -32.71 60.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 65.42 110.924 179.892 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.06 -28.4 41.5 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.735 -0.745 . . . . 63.33 112.492 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.8 mtpt -80.08 -31.53 39.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.728 0.299 . . . . 65.52 110.847 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.668 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -66.95 -36.74 82.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.257 -0.429 . . . . 61.54 111.139 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.655 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -70.29 -39.29 74.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 61.23 111.098 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 93.1 m -80.22 -24.16 40.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 65.35 111.129 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -75.37 -38.63 59.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 73.55 110.904 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 20' ' ' ALA . 92.4 t -70.66 -34.88 58.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.469 . . . . 70.02 111.104 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 21' ' ' ALA . 98.3 t -69.98 -36.81 70.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 60.5 111.097 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.12 -32.96 38.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 65.34 111.093 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 75.22 111.05 -179.989 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.038 0 CA-C-O 120.85 0.357 . . . . 54.45 110.938 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.39 -35.91 90.85 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.73 -0.748 . . . . 43.12 112.517 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 -67.19 -40.14 86.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.803 0.335 . . . . 73.02 110.876 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.411 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 20.2 pt -85.55 -19.72 8.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 75.33 111.154 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -68.75 -36.17 78.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 72.01 110.909 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.707 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.17 -56.44 36.05 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.563 0.697 . . . . 60.03 111.124 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.707 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 53.6 Cg_endo -69.78 -29.56 23.56 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.676 2.251 . . . . 64.11 112.347 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -80.29 -17.41 52.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.46 . . . . 71.3 110.817 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.587 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.79 -54.89 50.63 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.624 0.725 . . . . 74.0 110.898 -179.869 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 54.2 Cg_endo -69.78 -26.2 27.75 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.658 2.239 . . . . 75.52 112.338 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.79 -19.16 38.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 62.14 110.859 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.631 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 1.9 t -57.64 -52.14 76.51 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.688 0.756 . . . . 72.24 110.851 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 13' ' ' SER . 54.3 Cg_endo -69.64 -24.81 29.79 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.7 2.267 . . . . 71.33 112.364 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.3 -40.62 26.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 72.25 111.091 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 70.4 mt -72.31 -40.25 64.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 75.3 111.186 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.1 tt -71.47 -32.21 68.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 61.21 110.931 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.46 -28.87 42.09 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.706 -0.759 . . . . 74.24 112.524 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -80.05 -31.92 39.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.845 0.355 . . . . 71.41 110.94 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.668 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -66.92 -36.59 82.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.447 . . . . 71.4 111.091 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.654 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -70.47 -39.13 74.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 70.42 111.1 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.9 m -80.26 -24.13 40.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 73.14 111.185 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -75.39 -38.72 59.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 72.01 110.853 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 20' ' ' ALA . 91.7 t -70.63 -35.11 59.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 54.15 111.099 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 21' ' ' ALA . 96.9 t -69.86 -36.73 70.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 53.5 111.135 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.18 -32.93 38.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 71.41 111.083 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 75.22 111.141 179.905 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.831 0.348 . . . . 63.21 110.874 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.4 -35.89 90.81 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.712 -0.756 . . . . 64.54 112.521 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.2 mmm180 -67.2 -40.16 86.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.787 0.327 . . . . 75.21 110.856 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.409 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 19.9 pt -85.49 -19.74 8.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 71.1 111.129 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -68.81 -36.1 77.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 55.55 110.874 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.703 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.2 -56.46 35.81 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.582 0.706 . . . . 71.0 111.097 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.703 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 53.7 Cg_endo -69.74 -29.58 23.71 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.705 2.27 . . . . 73.03 112.333 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -80.27 -17.3 52.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 74.24 110.941 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.586 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.83 -54.94 50.18 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.69 0.757 . . . . 72.43 110.882 -179.901 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 54.1 Cg_endo -69.75 -26.14 27.92 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.655 2.237 . . . . 53.44 112.369 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.1 m -82.82 -19.22 38.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.461 . . . . 52.14 110.862 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.631 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 1.9 t -57.57 -52.09 76.91 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.673 0.749 . . . . 55.33 110.889 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.9 Cg_endo -69.83 -24.67 29.09 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.663 2.242 . . . . 63.4 112.336 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.32 -40.59 26.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.28 -0.418 . . . . 72.44 111.081 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 24.0 mm -72.32 -40.3 64.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 71.43 111.173 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.7 tt -71.44 -32.19 68.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 71.13 110.909 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.54 -28.83 41.91 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.753 -0.737 . . . . 70.22 112.472 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.8 mttm -80.08 -31.99 39.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.866 0.365 . . . . 71.23 110.905 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.667 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -66.86 -36.67 82.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 62.54 111.066 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.647 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -70.44 -39.11 74.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 72.43 111.101 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.3 m -80.33 -24.09 40.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.204 -0.453 . . . . 65.4 111.143 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -75.47 -38.63 59.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 54.12 110.88 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 20' ' ' ALA . 92.6 t -70.93 -35.53 60.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 61.53 111.122 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 21' ' ' ALA . 97.5 t -70.34 -37.0 69.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 75.22 111.13 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.22 -30.74 38.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 72.35 111.082 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 53.51 111.132 179.927 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.844 0.354 . . . . 74.22 110.916 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -65.36 -35.64 91.7 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.77 -0.729 . . . . 52.02 112.473 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 9.4 mmm-85 -67.36 -40.23 85.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.766 0.317 . . . . 75.2 110.862 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.408 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 9.1 tt -85.66 -19.64 8.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 61.4 111.144 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -68.71 -36.31 78.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 72.13 110.876 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.697 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.17 -56.51 35.31 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.615 0.721 . . . . 51.34 111.108 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.697 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 53.3 Cg_endo -69.82 -29.3 23.77 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.632 2.221 . . . . 71.54 112.339 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -80.43 -17.34 52.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 53.41 110.871 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.591 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.92 -54.74 52.36 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.605 0.717 . . . . 73.24 110.855 -179.877 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.8 Cg_endo -69.74 -27.41 26.61 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.714 2.276 . . . . 63.25 112.318 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.6 t -82.3 -18.43 42.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.43 . . . . 60.11 110.877 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.636 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -57.79 -52.24 75.82 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.662 0.744 . . . . 72.13 110.858 -179.819 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.8 Cg_endo -69.73 -24.03 30.26 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.661 2.241 . . . . 54.04 112.321 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.7 -42.02 22.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 75.51 111.092 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.6 tp -74.58 -34.29 34.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 73.24 111.162 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 30.6 mt -75.75 -32.77 60.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.12 -0.491 . . . . 72.2 110.902 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.1 -28.46 41.08 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.747 -0.739 . . . . 73.32 112.518 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.4 mttp -80.07 -31.24 39.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.809 0.338 . . . . 73.24 110.91 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.664 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -67.16 -36.64 82.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 70.45 111.104 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.645 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -70.37 -39.22 74.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.434 . . . . 64.02 111.08 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.1 m -80.3 -24.04 40.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 75.25 111.131 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -75.43 -38.58 59.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 71.54 110.853 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 20' ' ' ALA . 92.7 t -71.1 -35.44 58.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.446 . . . . 64.53 111.106 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 21' ' ' ALA . 95.9 t -70.37 -37.12 69.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 74.15 111.11 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.17 -30.69 38.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 62.22 111.1 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 64.1 111.042 179.996 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.847 0.355 . . . . 73.34 110.92 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -65.06 -34.2 89.17 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.706 -0.759 . . . . 74.34 112.545 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -68.53 -39.81 81.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.82 0.343 . . . . 64.52 110.876 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.409 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 28.9 pt -85.65 -19.99 8.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 75.55 111.164 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.6 -36.4 78.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.189 -0.46 . . . . 75.43 110.878 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.709 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.09 -56.53 35.22 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.587 0.708 . . . . 61.35 111.108 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.709 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 53.9 Cg_endo -69.79 -29.27 23.98 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.661 2.241 . . . . 65.45 112.389 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -80.45 -17.38 51.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 73.44 110.859 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.594 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.91 -54.71 52.64 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.664 0.745 . . . . 74.45 110.918 -179.916 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.4 Cg_endo -69.79 -27.77 25.93 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.69 2.26 . . . . 63.41 112.332 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.04 -18.09 44.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 74.02 110.836 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.627 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -57.75 -52.56 73.47 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.676 0.75 . . . . 71.22 110.885 -179.804 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.7 Cg_endo -69.76 -23.85 30.34 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.713 2.275 . . . . 74.22 112.33 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.69 -42.07 22.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 74.42 111.114 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.6 tp -74.76 -34.3 33.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 73.51 111.111 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 51.1 tp -75.66 -32.71 60.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 65.32 110.958 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.22 -28.54 40.3 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.757 -0.735 . . . . 62.14 112.419 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.441 ' HA ' HG22 ' A' ' 22' ' ' THR . 4.9 mtpp -80.12 -30.83 39.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.752 0.31 . . . . 61.02 110.889 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.653 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -68.28 -33.83 75.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.283 -0.417 . . . . 62.5 111.071 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.648 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -71.81 -40.41 69.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 63.23 111.048 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.441 HG22 ' HA ' ' A' ' 19' ' ' LYS . 9.2 t -80.71 -23.38 39.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 70.31 111.111 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -74.72 -38.49 62.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 62.3 110.87 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 20' ' ' ALA . 94.2 t -71.94 -35.12 53.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 62.14 111.151 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 21' ' ' ALA . 96.1 t -69.79 -36.86 71.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 73.34 111.125 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.22 -32.9 38.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 71.41 111.128 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 72.23 111.127 179.905 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.822 0.344 . . . . 71.44 110.902 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.4 -35.95 90.9 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.794 -0.717 . . . . 35.13 112.473 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 79.8 mtt180 -67.16 -40.15 86.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.758 0.313 . . . . 74.35 110.853 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.411 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 14.7 tt -85.49 -19.75 8.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 75.54 111.138 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -68.75 -36.15 78.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 73.42 110.823 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.706 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.24 -56.47 35.74 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.604 0.716 . . . . 64.24 111.101 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.706 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 53.9 Cg_endo -69.75 -29.39 24.01 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.676 2.25 . . . . 53.12 112.371 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -80.54 -17.22 52.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 74.11 110.89 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.595 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -58.02 -54.45 55.46 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.659 0.742 . . . . 62.11 110.887 -179.883 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.8 Cg_endo -69.74 -27.35 26.69 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.7 2.266 . . . . 73.21 112.321 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.42 -19.1 39.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 71.34 110.865 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.644 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -56.09 -52.07 75.66 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.633 0.73 . . . . 72.33 110.83 -179.778 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.644 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.5 Cg_endo -69.78 -20.24 35.0 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.675 2.25 . . . . 70.41 112.36 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.9 -42.54 19.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.434 . . . . 75.53 111.089 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.449 HG13 HD22 ' A' ' 17' ' ' LEU . 22.2 pt -74.29 -35.91 41.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 65.41 111.099 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.449 HD22 HG13 ' A' ' 16' ' ' ILE . 2.7 mm? -74.32 -32.81 62.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 72.22 110.901 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.04 -28.64 40.66 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.743 -0.741 . . . . 72.04 112.489 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.456 ' HA ' HG22 ' A' ' 22' ' ' THR . 10.0 mtpt -80.19 -30.44 38.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.762 0.315 . . . . 70.42 110.838 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.679 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -68.49 -34.48 75.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.284 -0.416 . . . . 72.54 111.089 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.61 -40.24 69.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 64.21 111.073 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.456 HG22 ' HA ' ' A' ' 19' ' ' LYS . 9.3 t -80.75 -22.59 40.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 52.23 111.148 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -75.76 -38.53 58.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 72.23 110.903 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 20' ' ' ALA . 96.3 t -67.83 -40.34 83.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 73.03 111.146 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.2 p -69.56 -34.28 60.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 74.33 111.171 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.25 -29.13 38.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.126 -0.488 . . . . 53.03 111.133 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 54.14 111.109 179.94 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.852 0.358 . . . . 73.34 110.895 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.42 -35.89 90.78 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.705 -0.759 . . . . 64.45 112.499 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 26.4 mmt85 -67.17 -40.2 86.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.813 0.339 . . . . 73.51 110.84 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.41 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 31.4 pt -85.5 -19.69 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 52.4 111.137 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -68.81 -36.12 77.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.458 . . . . 62.31 110.887 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.703 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.21 -56.47 35.72 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.599 0.714 . . . . 73.54 111.113 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.703 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 54.4 Cg_endo -69.71 -29.56 23.92 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.714 2.276 . . . . 73.35 112.395 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -80.34 -17.3 52.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 52.53 110.897 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.593 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.82 -54.95 50.07 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.632 0.73 . . . . 72.23 110.884 -179.906 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.7 Cg_endo -69.7 -26.17 28.11 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.716 2.277 . . . . 73.24 112.363 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.7 t -82.88 -19.14 37.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 62.11 110.857 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.634 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 2.0 t -57.63 -51.96 77.88 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.665 0.745 . . . . 74.11 110.886 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.634 ' HD2' ' N ' ' A' ' 13' ' ' SER . 54.0 Cg_endo -69.77 -24.08 30.03 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.693 2.262 . . . . 63.32 112.387 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.67 -42.02 22.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 64.0 111.101 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 12.4 tt -74.62 -34.29 34.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 62.12 111.083 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.9 tp -75.74 -32.75 60.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 73.13 110.899 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.19 -28.36 41.11 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.695 -0.764 . . . . 45.45 112.462 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.8 mttt -80.11 -31.29 39.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.752 0.311 . . . . 75.4 110.882 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.661 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -66.76 -39.97 88.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 63.45 111.133 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.24 -37.07 77.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 63.13 111.084 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.0 m -80.32 -24.74 39.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.25 -0.432 . . . . 33.04 111.161 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -77.39 -37.49 51.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 72.04 110.882 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 20' ' ' ALA . 91.5 t -71.08 -40.1 75.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.448 . . . . 51.43 111.184 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.0 p -68.67 -33.82 61.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 71.0 111.105 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.29 -32.56 38.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 74.14 111.028 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 42.44 111.051 179.993 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.8 pptp? . . . . . 0 C--O 1.23 0.041 0 CA-C-O 120.829 0.347 . . . . 75.1 110.891 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -65.02 -34.36 89.65 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.719 -0.753 . . . . 74.34 112.472 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 -68.48 -39.76 81.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.766 0.317 . . . . 72.11 110.866 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.408 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 29.4 pt -85.68 -19.99 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 73.41 111.102 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.64 -36.31 78.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 71.25 110.905 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.698 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.11 -56.58 34.63 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.613 0.72 . . . . 72.42 111.068 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.698 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 53.7 Cg_endo -69.78 -29.34 23.92 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.687 2.258 . . . . 60.32 112.313 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -80.4 -17.28 52.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.221 -0.445 . . . . 74.23 110.922 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.593 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.95 -54.75 52.27 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.634 0.731 . . . . 72.35 110.851 -179.918 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.8 Cg_endo -69.78 -27.71 26.07 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.741 2.294 . . . . 61.24 112.33 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.3 m -82.19 -17.99 44.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 60.5 110.844 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.635 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.2 OUTLIER -57.78 -52.62 73.08 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.68 0.752 . . . . 73.25 110.842 -179.838 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.635 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.7 Cg_endo -69.75 -23.85 30.39 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.73 2.287 . . . . 72.41 112.341 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.7 -41.99 22.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 64.11 111.153 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 15.4 tt -74.76 -34.33 33.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 71.52 111.125 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.66 -32.73 60.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 60.42 110.893 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.24 -28.52 40.31 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.792 -0.718 . . . . 73.15 112.434 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.432 ' HA ' HG22 ' A' ' 22' ' ' THR . 4.0 mtpm? -80.2 -30.84 38.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.74 0.305 . . . . 64.2 110.873 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.634 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -68.34 -33.69 74.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 60.53 111.134 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.636 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -71.88 -40.37 68.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 71.0 111.099 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.432 HG22 ' HA ' ' A' ' 19' ' ' LYS . 9.3 t -80.65 -23.4 39.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 72.15 111.188 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -75.18 -37.82 61.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 74.25 110.881 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 20' ' ' ALA . 85.7 t -72.77 -35.7 50.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.228 -0.442 . . . . 63.45 111.125 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 21' ' ' ALA . 95.9 t -70.17 -37.3 71.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 61.34 111.137 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.23 -30.57 38.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 74.21 111.073 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 60.24 111.104 179.944 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.058 0 CA-C-O 120.81 0.338 . . . . 75.34 110.878 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.42 -35.89 90.78 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.688 -0.768 . . . . 70.42 112.537 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.3 mtt180 -67.15 -40.11 86.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.853 0.359 . . . . 64.52 110.891 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.407 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 10.7 tp -85.55 -19.81 8.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 73.53 111.167 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -68.55 -36.43 78.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 74.42 110.86 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.71 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.06 -56.62 34.32 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.581 0.705 . . . . 73.25 111.089 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.71 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 53.3 Cg_endo -69.74 -29.27 24.22 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.696 2.264 . . . . 64.01 112.326 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -80.54 -17.32 51.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 74.52 110.806 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.59 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.93 -54.67 53.02 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.696 0.76 . . . . 72.33 110.866 -179.884 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.8 Cg_endo -69.69 -27.71 26.45 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.705 2.27 . . . . 71.13 112.386 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m -82.16 -18.34 43.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.46 . . . . 71.01 110.872 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.633 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -57.2 -52.55 73.32 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.667 0.746 . . . . 75.21 110.88 -179.823 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.633 ' HD2' ' N ' ' A' ' 13' ' ' SER . 54.0 Cg_endo -69.76 -23.48 30.77 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.659 2.24 . . . . 74.34 112.3 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.56 -41.67 23.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.26 -0.427 . . . . 63.55 111.091 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 33.6 mm -72.41 -40.07 63.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.462 . . . . 71.13 111.16 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -71.83 -31.87 66.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 44.1 110.911 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.61 -28.93 41.21 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.715 -0.755 . . . . 54.25 112.534 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.8 mtpp -80.05 -32.17 39.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.731 0.301 . . . . 72.25 110.881 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.67 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -66.83 -36.64 82.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 55.55 111.134 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.655 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -70.42 -39.09 74.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 64.4 111.122 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.9 m -80.31 -24.11 40.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 65.32 111.163 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -75.38 -38.94 59.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 74.33 110.802 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.67 HG23 ' O ' ' A' ' 20' ' ' ALA . 92.6 t -70.35 -35.02 60.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 75.41 111.167 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 21' ' ' ALA . 96.7 t -69.94 -36.7 70.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 63.31 111.123 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.21 -32.81 38.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.481 . . . . 52.13 111.093 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.271 -0.422 . . . . 72.24 111.105 179.946 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.789 0.328 . . . . 74.5 110.882 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -67.37 -34.34 84.74 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.725 -0.75 . . . . 64.32 112.508 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -69.99 -37.59 75.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.815 0.34 . . . . 71.12 110.826 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.6 tt -87.09 -19.88 7.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 73.51 111.149 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -69.47 -36.57 76.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 51.55 110.854 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.688 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.09 -56.2 38.6 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.557 0.694 . . . . 61.34 111.068 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.688 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 53.8 Cg_endo -69.76 -29.56 23.66 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.69 2.26 . . . . 70.41 112.346 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -80.4 -17.31 52.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 74.35 110.896 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.599 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -57.83 -54.81 51.51 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.648 0.737 . . . . 75.11 110.876 -179.901 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 54.2 Cg_endo -69.71 -27.76 26.3 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.73 2.287 . . . . 73.43 112.324 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.1 -18.04 44.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 65.43 110.856 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.635 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -57.75 -52.59 73.23 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.657 0.741 . . . . 55.25 110.869 -179.832 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.635 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.5 Cg_endo -69.8 -23.79 30.21 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.664 2.243 . . . . 53.31 112.351 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.75 -41.98 22.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.227 -0.442 . . . . 62.44 111.086 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 11.2 tp -74.82 -34.24 32.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 72.12 111.113 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.3 tp -75.86 -32.6 59.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 74.24 110.925 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.21 -28.43 40.8 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.708 -0.758 . . . . 74.24 112.526 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.3 mttt -80.0 -31.36 39.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.823 0.344 . . . . 63.4 110.938 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.662 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -67.05 -36.65 82.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 73.45 111.089 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.654 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -70.29 -39.4 74.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.244 -0.434 . . . . 54.41 111.081 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.4 m -80.27 -24.0 40.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 51.33 111.14 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -75.39 -38.63 59.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.438 . . . . 65.31 110.857 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 20' ' ' ALA . 92.8 t -70.83 -35.14 58.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.202 -0.454 . . . . 53.32 111.142 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 21' ' ' ALA . 96.2 t -69.87 -36.67 70.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 70.22 111.141 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.17 -32.91 38.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.465 . . . . 74.22 111.111 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 75.42 111.087 179.972 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.823 0.344 . . . . 73.13 110.876 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.29 -35.94 91.0 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.742 -0.742 . . . . 73.43 112.51 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 44.5 mmm-85 -67.19 -40.16 86.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.777 0.323 . . . . 73.3 110.866 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.411 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 0.8 OUTLIER -85.52 -19.75 8.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.46 . . . . 53.31 111.107 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -68.77 -36.17 77.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.46 . . . . 72.02 110.831 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.704 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.16 -56.52 35.25 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.607 0.718 . . . . 71.3 111.083 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.704 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 53.4 Cg_endo -69.78 -29.46 23.72 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.665 2.243 . . . . 73.13 112.345 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -80.36 -17.34 52.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 71.13 110.864 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.594 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.89 -54.72 52.52 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.668 0.747 . . . . 72.51 110.883 -179.866 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.6 Cg_endo -69.79 -27.77 25.92 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.732 2.288 . . . . 71.01 112.298 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.1 -18.0 44.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.272 -0.422 . . . . 72.35 110.9 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.628 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -57.85 -52.58 73.34 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.638 0.732 . . . . 73.34 110.811 -179.806 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.628 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.9 Cg_endo -69.75 -23.79 30.46 Favored 'Trans proline' 0 C--N 1.341 0.132 0 C-N-CA 122.682 2.255 . . . . 75.1 112.367 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.78 -41.98 22.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 74.13 111.095 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.1 tp -74.82 -34.25 32.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.431 . . . . 73.41 111.111 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.7 tp -75.74 -32.7 60.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.461 . . . . 60.24 110.933 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.22 -28.49 40.5 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.746 -0.74 . . . . 54.12 112.481 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -80.04 -31.1 39.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.841 0.353 . . . . 73.01 110.931 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.691 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -66.95 -40.08 87.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 72.41 111.07 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.48 -37.44 77.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 70.22 111.131 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.6 m -80.46 -23.27 40.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 74.23 111.166 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -77.92 -38.86 44.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 74.4 110.905 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 20' ' ' ALA . 99.3 t -66.19 -40.31 86.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 74.31 111.133 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.5 m -68.92 -31.91 52.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 73.25 111.094 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.48 -34.18 36.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 50.13 111.105 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 71.01 111.081 179.956 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.839 0.352 . . . . 61.11 110.906 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.46 -35.98 90.87 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.726 -0.749 . . . . 75.14 112.459 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.7 mmt-85 -67.05 -40.14 87.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.773 0.321 . . . . 65.5 110.915 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.411 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 1.1 tt -85.55 -19.73 8.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 63.2 111.084 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -68.74 -36.15 78.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.207 -0.451 . . . . 65.42 110.86 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.695 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.23 -56.47 35.7 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.572 0.701 . . . . 63.14 111.126 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.695 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 54.0 Cg_endo -69.75 -29.4 24.0 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.705 2.27 . . . . 45.14 112.342 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -80.54 -17.26 52.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.242 -0.436 . . . . 70.14 110.866 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.601 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.98 -54.44 55.52 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.646 0.736 . . . . 75.23 110.941 -179.928 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.8 Cg_endo -69.77 -27.31 26.56 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.661 2.241 . . . . 65.11 112.342 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.46 -19.11 39.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 72.54 110.802 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.643 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.2 OUTLIER -55.99 -52.14 74.91 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.689 0.757 . . . . 73.21 110.874 -179.83 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.643 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.6 Cg_endo -69.79 -20.58 34.49 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.687 2.258 . . . . 70.34 112.302 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.42 -42.38 20.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.283 -0.417 . . . . 71.43 111.08 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.1 pt -75.73 -35.17 30.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 62.21 111.115 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.482 HD13 ' O ' ' A' ' 17' ' ' LEU . 0.2 OUTLIER -76.55 -30.57 57.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 45.35 110.947 179.89 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.54 -29.78 35.04 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.706 -0.759 . . . . 71.2 112.467 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.439 ' HA ' HG22 ' A' ' 22' ' ' THR . 0.0 OUTLIER -80.9 -31.28 35.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.786 0.327 . . . . 72.03 110.884 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.657 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -68.12 -33.75 75.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 64.34 111.081 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.648 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -71.86 -40.37 69.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 74.23 111.117 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.439 HG22 ' HA ' ' A' ' 19' ' ' LYS . 9.2 t -80.77 -23.33 39.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.215 -0.448 . . . . 60.43 111.121 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -74.7 -38.51 62.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.24 -0.436 . . . . 65.42 110.863 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 20' ' ' ALA . 93.1 t -72.02 -35.06 52.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 72.32 111.121 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 21' ' ' ALA . 95.9 t -69.82 -36.85 71.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.46 . . . . 64.22 111.157 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.19 -32.95 38.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 72.42 111.11 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 73.12 111.112 179.927 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 16.8 m . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.904 0.383 . . . . 53.52 111.101 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.13 -19.46 47.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 74.42 110.874 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.42 -35.88 90.77 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.762 -0.732 . . . . 74.53 112.543 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.15 -40.17 86.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.767 0.318 . . . . 72.33 110.844 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.407 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 1.6 tt -85.52 -19.74 8.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 71.25 111.126 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -68.77 -36.15 77.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.143 -0.481 . . . . 70.02 110.872 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.708 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.2 -56.41 36.3 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.644 0.735 . . . . 73.15 111.144 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.708 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 53.5 Cg_endo -69.82 -29.48 23.51 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.663 2.242 . . . . 62.31 112.316 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -80.43 -17.24 52.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.435 . . . . 73.0 110.862 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.586 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.87 -54.8 51.68 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.632 0.729 . . . . 60.11 110.894 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.9 Cg_endo -69.75 -27.78 26.08 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.695 2.263 . . . . 71.12 112.344 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.03 -18.0 44.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.441 . . . . 73.33 110.879 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.62 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -57.79 -52.72 72.35 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.696 0.76 . . . . 75.21 110.861 -179.823 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.62 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.6 Cg_endo -69.76 -24.5 29.6 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.691 2.261 . . . . 70.13 112.344 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.32 -40.85 25.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 74.53 111.068 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 23.9 mm -72.19 -40.44 65.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 75.52 111.132 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.4 mt -71.9 -30.23 65.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.469 . . . . 74.44 110.923 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.44 -30.29 37.34 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.712 -0.756 . . . . 51.44 112.493 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.438 ' HA ' HG22 ' A' ' 22' ' ' THR . 0.0 OUTLIER -80.09 -32.65 39.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.811 0.338 . . . . 72.41 110.882 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.655 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -67.65 -33.19 74.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.251 -0.432 . . . . 54.45 111.113 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.647 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -72.18 -40.49 67.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 72.54 111.122 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.438 HG22 ' HA ' ' A' ' 19' ' ' LYS . 9.1 t -80.79 -23.3 39.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 61.12 111.154 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -74.63 -38.55 62.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 75.35 110.911 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 20' ' ' ALA . 94.4 t -71.99 -35.1 52.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 74.34 111.159 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 21' ' ' ALA . 96.5 t -69.85 -36.88 71.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 74.43 111.091 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.23 -32.92 38.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 64.03 111.105 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.91 -19.97 54.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 61.35 111.115 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -59.94 -25.97 65.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.206 -0.452 . . . . 71.11 110.902 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.7 ptmm? -73.64 -32.57 64.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 73.44 110.884 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.0 m . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 65.34 110.806 -179.87 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 6.7 m . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.886 0.374 . . . . 72.42 111.102 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.12 -19.43 47.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 75.23 110.91 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.42 -35.86 90.74 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.784 -0.722 . . . . 72.14 112.474 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -67.27 -40.08 86.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.759 0.314 . . . . 74.13 110.875 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.408 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 4.0 tt -85.61 -19.62 8.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.2 -0.454 . . . . 71.51 111.105 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -68.76 -36.4 78.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 74.05 110.85 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.706 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.14 -56.49 35.53 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.567 0.699 . . . . 74.54 111.077 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.706 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 53.9 Cg_endo -69.75 -29.35 24.04 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.715 2.277 . . . . 61.32 112.34 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -80.44 -17.35 52.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.258 -0.428 . . . . 72.52 110.894 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.594 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.93 -54.67 53.1 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.628 0.728 . . . . 75.24 110.902 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.8 Cg_endo -69.74 -27.9 26.01 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.705 2.27 . . . . 64.13 112.357 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.96 -18.09 44.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.436 . . . . 71.42 110.84 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.625 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -57.73 -52.83 71.49 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.66 0.743 . . . . 74.11 110.794 -179.755 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.625 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.6 Cg_endo -69.73 -24.39 29.88 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.717 2.278 . . . . 74.15 112.336 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.22 -40.53 26.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 51.3 111.085 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 54.8 mt -73.25 -39.88 56.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 64.42 111.122 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.23 -29.65 62.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 41.34 110.921 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.84 -30.46 35.4 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.763 -0.732 . . . . 75.15 112.473 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.439 ' HA ' HG22 ' A' ' 22' ' ' THR . 50.8 pttt -80.8 -31.9 35.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.797 0.332 . . . . 73.02 110.916 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.65 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -67.89 -33.44 74.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 73.14 111.141 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.649 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -72.05 -40.43 68.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 74.04 111.063 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.439 HG22 ' HA ' ' A' ' 19' ' ' LYS . 9.0 t -80.78 -23.34 39.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 74.44 111.104 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -74.68 -38.51 62.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 73.14 110.874 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 20' ' ' ALA . 93.6 t -72.03 -35.12 52.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 75.52 111.123 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 21' ' ' ALA . 95.2 t -69.81 -36.86 71.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 70.44 111.11 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.17 -32.96 38.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 73.44 111.111 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.92 -20.03 55.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 71.21 111.085 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -59.87 -25.94 65.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.201 -0.454 . . . . 74.1 110.923 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.62 -32.62 64.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 73.1 110.844 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 36.6 t . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.289 -0.414 . . . . 75.13 110.899 -179.919 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.41 ' O ' HG12 ' A' ' 1' ' ' VAL . 14.5 t . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.884 0.374 . . . . 72.32 111.11 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.06 -19.45 47.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 74.1 110.923 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.42 -35.89 90.77 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.761 -0.733 . . . . 60.51 112.499 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 11.6 mtm180 -67.24 -40.09 86.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.788 0.328 . . . . 71.55 110.903 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.402 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 4.7 tt -85.59 -19.65 8.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 74.34 111.087 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -68.7 -36.47 78.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 73.33 110.88 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.706 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.06 -56.48 35.73 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.567 0.699 . . . . 62.55 111.124 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.706 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 53.5 Cg_endo -69.83 -29.33 23.71 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.653 2.235 . . . . 55.05 112.319 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -80.46 -17.31 52.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 74.34 110.805 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.586 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.91 -54.76 52.06 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.664 0.745 . . . . 64.22 110.862 -179.87 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.8 Cg_endo -69.71 -27.82 26.23 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.71 2.273 . . . . 71.04 112.363 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.9 m -82.01 -18.03 44.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 74.35 110.857 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.629 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -57.84 -52.69 72.54 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.617 0.722 . . . . 55.14 110.848 -179.769 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.629 ' HD2' ' N ' ' A' ' 13' ' ' SER . 54.4 Cg_endo -69.75 -24.54 29.61 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.624 2.216 . . . . 75.43 112.378 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.26 -40.63 26.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 71.34 111.092 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 24.1 mm -72.53 -40.24 62.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 65.11 111.151 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.9 tp -71.47 -32.12 67.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.21 -0.45 . . . . 72.21 110.916 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.56 -28.97 41.27 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.712 -0.756 . . . . 52.03 112.458 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.433 ' HA ' HG22 ' A' ' 22' ' ' THR . 26.0 mttm -80.17 -31.53 38.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.774 0.321 . . . . 74.22 110.886 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.647 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -68.11 -33.42 74.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 75.22 111.116 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.653 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -72.09 -40.4 68.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 64.51 111.064 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.433 HG22 ' HA ' ' A' ' 19' ' ' LYS . 9.2 t -80.77 -23.28 39.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.209 -0.451 . . . . 72.12 111.181 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -74.98 -38.07 61.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 62.41 110.899 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 20' ' ' ALA . 85.2 t -72.36 -35.14 51.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 71.5 111.164 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 21' ' ' ALA . 94.8 t -69.83 -36.83 71.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 64.34 111.14 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.24 -32.84 38.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 54.03 111.102 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -80.11 -19.92 46.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 54.43 111.119 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.424 ' HD1' HG12 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -59.97 -34.01 72.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.476 . . . . 72.12 110.897 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -71.03 -32.3 69.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.272 -0.422 . . . . 55.43 110.94 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.6 t . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 74.32 110.838 -179.901 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.1 m . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.92 0.39 . . . . 71.53 111.112 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.22 -19.23 47.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.133 -0.485 . . . . 74.13 110.914 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -65.34 -35.66 91.74 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.74 -0.743 . . . . 72.11 112.491 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.2 mmm-85 -67.32 -40.21 85.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.777 0.322 . . . . 61.1 110.882 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.406 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 1.3 tt -85.68 -19.64 8.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 54.02 111.125 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -68.69 -36.34 78.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 72.24 110.882 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.71 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.23 -56.47 35.72 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.589 0.709 . . . . 70.34 111.099 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.71 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 54.5 Cg_endo -69.72 -29.4 24.13 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.691 2.26 . . . . 61.32 112.35 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -80.48 -17.27 52.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 74.04 110.87 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.59 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.91 -54.75 52.18 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.622 0.725 . . . . 64.21 110.864 -179.919 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 54.3 Cg_endo -69.74 -27.8 26.13 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.677 2.251 . . . . 74.33 112.361 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.7 m -82.05 -18.0 44.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 52.24 110.828 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.619 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -57.79 -52.69 72.56 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.69 0.757 . . . . 74.14 110.871 -179.816 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.7 Cg_endo -69.8 -24.56 29.34 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.697 2.265 . . . . 63.01 112.313 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.24 -40.66 26.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 72.3 111.124 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 15.8 mt -72.51 -40.27 63.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 54.12 111.134 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.6 tt -71.41 -32.15 68.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 63.33 110.989 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.55 -28.93 41.43 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.72 -0.752 . . . . 73.32 112.508 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.436 ' HA ' HG22 ' A' ' 22' ' ' THR . 9.2 mttm -80.16 -31.53 38.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.835 0.35 . . . . 74.03 110.889 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.654 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -68.07 -33.57 74.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.44 . . . . 71.53 111.083 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.651 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -71.95 -40.42 68.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.438 . . . . 51.43 111.061 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.436 HG22 ' HA ' ' A' ' 19' ' ' LYS . 9.2 t -80.76 -23.33 39.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.264 -0.425 . . . . 74.13 111.126 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.68 -38.56 62.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.461 . . . . 75.43 110.879 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 20' ' ' ALA . 94.2 t -71.96 -35.19 53.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.174 -0.467 . . . . 73.13 111.146 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 21' ' ' ALA . 95.8 t -69.78 -36.84 71.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.485 . . . . 62.11 111.119 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.22 -33.0 38.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 75.5 111.079 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.95 -20.0 55.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.434 . . . . 53.34 111.125 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -59.93 -25.95 65.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 54.32 110.9 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.49 -32.63 64.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.253 -0.431 . . . . 62.43 110.929 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 75.35 110.827 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.46 HG22 ' HD2' ' A' ' 4' ' ' ARG . 35.6 m . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.925 0.393 . . . . 53.11 111.132 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.13 -19.43 47.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 71.42 110.884 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.44 -35.87 90.74 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.77 -0.729 . . . . 62.21 112.47 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.46 ' HD2' HG22 ' A' ' 1' ' ' VAL . 1.1 mtt180 -67.22 -40.18 86.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.847 0.356 . . . . 70.43 110.859 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.402 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 4.7 tt -85.54 -19.68 8.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 65.15 111.125 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -68.6 -36.5 78.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 75.03 110.868 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.703 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.1 -56.48 35.7 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.606 0.717 . . . . 72.41 111.114 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.703 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 54.2 Cg_endo -69.74 -29.39 24.03 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.679 2.253 . . . . 73.44 112.334 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -80.38 -17.37 52.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 61.12 110.91 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.585 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.86 -54.75 52.2 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.655 0.74 . . . . 71.54 110.891 -179.919 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 54.0 Cg_endo -69.7 -27.53 26.66 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.691 2.26 . . . . 65.21 112.324 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.23 -18.33 42.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 75.01 110.898 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.635 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -57.84 -52.34 75.14 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.659 0.742 . . . . 71.23 110.827 -179.827 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.635 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.5 Cg_endo -69.69 -24.81 29.56 Favored 'Trans proline' 0 N--CA 1.465 -0.178 0 C-N-CA 122.723 2.282 . . . . 73.43 112.365 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.23 -40.55 26.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 72.24 111.158 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.6 mt -72.43 -40.23 63.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 72.3 111.132 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.54 -32.06 67.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 74.13 110.915 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.54 -28.89 41.67 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.74 -0.743 . . . . 55.15 112.509 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.2 mttm -80.06 -31.94 39.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.825 0.345 . . . . 64.35 110.951 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.666 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -66.87 -36.74 83.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 71.34 111.11 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.644 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -70.41 -39.0 74.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 53.3 111.147 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.8 m -80.37 -24.06 40.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.237 -0.438 . . . . 64.54 111.144 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -75.5 -38.67 59.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 75.34 110.842 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 20' ' ' ALA . 93.2 t -70.94 -35.46 59.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.194 -0.457 . . . . 33.33 111.127 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 21' ' ' ALA . 96.3 t -70.7 -38.57 73.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 72.42 111.112 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.25 -27.44 38.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 23.52 111.129 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -80.49 -34.66 35.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 72.34 111.092 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 62.6 t-105 -69.93 -40.17 75.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.232 -0.44 . . . . 73.04 110.917 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.05 -27.99 60.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 73.2 110.915 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.197 -0.456 . . . . 41.41 110.844 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 24.5 m . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.873 0.368 . . . . 62.11 111.161 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.06 -19.44 47.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 74.31 110.877 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.42 -35.9 90.81 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.787 -0.72 . . . . 70.4 112.474 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 32.3 mmt-85 -67.19 -40.17 86.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.819 0.343 . . . . 72.33 110.888 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.408 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 6.5 tt -85.53 -19.65 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 74.52 111.176 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -68.68 -36.49 78.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 75.23 110.846 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.704 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.05 -56.53 35.19 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.565 0.697 . . . . 71.02 111.074 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.704 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 53.7 Cg_endo -69.75 -29.34 24.08 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.709 2.273 . . . . 72.14 112.337 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -80.49 -17.35 51.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 74.33 110.825 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.597 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -57.92 -54.71 52.62 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.666 0.746 . . . . 73.51 110.909 -179.909 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.8 Cg_endo -69.75 -27.73 26.18 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.676 2.251 . . . . 63.24 112.398 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.4 t -82.11 -18.03 44.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 33.52 110.871 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.631 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -57.75 -52.63 72.95 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.673 0.749 . . . . 50.11 110.88 -179.838 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 13' ' ' SER . 54.1 Cg_endo -69.72 -23.82 30.56 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.686 2.257 . . . . 73.12 112.382 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.68 -42.09 22.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 64.41 111.129 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 10.2 tp -74.75 -34.25 33.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 70.24 111.12 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.79 -32.74 60.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 74.24 110.9 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.11 -28.57 40.62 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.771 -0.728 . . . . 50.12 112.535 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.44 ' HA ' HG22 ' A' ' 22' ' ' THR . 30.4 mmtt -80.12 -30.82 39.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.783 0.325 . . . . 75.31 110.922 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.647 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -68.3 -33.79 74.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 72.34 111.098 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.648 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -71.85 -40.34 69.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 54.21 111.079 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.44 HG22 ' HA ' ' A' ' 19' ' ' LYS . 9.2 t -80.7 -23.43 39.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.254 -0.43 . . . . 70.44 111.114 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -74.69 -38.48 62.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 71.45 110.859 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 20' ' ' ALA . 93.0 t -72.1 -35.1 52.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 63.41 111.108 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 21' ' ' ALA . 95.4 t -69.79 -36.89 71.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 75.11 111.14 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.17 -32.93 38.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 63.13 111.12 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.03 -19.79 54.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 33.01 111.119 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -59.74 -20.94 59.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.215 -0.448 . . . . 74.24 110.913 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.91 -33.41 73.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 73.04 110.878 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 73.03 110.858 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.8 m . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.843 0.354 . . . . 62.03 111.139 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.07 -19.44 47.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.469 . . . . 75.23 110.928 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.42 -35.93 90.83 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.747 -0.74 . . . . 55.32 112.47 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -67.23 -40.11 86.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.764 0.316 . . . . 74.32 110.847 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.406 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 1.2 tt -85.51 -19.67 8.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 70.3 111.151 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -68.69 -36.48 78.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 72.05 110.869 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.703 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.1 -56.53 35.17 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.534 0.683 . . . . 73.34 111.075 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.703 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 53.9 Cg_endo -69.69 -29.39 24.26 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.657 2.238 . . . . 74.24 112.385 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -80.4 -17.36 52.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 65.0 110.859 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.587 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.87 -54.73 52.38 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.683 0.754 . . . . 72.25 110.901 -179.917 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 54.0 Cg_endo -69.81 -27.72 25.91 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.668 2.245 . . . . 62.33 112.348 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.4 m -82.09 -18.04 44.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 74.25 110.828 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.629 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -57.75 -52.61 73.07 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.649 0.737 . . . . 73.4 110.869 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.629 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.5 Cg_endo -69.75 -23.85 30.4 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.693 2.262 . . . . 71.42 112.345 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.68 -42.08 22.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 44.51 111.125 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 11.2 tp -74.8 -34.25 33.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.435 . . . . 65.12 111.117 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.513 HD12 ' O ' ' A' ' 13' ' ' SER . 3.7 mt -75.62 -32.82 60.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 74.11 110.956 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.17 -28.54 40.5 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.744 -0.741 . . . . 64.54 112.484 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.436 ' HA ' HG22 ' A' ' 22' ' ' THR . 84.6 mttt -80.12 -30.83 39.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.803 0.335 . . . . 75.43 110.943 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.655 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -68.32 -33.77 74.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 74.13 111.075 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.594 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -71.83 -40.38 69.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.263 -0.426 . . . . 62.43 111.076 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.436 HG22 ' HA ' ' A' ' 19' ' ' LYS . 9.2 t -80.77 -23.26 39.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 62.32 111.136 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -74.78 -38.53 62.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 71.23 110.831 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 20' ' ' ALA . 93.2 t -71.81 -35.8 56.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 71.1 111.129 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 21' ' ' ALA . 90.5 t -70.22 -36.96 69.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 63.25 111.11 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.17 -30.83 38.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 45.21 111.107 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -80.4 -36.49 33.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.216 -0.447 . . . . 65.44 111.083 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 90.0 t90 -68.05 -40.09 82.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 71.3 110.968 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.92 -29.36 63.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 71.33 110.902 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.4 t . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 62.3 110.888 -179.894 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 6.9 m . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.864 0.364 . . . . 74.25 111.103 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.19 -19.38 47.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.148 -0.478 . . . . 75.43 110.839 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.44 -35.88 90.75 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.779 -0.724 . . . . 72.42 112.503 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 13.0 mmt85 -67.24 -40.16 86.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.817 0.341 . . . . 70.42 110.853 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.407 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 2.4 tt -85.57 -19.61 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.452 . . . . 64.31 111.133 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -68.67 -36.41 78.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 64.41 110.898 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.7 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.12 -56.49 35.59 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.63 0.729 . . . . 72.25 111.121 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.7 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 53.5 Cg_endo -69.77 -29.37 23.94 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.659 2.24 . . . . 70.53 112.338 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -80.39 -17.39 52.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 71.22 110.851 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.588 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -57.81 -54.77 51.86 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.679 0.752 . . . . 70.11 110.88 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.588 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.4 Cg_endo -69.77 -27.42 26.45 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.67 2.247 . . . . 74.23 112.341 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.0 m -82.25 -18.33 42.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 55.03 110.92 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.636 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -57.84 -52.25 75.82 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.683 0.754 . . . . 72.55 110.837 -179.812 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.8 Cg_endo -69.76 -23.97 30.18 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.674 2.249 . . . . 74.32 112.378 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.73 -42.04 22.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 45.3 111.068 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.7 tp -74.61 -34.22 34.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 64.42 111.189 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.3 tt -75.84 -32.67 59.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 73.31 110.919 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.19 -28.42 40.92 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.719 -0.753 . . . . 72.54 112.506 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.1 mmtp -80.08 -31.28 39.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.78 0.324 . . . . 62.41 110.879 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.666 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -67.04 -36.93 83.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 40.15 111.097 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.647 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -70.24 -39.16 75.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 73.11 111.101 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 85.8 m -80.25 -24.15 40.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.439 . . . . 71.23 111.134 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -75.44 -38.68 59.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 73.22 110.832 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 20' ' ' ALA . 93.7 t -70.9 -35.42 59.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 73.43 111.151 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 21' ' ' ALA . 94.9 t -70.37 -37.06 69.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 62.33 111.165 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.24 -30.73 38.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 55.13 111.072 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -80.34 -36.62 33.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 73.41 111.116 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 86.9 t90 -67.98 -40.15 83.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.183 -0.462 . . . . 75.14 110.908 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.92 -29.33 63.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 64.53 110.858 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.432 . . . . 72.23 110.845 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 31.4 m . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.894 0.378 . . . . 73.43 111.137 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.15 -19.62 46.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 72.22 110.88 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -65.0 -34.34 89.63 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.734 -0.746 . . . . 72.43 112.482 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.51 -39.73 81.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.779 0.323 . . . . 73.21 110.873 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.407 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 1.1 tt -85.7 -20.02 8.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 65.32 111.15 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.58 -36.4 78.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 51.51 110.87 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.709 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.1 -56.58 34.71 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.557 0.694 . . . . 73.31 111.077 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.709 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 54.2 Cg_endo -69.7 -29.39 24.21 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.704 2.269 . . . . 73.03 112.327 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -80.37 -17.35 52.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.229 -0.441 . . . . 62.42 110.893 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.591 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.92 -54.72 52.49 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.664 0.745 . . . . 74.24 110.9 -179.897 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.6 Cg_endo -69.74 -27.74 26.22 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.656 2.237 . . . . 61.3 112.367 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.15 -18.07 44.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 61.13 110.821 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.621 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -57.67 -52.65 72.81 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.635 0.731 . . . . 62.33 110.847 -179.831 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.6 Cg_endo -69.75 -23.23 31.07 Favored 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.724 2.283 . . . . 73.2 112.351 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.06 -42.13 21.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 42.04 111.102 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.8 tp -74.43 -34.86 37.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 63.33 111.127 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.542 HD13 ' O ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -75.43 -32.71 60.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 65.42 110.924 179.892 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.06 -28.4 41.5 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.735 -0.745 . . . . 63.33 112.492 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.8 mtpt -80.08 -31.53 39.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.728 0.299 . . . . 65.52 110.847 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.668 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -66.95 -36.74 82.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.257 -0.429 . . . . 61.54 111.139 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.655 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -70.29 -39.29 74.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 61.23 111.098 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 93.1 m -80.22 -24.16 40.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 65.35 111.129 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -75.37 -38.63 59.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 73.55 110.904 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 20' ' ' ALA . 92.4 t -70.66 -34.88 58.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.469 . . . . 70.02 111.104 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 21' ' ' ALA . 98.3 t -69.98 -36.81 70.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 60.5 111.097 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.12 -32.96 38.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 65.34 111.093 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.97 -20.03 55.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 75.22 111.05 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -59.84 -25.97 65.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.251 -0.431 . . . . 63.23 110.961 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -73.62 -32.59 64.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 72.44 110.878 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 28.5 t . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 45.24 110.85 -179.879 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 18.1 m . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.929 0.395 . . . . 74.01 111.137 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.09 -19.42 47.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.475 . . . . 54.45 110.938 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.39 -35.91 90.85 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.73 -0.748 . . . . 43.12 112.517 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 -67.19 -40.14 86.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.803 0.335 . . . . 73.02 110.876 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.411 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 20.2 pt -85.55 -19.72 8.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 75.33 111.154 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -68.75 -36.17 78.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 72.01 110.909 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.707 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.17 -56.44 36.05 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.563 0.697 . . . . 60.03 111.124 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.707 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 53.6 Cg_endo -69.78 -29.56 23.56 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.676 2.251 . . . . 64.11 112.347 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -80.29 -17.41 52.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.46 . . . . 71.3 110.817 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.587 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.79 -54.89 50.63 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.624 0.725 . . . . 74.0 110.898 -179.869 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 54.2 Cg_endo -69.78 -26.2 27.75 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.658 2.239 . . . . 75.52 112.338 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.79 -19.16 38.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 62.14 110.859 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.631 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 1.9 t -57.64 -52.14 76.51 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.688 0.756 . . . . 72.24 110.851 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 13' ' ' SER . 54.3 Cg_endo -69.64 -24.81 29.79 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.7 2.267 . . . . 71.33 112.364 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.3 -40.62 26.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 72.25 111.091 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 70.4 mt -72.31 -40.25 64.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 75.3 111.186 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.1 tt -71.47 -32.21 68.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 61.21 110.931 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.46 -28.87 42.09 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.706 -0.759 . . . . 74.24 112.524 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -80.05 -31.92 39.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.845 0.355 . . . . 71.41 110.94 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.668 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -66.92 -36.59 82.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.447 . . . . 71.4 111.091 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.654 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -70.47 -39.13 74.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 70.42 111.1 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.9 m -80.26 -24.13 40.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 73.14 111.185 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -75.39 -38.72 59.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 72.01 110.853 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 20' ' ' ALA . 91.7 t -70.63 -35.11 59.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 54.15 111.099 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 21' ' ' ALA . 96.9 t -69.86 -36.73 70.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 53.5 111.135 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.18 -32.93 38.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 71.41 111.083 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.94 -20.0 54.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 75.22 111.141 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -59.88 -26.03 65.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 71.31 110.914 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.36 -32.7 64.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.254 -0.43 . . . . 73.5 110.942 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.8 t . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 74.24 110.907 -179.953 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.8 m . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.889 0.376 . . . . 54.32 111.142 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.06 -19.5 47.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 63.21 110.874 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.4 -35.89 90.81 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.712 -0.756 . . . . 64.54 112.521 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.2 mmm180 -67.2 -40.16 86.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.787 0.327 . . . . 75.21 110.856 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.409 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 19.9 pt -85.49 -19.74 8.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 71.1 111.129 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -68.81 -36.1 77.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 55.55 110.874 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.703 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.2 -56.46 35.81 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.582 0.706 . . . . 71.0 111.097 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.703 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 53.7 Cg_endo -69.74 -29.58 23.71 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.705 2.27 . . . . 73.03 112.333 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -80.27 -17.3 52.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 74.24 110.941 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.586 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.83 -54.94 50.18 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.69 0.757 . . . . 72.43 110.882 -179.901 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 54.1 Cg_endo -69.75 -26.14 27.92 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.655 2.237 . . . . 53.44 112.369 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.1 m -82.82 -19.22 38.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.461 . . . . 52.14 110.862 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.631 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 1.9 t -57.57 -52.09 76.91 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.673 0.749 . . . . 55.33 110.889 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.9 Cg_endo -69.83 -24.67 29.09 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.663 2.242 . . . . 63.4 112.336 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.32 -40.59 26.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.28 -0.418 . . . . 72.44 111.081 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 24.0 mm -72.32 -40.3 64.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 71.43 111.173 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.7 tt -71.44 -32.19 68.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 71.13 110.909 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.54 -28.83 41.91 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.753 -0.737 . . . . 70.22 112.472 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.8 mttm -80.08 -31.99 39.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.866 0.365 . . . . 71.23 110.905 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.667 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -66.86 -36.67 82.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 62.54 111.066 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.647 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -70.44 -39.11 74.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 72.43 111.101 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.3 m -80.33 -24.09 40.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.204 -0.453 . . . . 65.4 111.143 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -75.47 -38.63 59.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 54.12 110.88 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 20' ' ' ALA . 92.6 t -70.93 -35.53 60.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 61.53 111.122 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 21' ' ' ALA . 97.5 t -70.34 -37.0 69.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 75.22 111.13 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.22 -30.74 38.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 72.35 111.082 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -80.4 -36.53 33.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 53.51 111.132 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 68.2 t-105 -68.02 -40.13 83.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.451 . . . . 75.33 110.954 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.92 -29.37 63.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 74.04 110.895 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 64.31 110.834 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.7 m . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.888 0.375 . . . . 75.31 111.179 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.18 -19.21 47.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.453 . . . . 74.22 110.916 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -65.36 -35.64 91.7 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.77 -0.729 . . . . 52.02 112.473 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 9.4 mmm-85 -67.36 -40.23 85.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.766 0.317 . . . . 75.2 110.862 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.408 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 9.1 tt -85.66 -19.64 8.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 61.4 111.144 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -68.71 -36.31 78.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 72.13 110.876 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.697 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.17 -56.51 35.31 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.615 0.721 . . . . 51.34 111.108 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.697 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 53.3 Cg_endo -69.82 -29.3 23.77 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.632 2.221 . . . . 71.54 112.339 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -80.43 -17.34 52.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 53.41 110.871 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.591 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.92 -54.74 52.36 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.605 0.717 . . . . 73.24 110.855 -179.877 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.8 Cg_endo -69.74 -27.41 26.61 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.714 2.276 . . . . 63.25 112.318 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.6 t -82.3 -18.43 42.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.43 . . . . 60.11 110.877 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.636 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -57.79 -52.24 75.82 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.662 0.744 . . . . 72.13 110.858 -179.819 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.8 Cg_endo -69.73 -24.03 30.26 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.661 2.241 . . . . 54.04 112.321 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.7 -42.02 22.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 75.51 111.092 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.6 tp -74.58 -34.29 34.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 73.24 111.162 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 30.6 mt -75.75 -32.77 60.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.12 -0.491 . . . . 72.2 110.902 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.1 -28.46 41.08 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.747 -0.739 . . . . 73.32 112.518 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.4 mttp -80.07 -31.24 39.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.809 0.338 . . . . 73.24 110.91 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.664 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -67.16 -36.64 82.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 70.45 111.104 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.645 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -70.37 -39.22 74.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.434 . . . . 64.02 111.08 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.1 m -80.3 -24.04 40.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 75.25 111.131 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -75.43 -38.58 59.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 71.54 110.853 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 20' ' ' ALA . 92.7 t -71.1 -35.44 58.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.446 . . . . 64.53 111.106 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 21' ' ' ALA . 95.9 t -70.37 -37.12 69.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 74.15 111.11 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.17 -30.69 38.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 62.22 111.1 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -80.39 -36.69 33.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 64.1 111.042 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 50.4 t90 -68.0 -40.06 83.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.434 . . . . 74.14 110.919 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.99 -29.26 62.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.285 -0.416 . . . . 71.45 110.849 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 10.6 t . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.248 -0.433 . . . . 62.32 110.833 -179.871 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.413 ' O ' HG12 ' A' ' 1' ' ' VAL . 14.5 t . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.861 0.363 . . . . 71.43 111.096 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.14 -19.59 46.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.457 . . . . 73.34 110.92 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -65.06 -34.2 89.17 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.706 -0.759 . . . . 74.34 112.545 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -68.53 -39.81 81.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.82 0.343 . . . . 64.52 110.876 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.409 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 28.9 pt -85.65 -19.99 8.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 75.55 111.164 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.6 -36.4 78.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.189 -0.46 . . . . 75.43 110.878 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.709 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.09 -56.53 35.22 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.587 0.708 . . . . 61.35 111.108 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.709 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 53.9 Cg_endo -69.79 -29.27 23.98 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.661 2.241 . . . . 65.45 112.389 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -80.45 -17.38 51.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 73.44 110.859 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.594 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.91 -54.71 52.64 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.664 0.745 . . . . 74.45 110.918 -179.916 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.4 Cg_endo -69.79 -27.77 25.93 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.69 2.26 . . . . 63.41 112.332 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.04 -18.09 44.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 74.02 110.836 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.627 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -57.75 -52.56 73.47 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.676 0.75 . . . . 71.22 110.885 -179.804 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.7 Cg_endo -69.76 -23.85 30.34 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.713 2.275 . . . . 74.22 112.33 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.69 -42.07 22.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 74.42 111.114 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.6 tp -74.76 -34.3 33.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 73.51 111.111 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 51.1 tp -75.66 -32.71 60.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 65.32 110.958 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.22 -28.54 40.3 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.757 -0.735 . . . . 62.14 112.419 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.441 ' HA ' HG22 ' A' ' 22' ' ' THR . 4.9 mtpp -80.12 -30.83 39.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.752 0.31 . . . . 61.02 110.889 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.653 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -68.28 -33.83 75.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.283 -0.417 . . . . 62.5 111.071 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.648 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -71.81 -40.41 69.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 63.23 111.048 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.441 HG22 ' HA ' ' A' ' 19' ' ' LYS . 9.2 t -80.71 -23.38 39.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 70.31 111.111 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -74.72 -38.49 62.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 62.3 110.87 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 20' ' ' ALA . 94.2 t -71.94 -35.12 53.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 62.14 111.151 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 21' ' ' ALA . 96.1 t -69.79 -36.86 71.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 73.34 111.125 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.22 -32.9 38.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 71.41 111.128 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.01 -19.83 54.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 72.23 111.127 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -59.67 -20.99 59.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 73.43 110.922 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.95 -33.3 73.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 64.13 110.907 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 74.35 110.844 -179.916 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.9 m . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.854 0.359 . . . . 73.41 111.155 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.07 -19.48 47.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 71.44 110.902 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.4 -35.95 90.9 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.794 -0.717 . . . . 35.13 112.473 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 79.8 mtt180 -67.16 -40.15 86.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.758 0.313 . . . . 74.35 110.853 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.411 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 14.7 tt -85.49 -19.75 8.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 75.54 111.138 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -68.75 -36.15 78.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 73.42 110.823 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.706 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.24 -56.47 35.74 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.604 0.716 . . . . 64.24 111.101 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.706 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 53.9 Cg_endo -69.75 -29.39 24.01 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.676 2.25 . . . . 53.12 112.371 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -80.54 -17.22 52.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 74.11 110.89 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.595 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -58.02 -54.45 55.46 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.659 0.742 . . . . 62.11 110.887 -179.883 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.8 Cg_endo -69.74 -27.35 26.69 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.7 2.266 . . . . 73.21 112.321 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.42 -19.1 39.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 71.34 110.865 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.644 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -56.09 -52.07 75.66 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.633 0.73 . . . . 72.33 110.83 -179.778 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.644 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.5 Cg_endo -69.78 -20.24 35.0 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.675 2.25 . . . . 70.41 112.36 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.9 -42.54 19.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.434 . . . . 75.53 111.089 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.449 HG13 HD22 ' A' ' 17' ' ' LEU . 22.2 pt -74.29 -35.91 41.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 65.41 111.099 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.449 HD22 HG13 ' A' ' 16' ' ' ILE . 2.7 mm? -74.32 -32.81 62.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 72.22 110.901 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.04 -28.64 40.66 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.743 -0.741 . . . . 72.04 112.489 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.456 ' HA ' HG22 ' A' ' 22' ' ' THR . 10.0 mtpt -80.19 -30.44 38.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.762 0.315 . . . . 70.42 110.838 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.679 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -68.49 -34.48 75.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.284 -0.416 . . . . 72.54 111.089 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.61 -40.24 69.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 64.21 111.073 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.456 HG22 ' HA ' ' A' ' 19' ' ' LYS . 9.3 t -80.75 -22.59 40.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 52.23 111.148 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -75.76 -38.53 58.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 72.23 110.903 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 20' ' ' ALA . 96.3 t -67.83 -40.34 83.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 73.03 111.146 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.2 p -69.56 -34.28 60.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 74.33 111.171 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.25 -29.13 38.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.126 -0.488 . . . . 53.03 111.133 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.98 -19.94 54.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 54.14 111.109 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 13.0 t-105 -59.95 -28.52 67.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 62.42 110.934 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.1 ptmt -70.1 -32.57 70.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 75.34 110.958 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.1 t . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 54.02 110.864 -179.892 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 31.6 m . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.898 0.38 . . . . 71.22 111.112 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.14 -19.44 47.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.141 -0.481 . . . . 73.34 110.895 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.42 -35.89 90.78 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.705 -0.759 . . . . 64.45 112.499 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 26.4 mmt85 -67.17 -40.2 86.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.813 0.339 . . . . 73.51 110.84 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.41 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 31.4 pt -85.5 -19.69 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 52.4 111.137 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -68.81 -36.12 77.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.458 . . . . 62.31 110.887 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.703 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.21 -56.47 35.72 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.599 0.714 . . . . 73.54 111.113 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.703 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 54.4 Cg_endo -69.71 -29.56 23.92 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.714 2.276 . . . . 73.35 112.395 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -80.34 -17.3 52.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 52.53 110.897 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.593 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.82 -54.95 50.07 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.632 0.73 . . . . 72.23 110.884 -179.906 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.7 Cg_endo -69.7 -26.17 28.11 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.716 2.277 . . . . 73.24 112.363 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.7 t -82.88 -19.14 37.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 62.11 110.857 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.634 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 2.0 t -57.63 -51.96 77.88 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.665 0.745 . . . . 74.11 110.886 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.634 ' HD2' ' N ' ' A' ' 13' ' ' SER . 54.0 Cg_endo -69.77 -24.08 30.03 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.693 2.262 . . . . 63.32 112.387 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.67 -42.02 22.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 64.0 111.101 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 12.4 tt -74.62 -34.29 34.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 62.12 111.083 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.9 tp -75.74 -32.75 60.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 73.13 110.899 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.19 -28.36 41.11 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.695 -0.764 . . . . 45.45 112.462 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.8 mttt -80.11 -31.29 39.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.752 0.311 . . . . 75.4 110.882 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.661 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -66.76 -39.97 88.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 63.45 111.133 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.24 -37.07 77.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 63.13 111.084 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.0 m -80.32 -24.74 39.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.25 -0.432 . . . . 33.04 111.161 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -77.39 -37.49 51.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 72.04 110.882 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 20' ' ' ALA . 91.5 t -71.08 -40.1 75.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.448 . . . . 51.43 111.184 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.0 p -68.67 -33.82 61.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 71.0 111.105 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.29 -32.56 38.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 74.14 111.028 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.01 -19.94 55.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 42.44 111.051 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -59.95 -30.72 69.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.245 -0.434 . . . . 70.12 110.905 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.5 ptmm? -67.36 -32.64 73.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 63.34 110.921 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.4 p . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.223 -0.444 . . . . 64.34 110.889 -179.917 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.422 ' O ' HG12 ' A' ' 1' ' ' VAL . 14.4 t . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.902 0.382 . . . . 74.11 111.117 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.8 pptp? -80.18 -19.61 46.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.459 . . . . 75.1 110.891 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -65.02 -34.36 89.65 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.719 -0.753 . . . . 74.34 112.472 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 -68.48 -39.76 81.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.766 0.317 . . . . 72.11 110.866 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.408 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 29.4 pt -85.68 -19.99 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 73.41 111.102 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.64 -36.31 78.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 71.25 110.905 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.698 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.11 -56.58 34.63 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.613 0.72 . . . . 72.42 111.068 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.698 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 53.7 Cg_endo -69.78 -29.34 23.92 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.687 2.258 . . . . 60.32 112.313 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -80.4 -17.28 52.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.221 -0.445 . . . . 74.23 110.922 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.593 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.95 -54.75 52.27 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.634 0.731 . . . . 72.35 110.851 -179.918 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.8 Cg_endo -69.78 -27.71 26.07 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.741 2.294 . . . . 61.24 112.33 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.3 m -82.19 -17.99 44.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 60.5 110.844 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.635 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.2 OUTLIER -57.78 -52.62 73.08 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.68 0.752 . . . . 73.25 110.842 -179.838 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.635 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.7 Cg_endo -69.75 -23.85 30.39 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.73 2.287 . . . . 72.41 112.341 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.7 -41.99 22.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 64.11 111.153 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 15.4 tt -74.76 -34.33 33.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 71.52 111.125 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.66 -32.73 60.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 60.42 110.893 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.24 -28.52 40.31 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.792 -0.718 . . . . 73.15 112.434 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.432 ' HA ' HG22 ' A' ' 22' ' ' THR . 4.0 mtpm? -80.2 -30.84 38.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.74 0.305 . . . . 64.2 110.873 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.634 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -68.34 -33.69 74.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 60.53 111.134 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.636 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -71.88 -40.37 68.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 71.0 111.099 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.432 HG22 ' HA ' ' A' ' 19' ' ' LYS . 9.3 t -80.65 -23.4 39.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 72.15 111.188 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -75.18 -37.82 61.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 74.25 110.881 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 20' ' ' ALA . 85.7 t -72.77 -35.7 50.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.228 -0.442 . . . . 63.45 111.125 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 21' ' ' ALA . 95.9 t -70.17 -37.3 71.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 61.34 111.137 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.23 -30.57 38.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 74.21 111.073 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -80.36 -36.79 33.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 60.24 111.104 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 30.2 t90 -67.91 -40.13 83.44 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.196 -0.456 . . . . 71.52 110.938 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.89 -29.3 63.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 74.45 110.92 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.5 m . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.236 -0.438 . . . . 74.31 110.87 -179.915 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 18.4 m . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.886 0.374 . . . . 55.33 111.137 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.07 -19.48 47.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 75.34 110.878 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.42 -35.89 90.78 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.688 -0.768 . . . . 70.42 112.537 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.3 mtt180 -67.15 -40.11 86.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.853 0.359 . . . . 64.52 110.891 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.407 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 10.7 tp -85.55 -19.81 8.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 73.53 111.167 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -68.55 -36.43 78.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 74.42 110.86 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.71 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.06 -56.62 34.32 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.581 0.705 . . . . 73.25 111.089 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.71 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 53.3 Cg_endo -69.74 -29.27 24.22 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.696 2.264 . . . . 64.01 112.326 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -80.54 -17.32 51.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 74.52 110.806 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.59 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.93 -54.67 53.02 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.696 0.76 . . . . 72.33 110.866 -179.884 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.8 Cg_endo -69.69 -27.71 26.45 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.705 2.27 . . . . 71.13 112.386 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m -82.16 -18.34 43.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.46 . . . . 71.01 110.872 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.633 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -57.2 -52.55 73.32 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.667 0.746 . . . . 75.21 110.88 -179.823 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.633 ' HD2' ' N ' ' A' ' 13' ' ' SER . 54.0 Cg_endo -69.76 -23.48 30.77 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.659 2.24 . . . . 74.34 112.3 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.56 -41.67 23.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.26 -0.427 . . . . 63.55 111.091 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 33.6 mm -72.41 -40.07 63.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.462 . . . . 71.13 111.16 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -71.83 -31.87 66.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 44.1 110.911 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.61 -28.93 41.21 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.715 -0.755 . . . . 54.25 112.534 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.8 mtpp -80.05 -32.17 39.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.731 0.301 . . . . 72.25 110.881 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.67 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -66.83 -36.64 82.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 55.55 111.134 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.655 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -70.42 -39.09 74.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 64.4 111.122 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.9 m -80.31 -24.11 40.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 65.32 111.163 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -75.38 -38.94 59.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 74.33 110.802 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.67 HG23 ' O ' ' A' ' 20' ' ' ALA . 92.6 t -70.35 -35.02 60.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 75.41 111.167 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 21' ' ' ALA . 96.7 t -69.94 -36.7 70.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 63.31 111.123 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.21 -32.81 38.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.481 . . . . 52.13 111.093 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.03 -19.96 55.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.271 -0.422 . . . . 72.24 111.105 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 9.9 t90 -59.93 -27.59 66.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.457 . . . . 64.13 110.932 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.32 -32.61 68.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 64.14 110.922 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.9 t . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.445 . . . . 73.34 110.883 -179.917 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 31.1 m . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.865 0.364 . . . . 74.21 111.168 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.09 -18.72 45.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 74.5 110.882 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -67.37 -34.34 84.74 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.725 -0.75 . . . . 64.32 112.508 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -69.99 -37.59 75.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.815 0.34 . . . . 71.12 110.826 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.6 tt -87.09 -19.88 7.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 73.51 111.149 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -69.47 -36.57 76.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 51.55 110.854 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.688 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.09 -56.2 38.6 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.557 0.694 . . . . 61.34 111.068 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.688 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 53.8 Cg_endo -69.76 -29.56 23.66 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.69 2.26 . . . . 70.41 112.346 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -80.4 -17.31 52.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 74.35 110.896 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.599 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -57.83 -54.81 51.51 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.648 0.737 . . . . 75.11 110.876 -179.901 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 54.2 Cg_endo -69.71 -27.76 26.3 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.73 2.287 . . . . 73.43 112.324 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.1 -18.04 44.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 65.43 110.856 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.635 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -57.75 -52.59 73.23 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.657 0.741 . . . . 55.25 110.869 -179.832 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.635 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.5 Cg_endo -69.8 -23.79 30.21 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.664 2.243 . . . . 53.31 112.351 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.75 -41.98 22.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.227 -0.442 . . . . 62.44 111.086 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 11.2 tp -74.82 -34.24 32.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 72.12 111.113 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.3 tp -75.86 -32.6 59.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 74.24 110.925 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.21 -28.43 40.8 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.708 -0.758 . . . . 74.24 112.526 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.3 mttt -80.0 -31.36 39.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.823 0.344 . . . . 63.4 110.938 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.662 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -67.05 -36.65 82.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 73.45 111.089 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.654 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -70.29 -39.4 74.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.244 -0.434 . . . . 54.41 111.081 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.4 m -80.27 -24.0 40.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 51.33 111.14 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -75.39 -38.63 59.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.438 . . . . 65.31 110.857 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 20' ' ' ALA . 92.8 t -70.83 -35.14 58.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.202 -0.454 . . . . 53.32 111.142 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 21' ' ' ALA . 96.2 t -69.87 -36.67 70.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 70.22 111.141 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.17 -32.91 38.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.465 . . . . 74.22 111.111 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -80.12 -19.82 46.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 75.42 111.087 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -59.77 -22.94 62.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 74.04 110.917 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.34 -33.23 74.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 73.21 110.922 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 73.51 110.844 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.75 HG12 ' H ' ' A' ' 3' ' ' GLY . 11.8 t . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.9 0.381 . . . . 73.51 111.114 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.15 -19.61 46.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 73.13 110.876 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.75 ' H ' HG12 ' A' ' 1' ' ' VAL . . . -66.29 -35.94 91.0 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.742 -0.742 . . . . 73.43 112.51 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 44.5 mmm-85 -67.19 -40.16 86.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.777 0.323 . . . . 73.3 110.866 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.411 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 0.8 OUTLIER -85.52 -19.75 8.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.46 . . . . 53.31 111.107 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -68.77 -36.17 77.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.46 . . . . 72.02 110.831 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.704 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.16 -56.52 35.25 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.607 0.718 . . . . 71.3 111.083 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.704 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 53.4 Cg_endo -69.78 -29.46 23.72 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.665 2.243 . . . . 73.13 112.345 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -80.36 -17.34 52.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 71.13 110.864 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.594 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.89 -54.72 52.52 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.668 0.747 . . . . 72.51 110.883 -179.866 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.6 Cg_endo -69.79 -27.77 25.92 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.732 2.288 . . . . 71.01 112.298 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.1 -18.0 44.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.272 -0.422 . . . . 72.35 110.9 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.628 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -57.85 -52.58 73.34 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.638 0.732 . . . . 73.34 110.811 -179.806 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.628 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.9 Cg_endo -69.75 -23.79 30.46 Favored 'Trans proline' 0 C--N 1.341 0.132 0 C-N-CA 122.682 2.255 . . . . 75.1 112.367 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.78 -41.98 22.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 74.13 111.095 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.1 tp -74.82 -34.25 32.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.431 . . . . 73.41 111.111 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.7 tp -75.74 -32.7 60.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.461 . . . . 60.24 110.933 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.22 -28.49 40.5 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.746 -0.74 . . . . 54.12 112.481 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -80.04 -31.1 39.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.841 0.353 . . . . 73.01 110.931 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.691 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -66.95 -40.08 87.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 72.41 111.07 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.48 -37.44 77.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 70.22 111.131 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.6 m -80.46 -23.27 40.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 74.23 111.166 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -77.92 -38.86 44.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 74.4 110.905 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 20' ' ' ALA . 99.3 t -66.19 -40.31 86.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 74.31 111.133 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.5 m -68.92 -31.91 52.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 73.25 111.094 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.48 -34.18 36.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 50.13 111.105 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.0 -19.96 55.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 71.01 111.081 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -59.9 -25.65 65.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.244 -0.434 . . . . 72.22 110.907 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.46 -32.82 74.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.252 -0.431 . . . . 61.34 110.88 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.9 t . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 63.02 110.833 -179.897 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.422 ' O ' HG12 ' A' ' 1' ' ' VAL . 14.3 t . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.875 0.369 . . . . 62.43 111.139 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.09 -19.44 47.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 61.11 110.906 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.46 -35.98 90.87 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.726 -0.749 . . . . 75.14 112.459 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.7 mmt-85 -67.05 -40.14 87.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.773 0.321 . . . . 65.5 110.915 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.411 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 1.1 tt -85.55 -19.73 8.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 63.2 111.084 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -68.74 -36.15 78.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.207 -0.451 . . . . 65.42 110.86 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.695 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.23 -56.47 35.7 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.572 0.701 . . . . 63.14 111.126 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.695 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 54.0 Cg_endo -69.75 -29.4 24.0 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.705 2.27 . . . . 45.14 112.342 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -80.54 -17.26 52.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.242 -0.436 . . . . 70.14 110.866 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.601 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.98 -54.44 55.52 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.646 0.736 . . . . 75.23 110.941 -179.928 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.8 Cg_endo -69.77 -27.31 26.56 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.661 2.241 . . . . 65.11 112.342 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.46 -19.11 39.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 72.54 110.802 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.643 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.2 OUTLIER -55.99 -52.14 74.91 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.689 0.757 . . . . 73.21 110.874 -179.83 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.643 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.6 Cg_endo -69.79 -20.58 34.49 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.687 2.258 . . . . 70.34 112.302 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.42 -42.38 20.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.283 -0.417 . . . . 71.43 111.08 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.1 pt -75.73 -35.17 30.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 62.21 111.115 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.482 HD13 ' O ' ' A' ' 17' ' ' LEU . 0.2 OUTLIER -76.55 -30.57 57.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 45.35 110.947 179.89 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.54 -29.78 35.04 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.706 -0.759 . . . . 71.2 112.467 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.439 ' HA ' HG22 ' A' ' 22' ' ' THR . 0.0 OUTLIER -80.9 -31.28 35.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.786 0.327 . . . . 72.03 110.884 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.657 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -68.12 -33.75 75.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 64.34 111.081 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.648 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -71.86 -40.37 69.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 74.23 111.117 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.439 HG22 ' HA ' ' A' ' 19' ' ' LYS . 9.2 t -80.77 -23.33 39.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.215 -0.448 . . . . 60.43 111.121 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -74.7 -38.51 62.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.24 -0.436 . . . . 65.42 110.863 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 20' ' ' ALA . 93.1 t -72.02 -35.06 52.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 72.32 111.121 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 21' ' ' ALA . 95.9 t -69.82 -36.85 71.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.46 . . . . 64.22 111.157 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.19 -32.95 38.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 72.42 111.11 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.98 -19.94 54.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 73.12 111.112 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 27.0 t90 -59.95 -26.11 65.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.205 -0.452 . . . . 73.22 110.885 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.2 ptmt -73.32 -32.62 64.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.279 -0.419 . . . . 65.22 110.914 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.9 t . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 72.43 110.862 -179.886 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.834 0.35 . . . . 74.420000000000002 110.874 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.42 -35.88 90.77 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.762 -0.732 . . . . 74.530000000000001 112.543 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.15 -40.17 86.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.767 0.318 . . . . 72.329999999999998 110.844 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.407 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 1.6 tt -85.52 -19.74 8.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 71.25 111.126 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -68.77 -36.15 77.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.143 -0.481 . . . . 70.019999999999996 110.872 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.708 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.2 -56.41 36.3 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.644 0.735 . . . . 73.150000000000006 111.144 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.708 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 53.5 Cg_endo -69.82 -29.48 23.51 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.663 2.242 . . . . 62.310000000000002 112.316 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -80.43 -17.24 52.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.435 . . . . 73.0 110.862 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.586 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.87 -54.8 51.68 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.632 0.729 . . . . 60.109999999999999 110.894 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.9 Cg_endo -69.75 -27.78 26.08 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.695 2.263 . . . . 71.120000000000005 112.344 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.03 -18.0 44.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.441 . . . . 73.329999999999998 110.879 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.62 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -57.79 -52.72 72.35 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.696 0.76 . . . . 75.209999999999994 110.861 -179.823 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.62 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.6 Cg_endo -69.76 -24.5 29.6 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.691 2.261 . . . . 70.129999999999995 112.344 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.32 -40.85 25.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 74.530000000000001 111.068 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 23.9 mm -72.19 -40.44 65.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 75.519999999999996 111.132 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.4 mt -71.9 -30.23 65.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.469 . . . . 74.439999999999998 110.923 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.44 -30.29 37.34 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.712 -0.756 . . . . 51.439999999999998 112.493 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.438 ' HA ' HG22 ' A' ' 22' ' ' THR . 0.0 OUTLIER -80.09 -32.65 39.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.811 0.338 . . . . 72.409999999999997 110.882 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.655 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -67.65 -33.19 74.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.251 -0.432 . . . . 54.450000000000003 111.113 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.647 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -72.18 -40.49 67.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 72.540000000000006 111.122 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.438 HG22 ' HA ' ' A' ' 19' ' ' LYS . 9.1 t -80.79 -23.3 39.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 61.119999999999997 111.154 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -74.63 -38.55 62.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 75.349999999999994 110.911 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 20' ' ' ALA . 94.4 t -71.99 -35.1 52.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 74.340000000000003 111.159 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 21' ' ' ALA . 96.5 t -69.85 -36.88 71.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 74.430000000000007 111.091 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.23 -32.92 38.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 64.030000000000001 111.105 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 61.350000000000001 111.115 179.889 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.07 0 CA-C-O 120.888 0.375 . . . . 75.230000000000004 110.91 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.42 -35.86 90.74 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.784 -0.722 . . . . 72.140000000000001 112.474 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -67.27 -40.08 86.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.759 0.314 . . . . 74.129999999999995 110.875 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.408 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 4.0 tt -85.61 -19.62 8.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.2 -0.454 . . . . 71.510000000000005 111.105 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -68.76 -36.4 78.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 74.049999999999997 110.85 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.706 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.14 -56.49 35.53 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.567 0.699 . . . . 74.540000000000006 111.077 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.706 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 53.9 Cg_endo -69.75 -29.35 24.04 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.715 2.277 . . . . 61.32 112.34 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -80.44 -17.35 52.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.258 -0.428 . . . . 72.519999999999996 110.894 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.594 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.93 -54.67 53.1 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.628 0.728 . . . . 75.239999999999995 110.902 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.8 Cg_endo -69.74 -27.9 26.01 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.705 2.27 . . . . 64.129999999999995 112.357 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.96 -18.09 44.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.436 . . . . 71.420000000000002 110.84 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.625 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -57.73 -52.83 71.49 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.66 0.743 . . . . 74.109999999999999 110.794 -179.755 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.625 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.6 Cg_endo -69.73 -24.39 29.88 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.717 2.278 . . . . 74.150000000000006 112.336 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.22 -40.53 26.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 51.299999999999997 111.085 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 54.8 mt -73.25 -39.88 56.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 64.420000000000002 111.122 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.23 -29.65 62.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 41.340000000000003 110.921 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.84 -30.46 35.4 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.763 -0.732 . . . . 75.150000000000006 112.473 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.439 ' HA ' HG22 ' A' ' 22' ' ' THR . 50.8 pttt -80.8 -31.9 35.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.797 0.332 . . . . 73.019999999999996 110.916 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.65 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -67.89 -33.44 74.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 73.140000000000001 111.141 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.649 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -72.05 -40.43 68.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 74.040000000000006 111.063 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.439 HG22 ' HA ' ' A' ' 19' ' ' LYS . 9.0 t -80.78 -23.34 39.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 74.439999999999998 111.104 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -74.68 -38.51 62.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 73.140000000000001 110.874 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 20' ' ' ALA . 93.6 t -72.03 -35.12 52.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 75.519999999999996 111.123 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 21' ' ' ALA . 95.2 t -69.81 -36.86 71.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 70.439999999999998 111.11 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.17 -32.96 38.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 73.439999999999998 111.111 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 71.209999999999994 111.085 179.935 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.861 0.363 . . . . 74.099999999999994 110.923 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.42 -35.89 90.77 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.761 -0.733 . . . . 60.509999999999998 112.499 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 11.6 mtm180 -67.24 -40.09 86.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.788 0.328 . . . . 71.549999999999997 110.903 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.402 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 4.7 tt -85.59 -19.65 8.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 74.340000000000003 111.087 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -68.7 -36.47 78.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 73.329999999999998 110.88 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.706 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.06 -56.48 35.73 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.567 0.699 . . . . 62.549999999999997 111.124 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.706 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 53.5 Cg_endo -69.83 -29.33 23.71 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.653 2.235 . . . . 55.049999999999997 112.319 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -80.46 -17.31 52.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 74.340000000000003 110.805 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.586 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.91 -54.76 52.06 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.664 0.745 . . . . 64.219999999999999 110.862 -179.87 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.8 Cg_endo -69.71 -27.82 26.23 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.71 2.273 . . . . 71.040000000000006 112.363 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.9 m -82.01 -18.03 44.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 74.349999999999994 110.857 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.629 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -57.84 -52.69 72.54 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.617 0.722 . . . . 55.140000000000001 110.848 -179.769 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.629 ' HD2' ' N ' ' A' ' 13' ' ' SER . 54.4 Cg_endo -69.75 -24.54 29.61 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.624 2.216 . . . . 75.430000000000007 112.378 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.26 -40.63 26.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 71.340000000000003 111.092 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 24.1 mm -72.53 -40.24 62.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 65.109999999999999 111.151 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.9 tp -71.47 -32.12 67.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.21 -0.45 . . . . 72.209999999999994 110.916 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.56 -28.97 41.27 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.712 -0.756 . . . . 52.030000000000001 112.458 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.433 ' HA ' HG22 ' A' ' 22' ' ' THR . 26.0 mttm -80.17 -31.53 38.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.774 0.321 . . . . 74.219999999999999 110.886 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.647 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -68.11 -33.42 74.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 75.219999999999999 111.116 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.653 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -72.09 -40.4 68.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 64.510000000000005 111.064 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.433 HG22 ' HA ' ' A' ' 19' ' ' LYS . 9.2 t -80.77 -23.28 39.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.209 -0.451 . . . . 72.120000000000005 111.181 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -74.98 -38.07 61.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 62.409999999999997 110.899 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 20' ' ' ALA . 85.2 t -72.36 -35.14 51.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 71.5 111.164 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 21' ' ' ALA . 94.8 t -69.83 -36.83 71.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 64.340000000000003 111.14 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.24 -32.84 38.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 54.030000000000001 111.102 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 54.43 111.119 179.946 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.05 0 CA-C-O 120.793 0.33 . . . . 74.129999999999995 110.914 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -65.34 -35.66 91.74 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.74 -0.743 . . . . 72.109999999999999 112.491 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.2 mmm-85 -67.32 -40.21 85.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.777 0.322 . . . . 61.100000000000001 110.882 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.406 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 1.3 tt -85.68 -19.64 8.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 54.020000000000003 111.125 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -68.69 -36.34 78.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 72.239999999999995 110.882 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.71 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.23 -56.47 35.72 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.589 0.709 . . . . 70.340000000000003 111.099 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.71 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 54.5 Cg_endo -69.72 -29.4 24.13 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.691 2.26 . . . . 61.32 112.35 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -80.48 -17.27 52.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 74.040000000000006 110.87 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.59 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.91 -54.75 52.18 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.622 0.725 . . . . 64.209999999999994 110.864 -179.919 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 54.3 Cg_endo -69.74 -27.8 26.13 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.677 2.251 . . . . 74.329999999999998 112.361 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.7 m -82.05 -18.0 44.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 52.240000000000002 110.828 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.619 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -57.79 -52.69 72.56 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.69 0.757 . . . . 74.140000000000001 110.871 -179.816 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.7 Cg_endo -69.8 -24.56 29.34 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.697 2.265 . . . . 63.009999999999998 112.313 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.24 -40.66 26.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 72.299999999999997 111.124 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 15.8 mt -72.51 -40.27 63.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 54.119999999999997 111.134 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.6 tt -71.41 -32.15 68.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 63.329999999999998 110.989 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.55 -28.93 41.43 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.72 -0.752 . . . . 73.319999999999993 112.508 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.436 ' HA ' HG22 ' A' ' 22' ' ' THR . 9.2 mttm -80.16 -31.53 38.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.835 0.35 . . . . 74.030000000000001 110.889 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.654 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -68.07 -33.57 74.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.44 . . . . 71.530000000000001 111.083 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.651 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -71.95 -40.42 68.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.438 . . . . 51.43 111.061 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.436 HG22 ' HA ' ' A' ' 19' ' ' LYS . 9.2 t -80.76 -23.33 39.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.264 -0.425 . . . . 74.129999999999995 111.126 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.68 -38.56 62.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.461 . . . . 75.430000000000007 110.879 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 20' ' ' ALA . 94.2 t -71.96 -35.19 53.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.174 -0.467 . . . . 73.129999999999995 111.146 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 21' ' ' ALA . 95.8 t -69.78 -36.84 71.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.485 . . . . 62.109999999999999 111.119 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.22 -33.0 38.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 75.5 111.079 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.434 . . . . 53.340000000000003 111.125 179.919 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.817 0.341 . . . . 71.420000000000002 110.884 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.44 -35.87 90.74 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.77 -0.729 . . . . 62.210000000000001 112.47 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -67.22 -40.18 86.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.847 0.356 . . . . 70.430000000000007 110.859 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.402 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 4.7 tt -85.54 -19.68 8.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 65.150000000000006 111.125 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -68.6 -36.5 78.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 75.030000000000001 110.868 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.703 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.1 -56.48 35.7 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.606 0.717 . . . . 72.409999999999997 111.114 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.703 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 54.2 Cg_endo -69.74 -29.39 24.03 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.679 2.253 . . . . 73.439999999999998 112.334 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -80.38 -17.37 52.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 61.119999999999997 110.91 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.585 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.86 -54.75 52.2 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.655 0.74 . . . . 71.540000000000006 110.891 -179.919 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 54.0 Cg_endo -69.7 -27.53 26.66 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.691 2.26 . . . . 65.209999999999994 112.324 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.23 -18.33 42.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 75.010000000000005 110.898 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.635 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -57.84 -52.34 75.14 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.659 0.742 . . . . 71.230000000000004 110.827 -179.827 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.635 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.5 Cg_endo -69.69 -24.81 29.56 Favored 'Trans proline' 0 N--CA 1.465 -0.178 0 C-N-CA 122.723 2.282 . . . . 73.430000000000007 112.365 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.23 -40.55 26.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 72.239999999999995 111.158 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.6 mt -72.43 -40.23 63.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 72.299999999999997 111.132 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.54 -32.06 67.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 74.129999999999995 110.915 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.54 -28.89 41.67 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.74 -0.743 . . . . 55.149999999999999 112.509 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.2 mttm -80.06 -31.94 39.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.825 0.345 . . . . 64.349999999999994 110.951 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.666 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -66.87 -36.74 83.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 71.340000000000003 111.11 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.644 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -70.41 -39.0 74.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 53.299999999999997 111.147 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.8 m -80.37 -24.06 40.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.237 -0.438 . . . . 64.540000000000006 111.144 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -75.5 -38.67 59.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 75.340000000000003 110.842 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 20' ' ' ALA . 93.2 t -70.94 -35.46 59.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.194 -0.457 . . . . 33.329999999999998 111.127 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 21' ' ' ALA . 96.3 t -70.7 -38.57 73.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 72.420000000000002 111.112 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.25 -27.44 38.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 23.52 111.129 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 72.340000000000003 111.092 179.927 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.766 0.317 . . . . 74.310000000000002 110.877 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.42 -35.9 90.81 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.787 -0.72 . . . . 70.400000000000006 112.474 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 32.3 mmt-85 -67.19 -40.17 86.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.819 0.343 . . . . 72.329999999999998 110.888 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.408 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 6.5 tt -85.53 -19.65 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 74.519999999999996 111.176 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -68.68 -36.49 78.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 75.230000000000004 110.846 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.704 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.05 -56.53 35.19 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.565 0.697 . . . . 71.019999999999996 111.074 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.704 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 53.7 Cg_endo -69.75 -29.34 24.08 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.709 2.273 . . . . 72.140000000000001 112.337 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -80.49 -17.35 51.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 74.329999999999998 110.825 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.597 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -57.92 -54.71 52.62 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.666 0.746 . . . . 73.510000000000005 110.909 -179.909 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.8 Cg_endo -69.75 -27.73 26.18 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.676 2.251 . . . . 63.240000000000002 112.398 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.4 t -82.11 -18.03 44.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 33.520000000000003 110.871 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.631 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -57.75 -52.63 72.95 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.673 0.749 . . . . 50.109999999999999 110.88 -179.838 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 13' ' ' SER . 54.1 Cg_endo -69.72 -23.82 30.56 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.686 2.257 . . . . 73.120000000000005 112.382 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.68 -42.09 22.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 64.409999999999997 111.129 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 10.2 tp -74.75 -34.25 33.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 70.239999999999995 111.12 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.79 -32.74 60.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 74.239999999999995 110.9 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.11 -28.57 40.62 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.771 -0.728 . . . . 50.119999999999997 112.535 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.44 ' HA ' HG22 ' A' ' 22' ' ' THR . 30.4 mmtt -80.12 -30.82 39.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.783 0.325 . . . . 75.310000000000002 110.922 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.647 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -68.3 -33.79 74.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 72.340000000000003 111.098 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.648 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -71.85 -40.34 69.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 54.210000000000001 111.079 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.44 HG22 ' HA ' ' A' ' 19' ' ' LYS . 9.2 t -80.7 -23.43 39.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.254 -0.43 . . . . 70.439999999999998 111.114 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -74.69 -38.48 62.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 71.450000000000003 110.859 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 20' ' ' ALA . 93.0 t -72.1 -35.1 52.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 63.409999999999997 111.108 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 21' ' ' ALA . 95.4 t -69.79 -36.89 71.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 75.109999999999999 111.14 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.17 -32.93 38.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 63.130000000000003 111.12 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 33.009999999999998 111.119 179.903 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.859 0.361 . . . . 75.230000000000004 110.928 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.42 -35.93 90.83 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.747 -0.74 . . . . 55.32 112.47 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -67.23 -40.11 86.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.764 0.316 . . . . 74.319999999999993 110.847 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.406 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 1.2 tt -85.51 -19.67 8.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 70.299999999999997 111.151 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -68.69 -36.48 78.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 72.049999999999997 110.869 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.703 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.1 -56.53 35.17 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.534 0.683 . . . . 73.340000000000003 111.075 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.703 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 53.9 Cg_endo -69.69 -29.39 24.26 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.657 2.238 . . . . 74.239999999999995 112.385 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -80.4 -17.36 52.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 65.0 110.859 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.587 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.87 -54.73 52.38 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.683 0.754 . . . . 72.25 110.901 -179.917 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 54.0 Cg_endo -69.81 -27.72 25.91 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.668 2.245 . . . . 62.329999999999998 112.348 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.4 m -82.09 -18.04 44.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 74.25 110.828 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.629 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -57.75 -52.61 73.07 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.649 0.737 . . . . 73.400000000000006 110.869 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.629 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.5 Cg_endo -69.75 -23.85 30.4 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.693 2.262 . . . . 71.420000000000002 112.345 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.68 -42.08 22.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 44.509999999999998 111.125 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 11.2 tp -74.8 -34.25 33.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.435 . . . . 65.120000000000005 111.117 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.513 HD12 ' O ' ' A' ' 13' ' ' SER . 3.7 mt -75.62 -32.82 60.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 74.109999999999999 110.956 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.17 -28.54 40.5 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.744 -0.741 . . . . 64.540000000000006 112.484 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.436 ' HA ' HG22 ' A' ' 22' ' ' THR . 84.6 mttt -80.12 -30.83 39.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.803 0.335 . . . . 75.430000000000007 110.943 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.655 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -68.32 -33.77 74.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 74.129999999999995 111.075 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.594 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -71.83 -40.38 69.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.263 -0.426 . . . . 62.43 111.076 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.436 HG22 ' HA ' ' A' ' 19' ' ' LYS . 9.2 t -80.77 -23.26 39.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 62.32 111.136 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -74.78 -38.53 62.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 71.230000000000004 110.831 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 20' ' ' ALA . 93.2 t -71.81 -35.8 56.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 71.099999999999994 111.129 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 21' ' ' ALA . 90.5 t -70.22 -36.96 69.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 63.25 111.11 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.17 -30.83 38.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 45.210000000000001 111.107 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.216 -0.447 . . . . 65.439999999999998 111.083 179.983 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.782 0.325 . . . . 75.430000000000007 110.839 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.44 -35.88 90.75 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.779 -0.724 . . . . 72.420000000000002 112.503 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 13.0 mmt85 -67.24 -40.16 86.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.817 0.341 . . . . 70.420000000000002 110.853 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.407 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 2.4 tt -85.57 -19.61 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.452 . . . . 64.310000000000002 111.133 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -68.67 -36.41 78.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 64.409999999999997 110.898 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.7 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.12 -56.49 35.59 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.63 0.729 . . . . 72.25 111.121 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.7 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 53.5 Cg_endo -69.77 -29.37 23.94 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.659 2.24 . . . . 70.530000000000001 112.338 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -80.39 -17.39 52.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 71.219999999999999 110.851 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.588 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -57.81 -54.77 51.86 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.679 0.752 . . . . 70.109999999999999 110.88 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.588 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.4 Cg_endo -69.77 -27.42 26.45 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.67 2.247 . . . . 74.230000000000004 112.341 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.0 m -82.25 -18.33 42.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 55.030000000000001 110.92 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.636 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -57.84 -52.25 75.82 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.683 0.754 . . . . 72.549999999999997 110.837 -179.812 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.8 Cg_endo -69.76 -23.97 30.18 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.674 2.249 . . . . 74.319999999999993 112.378 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.73 -42.04 22.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 45.299999999999997 111.068 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.7 tp -74.61 -34.22 34.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 64.420000000000002 111.189 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.3 tt -75.84 -32.67 59.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 73.310000000000002 110.919 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.19 -28.42 40.92 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.719 -0.753 . . . . 72.540000000000006 112.506 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.1 mmtp -80.08 -31.28 39.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.78 0.324 . . . . 62.409999999999997 110.879 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.666 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -67.04 -36.93 83.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 40.149999999999999 111.097 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.647 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -70.24 -39.16 75.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 73.109999999999999 111.101 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 85.8 m -80.25 -24.15 40.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.439 . . . . 71.230000000000004 111.134 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -75.44 -38.68 59.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 73.219999999999999 110.832 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 20' ' ' ALA . 93.7 t -70.9 -35.42 59.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 73.430000000000007 111.151 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 21' ' ' ALA . 94.9 t -70.37 -37.06 69.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 62.329999999999998 111.165 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.24 -30.73 38.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 55.130000000000003 111.072 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 73.409999999999997 111.116 179.936 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.046 0 CA-C-O 120.838 0.352 . . . . 72.219999999999999 110.88 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -65.0 -34.34 89.63 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.734 -0.746 . . . . 72.430000000000007 112.482 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.51 -39.73 81.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.779 0.323 . . . . 73.209999999999994 110.873 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.407 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 1.1 tt -85.7 -20.02 8.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 65.319999999999993 111.15 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.58 -36.4 78.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 51.509999999999998 110.87 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.709 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.1 -56.58 34.71 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.557 0.694 . . . . 73.310000000000002 111.077 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.709 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 54.2 Cg_endo -69.7 -29.39 24.21 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.704 2.269 . . . . 73.030000000000001 112.327 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -80.37 -17.35 52.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.229 -0.441 . . . . 62.420000000000002 110.893 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.591 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.92 -54.72 52.49 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.664 0.745 . . . . 74.239999999999995 110.9 -179.897 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.6 Cg_endo -69.74 -27.74 26.22 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.656 2.237 . . . . 61.299999999999997 112.367 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.15 -18.07 44.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 61.130000000000003 110.821 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.621 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -57.67 -52.65 72.81 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.635 0.731 . . . . 62.329999999999998 110.847 -179.831 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.6 Cg_endo -69.75 -23.23 31.07 Favored 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.724 2.283 . . . . 73.200000000000003 112.351 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.06 -42.13 21.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 42.039999999999999 111.102 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.8 tp -74.43 -34.86 37.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 63.329999999999998 111.127 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.542 HD13 ' O ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -75.43 -32.71 60.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 65.420000000000002 110.924 179.892 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.06 -28.4 41.5 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.735 -0.745 . . . . 63.329999999999998 112.492 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.8 mtpt -80.08 -31.53 39.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.728 0.299 . . . . 65.519999999999996 110.847 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.668 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -66.95 -36.74 82.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.257 -0.429 . . . . 61.539999999999999 111.139 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.655 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -70.29 -39.29 74.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 61.229999999999997 111.098 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 93.1 m -80.22 -24.16 40.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 65.349999999999994 111.129 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -75.37 -38.63 59.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 73.549999999999997 110.904 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 20' ' ' ALA . 92.4 t -70.66 -34.88 58.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.469 . . . . 70.019999999999996 111.104 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 21' ' ' ALA . 98.3 t -69.98 -36.81 70.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 60.5 111.097 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.12 -32.96 38.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 65.340000000000003 111.093 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 75.219999999999999 111.05 -179.989 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.038 0 CA-C-O 120.85 0.357 . . . . 54.450000000000003 110.938 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.39 -35.91 90.85 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.73 -0.748 . . . . 43.119999999999997 112.517 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 -67.19 -40.14 86.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.803 0.335 . . . . 73.019999999999996 110.876 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.411 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 20.2 pt -85.55 -19.72 8.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 75.329999999999998 111.154 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -68.75 -36.17 78.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 72.010000000000005 110.909 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.707 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.17 -56.44 36.05 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.563 0.697 . . . . 60.030000000000001 111.124 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.707 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 53.6 Cg_endo -69.78 -29.56 23.56 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.676 2.251 . . . . 64.109999999999999 112.347 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -80.29 -17.41 52.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.46 . . . . 71.299999999999997 110.817 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.587 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.79 -54.89 50.63 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.624 0.725 . . . . 74.0 110.898 -179.869 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 54.2 Cg_endo -69.78 -26.2 27.75 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.658 2.239 . . . . 75.519999999999996 112.338 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.79 -19.16 38.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 62.140000000000001 110.859 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.631 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 1.9 t -57.64 -52.14 76.51 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.688 0.756 . . . . 72.239999999999995 110.851 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 13' ' ' SER . 54.3 Cg_endo -69.64 -24.81 29.79 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.7 2.267 . . . . 71.329999999999998 112.364 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.3 -40.62 26.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 72.25 111.091 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 70.4 mt -72.31 -40.25 64.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 75.299999999999997 111.186 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.1 tt -71.47 -32.21 68.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 61.210000000000001 110.931 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.46 -28.87 42.09 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.706 -0.759 . . . . 74.239999999999995 112.524 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -80.05 -31.92 39.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.845 0.355 . . . . 71.409999999999997 110.94 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.668 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -66.92 -36.59 82.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.447 . . . . 71.400000000000006 111.091 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.654 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -70.47 -39.13 74.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 70.420000000000002 111.1 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.9 m -80.26 -24.13 40.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 73.140000000000001 111.185 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -75.39 -38.72 59.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 72.010000000000005 110.853 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 20' ' ' ALA . 91.7 t -70.63 -35.11 59.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 54.149999999999999 111.099 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 21' ' ' ALA . 96.9 t -69.86 -36.73 70.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 53.5 111.135 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.18 -32.93 38.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 71.409999999999997 111.083 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 75.219999999999999 111.141 179.905 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.831 0.348 . . . . 63.210000000000001 110.874 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.4 -35.89 90.81 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.712 -0.756 . . . . 64.540000000000006 112.521 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.2 mmm180 -67.2 -40.16 86.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.787 0.327 . . . . 75.209999999999994 110.856 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.409 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 19.9 pt -85.49 -19.74 8.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 71.099999999999994 111.129 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -68.81 -36.1 77.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 55.549999999999997 110.874 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.703 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.2 -56.46 35.81 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.582 0.706 . . . . 71.0 111.097 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.703 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 53.7 Cg_endo -69.74 -29.58 23.71 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.705 2.27 . . . . 73.030000000000001 112.333 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -80.27 -17.3 52.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 74.239999999999995 110.941 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.586 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.83 -54.94 50.18 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.69 0.757 . . . . 72.430000000000007 110.882 -179.901 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 54.1 Cg_endo -69.75 -26.14 27.92 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.655 2.237 . . . . 53.439999999999998 112.369 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.1 m -82.82 -19.22 38.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.461 . . . . 52.140000000000001 110.862 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.631 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 1.9 t -57.57 -52.09 76.91 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.673 0.749 . . . . 55.329999999999998 110.889 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.9 Cg_endo -69.83 -24.67 29.09 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.663 2.242 . . . . 63.399999999999999 112.336 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.32 -40.59 26.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.28 -0.418 . . . . 72.439999999999998 111.081 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 24.0 mm -72.32 -40.3 64.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 71.430000000000007 111.173 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.7 tt -71.44 -32.19 68.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 71.129999999999995 110.909 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.54 -28.83 41.91 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.753 -0.737 . . . . 70.219999999999999 112.472 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.8 mttm -80.08 -31.99 39.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.866 0.365 . . . . 71.230000000000004 110.905 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.667 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -66.86 -36.67 82.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 62.539999999999999 111.066 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.647 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -70.44 -39.11 74.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 72.430000000000007 111.101 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.3 m -80.33 -24.09 40.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.204 -0.453 . . . . 65.400000000000006 111.143 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -75.47 -38.63 59.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 54.119999999999997 110.88 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 20' ' ' ALA . 92.6 t -70.93 -35.53 60.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 61.530000000000001 111.122 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 21' ' ' ALA . 97.5 t -70.34 -37.0 69.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 75.219999999999999 111.13 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.22 -30.74 38.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 72.349999999999994 111.082 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 53.509999999999998 111.132 179.927 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.844 0.354 . . . . 74.219999999999999 110.916 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -65.36 -35.64 91.7 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.77 -0.729 . . . . 52.020000000000003 112.473 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 9.4 mmm-85 -67.36 -40.23 85.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.766 0.317 . . . . 75.200000000000003 110.862 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.408 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 9.1 tt -85.66 -19.64 8.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 61.399999999999999 111.144 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -68.71 -36.31 78.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 72.129999999999995 110.876 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.697 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.17 -56.51 35.31 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.615 0.721 . . . . 51.340000000000003 111.108 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.697 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 53.3 Cg_endo -69.82 -29.3 23.77 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.632 2.221 . . . . 71.540000000000006 112.339 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -80.43 -17.34 52.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 53.409999999999997 110.871 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.591 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.92 -54.74 52.36 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.605 0.717 . . . . 73.239999999999995 110.855 -179.877 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.8 Cg_endo -69.74 -27.41 26.61 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.714 2.276 . . . . 63.25 112.318 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.6 t -82.3 -18.43 42.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.43 . . . . 60.109999999999999 110.877 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.636 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -57.79 -52.24 75.82 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.662 0.744 . . . . 72.129999999999995 110.858 -179.819 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.8 Cg_endo -69.73 -24.03 30.26 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.661 2.241 . . . . 54.039999999999999 112.321 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.7 -42.02 22.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 75.510000000000005 111.092 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.6 tp -74.58 -34.29 34.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 73.239999999999995 111.162 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 30.6 mt -75.75 -32.77 60.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.12 -0.491 . . . . 72.200000000000003 110.902 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.1 -28.46 41.08 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.747 -0.739 . . . . 73.319999999999993 112.518 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.4 mttp -80.07 -31.24 39.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.809 0.338 . . . . 73.239999999999995 110.91 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.664 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -67.16 -36.64 82.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 70.450000000000003 111.104 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.645 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -70.37 -39.22 74.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.434 . . . . 64.019999999999996 111.08 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.1 m -80.3 -24.04 40.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 75.25 111.131 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -75.43 -38.58 59.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 71.540000000000006 110.853 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 20' ' ' ALA . 92.7 t -71.1 -35.44 58.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.446 . . . . 64.530000000000001 111.106 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 21' ' ' ALA . 95.9 t -70.37 -37.12 69.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 74.150000000000006 111.11 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.17 -30.69 38.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 62.219999999999999 111.1 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 64.099999999999994 111.042 179.996 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.847 0.355 . . . . 73.340000000000003 110.92 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -65.06 -34.2 89.17 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.706 -0.759 . . . . 74.340000000000003 112.545 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -68.53 -39.81 81.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.82 0.343 . . . . 64.519999999999996 110.876 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.409 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 28.9 pt -85.65 -19.99 8.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 75.549999999999997 111.164 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.6 -36.4 78.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.189 -0.46 . . . . 75.430000000000007 110.878 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.709 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.09 -56.53 35.22 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.587 0.708 . . . . 61.350000000000001 111.108 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.709 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 53.9 Cg_endo -69.79 -29.27 23.98 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.661 2.241 . . . . 65.450000000000003 112.389 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -80.45 -17.38 51.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 73.439999999999998 110.859 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.594 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.91 -54.71 52.64 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.664 0.745 . . . . 74.450000000000003 110.918 -179.916 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.4 Cg_endo -69.79 -27.77 25.93 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.69 2.26 . . . . 63.409999999999997 112.332 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.04 -18.09 44.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 74.019999999999996 110.836 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.627 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -57.75 -52.56 73.47 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.676 0.75 . . . . 71.219999999999999 110.885 -179.804 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.7 Cg_endo -69.76 -23.85 30.34 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.713 2.275 . . . . 74.219999999999999 112.33 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.69 -42.07 22.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 74.420000000000002 111.114 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.6 tp -74.76 -34.3 33.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 73.510000000000005 111.111 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 51.1 tp -75.66 -32.71 60.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 65.319999999999993 110.958 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.22 -28.54 40.3 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.757 -0.735 . . . . 62.140000000000001 112.419 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.441 ' HA ' HG22 ' A' ' 22' ' ' THR . 4.9 mtpp -80.12 -30.83 39.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.752 0.31 . . . . 61.020000000000003 110.889 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.653 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -68.28 -33.83 75.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.283 -0.417 . . . . 62.5 111.071 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.648 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -71.81 -40.41 69.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 63.229999999999997 111.048 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.441 HG22 ' HA ' ' A' ' 19' ' ' LYS . 9.2 t -80.71 -23.38 39.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 70.310000000000002 111.111 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -74.72 -38.49 62.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 62.299999999999997 110.87 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 20' ' ' ALA . 94.2 t -71.94 -35.12 53.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 62.140000000000001 111.151 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 21' ' ' ALA . 96.1 t -69.79 -36.86 71.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 73.340000000000003 111.125 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.22 -32.9 38.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 71.409999999999997 111.128 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 72.230000000000004 111.127 179.905 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.822 0.344 . . . . 71.439999999999998 110.902 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.4 -35.95 90.9 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.794 -0.717 . . . . 35.130000000000003 112.473 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 79.8 mtt180 -67.16 -40.15 86.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.758 0.313 . . . . 74.349999999999994 110.853 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.411 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 14.7 tt -85.49 -19.75 8.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 75.540000000000006 111.138 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -68.75 -36.15 78.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 73.420000000000002 110.823 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.706 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.24 -56.47 35.74 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.604 0.716 . . . . 64.239999999999995 111.101 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.706 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 53.9 Cg_endo -69.75 -29.39 24.01 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.676 2.25 . . . . 53.119999999999997 112.371 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -80.54 -17.22 52.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 74.109999999999999 110.89 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.595 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -58.02 -54.45 55.46 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.659 0.742 . . . . 62.109999999999999 110.887 -179.883 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.8 Cg_endo -69.74 -27.35 26.69 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.7 2.266 . . . . 73.209999999999994 112.321 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.42 -19.1 39.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 71.340000000000003 110.865 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.644 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -56.09 -52.07 75.66 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.633 0.73 . . . . 72.329999999999998 110.83 -179.778 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.644 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.5 Cg_endo -69.78 -20.24 35.0 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.675 2.25 . . . . 70.409999999999997 112.36 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.9 -42.54 19.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.434 . . . . 75.530000000000001 111.089 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.449 HG13 HD22 ' A' ' 17' ' ' LEU . 22.2 pt -74.29 -35.91 41.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 65.409999999999997 111.099 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.449 HD22 HG13 ' A' ' 16' ' ' ILE . 2.7 mm? -74.32 -32.81 62.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 72.219999999999999 110.901 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.04 -28.64 40.66 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.743 -0.741 . . . . 72.040000000000006 112.489 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.456 ' HA ' HG22 ' A' ' 22' ' ' THR . 10.0 mtpt -80.19 -30.44 38.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.762 0.315 . . . . 70.420000000000002 110.838 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.679 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -68.49 -34.48 75.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.284 -0.416 . . . . 72.540000000000006 111.089 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.61 -40.24 69.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 64.209999999999994 111.073 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.456 HG22 ' HA ' ' A' ' 19' ' ' LYS . 9.3 t -80.75 -22.59 40.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 52.229999999999997 111.148 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -75.76 -38.53 58.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 72.230000000000004 110.903 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 20' ' ' ALA . 96.3 t -67.83 -40.34 83.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 73.030000000000001 111.146 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.2 p -69.56 -34.28 60.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 74.329999999999998 111.171 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.25 -29.13 38.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.126 -0.488 . . . . 53.030000000000001 111.133 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 54.140000000000001 111.109 179.94 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.852 0.358 . . . . 73.340000000000003 110.895 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.42 -35.89 90.78 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.705 -0.759 . . . . 64.450000000000003 112.499 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 26.4 mmt85 -67.17 -40.2 86.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.813 0.339 . . . . 73.510000000000005 110.84 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.41 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 31.4 pt -85.5 -19.69 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 52.399999999999999 111.137 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -68.81 -36.12 77.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.458 . . . . 62.310000000000002 110.887 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.703 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.21 -56.47 35.72 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.599 0.714 . . . . 73.540000000000006 111.113 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.703 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 54.4 Cg_endo -69.71 -29.56 23.92 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.714 2.276 . . . . 73.349999999999994 112.395 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -80.34 -17.3 52.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 52.530000000000001 110.897 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.593 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.82 -54.95 50.07 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.632 0.73 . . . . 72.230000000000004 110.884 -179.906 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.7 Cg_endo -69.7 -26.17 28.11 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.716 2.277 . . . . 73.239999999999995 112.363 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.7 t -82.88 -19.14 37.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 62.109999999999999 110.857 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.634 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 2.0 t -57.63 -51.96 77.88 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.665 0.745 . . . . 74.109999999999999 110.886 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.634 ' HD2' ' N ' ' A' ' 13' ' ' SER . 54.0 Cg_endo -69.77 -24.08 30.03 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.693 2.262 . . . . 63.32 112.387 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.67 -42.02 22.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 64.0 111.101 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 12.4 tt -74.62 -34.29 34.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 62.119999999999997 111.083 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.9 tp -75.74 -32.75 60.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 73.129999999999995 110.899 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.19 -28.36 41.11 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.695 -0.764 . . . . 45.450000000000003 112.462 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.8 mttt -80.11 -31.29 39.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.752 0.311 . . . . 75.400000000000006 110.882 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.661 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -66.76 -39.97 88.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 63.450000000000003 111.133 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.24 -37.07 77.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 63.130000000000003 111.084 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.0 m -80.32 -24.74 39.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.25 -0.432 . . . . 33.039999999999999 111.161 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -77.39 -37.49 51.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 72.040000000000006 110.882 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 20' ' ' ALA . 91.5 t -71.08 -40.1 75.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.448 . . . . 51.43 111.184 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.0 p -68.67 -33.82 61.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 71.0 111.105 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.29 -32.56 38.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 74.140000000000001 111.028 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 42.439999999999998 111.051 179.993 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.8 pptp? . . . . . 0 C--O 1.23 0.041 0 CA-C-O 120.829 0.347 . . . . 75.099999999999994 110.891 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -65.02 -34.36 89.65 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.719 -0.753 . . . . 74.340000000000003 112.472 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 -68.48 -39.76 81.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.766 0.317 . . . . 72.109999999999999 110.866 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.408 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 29.4 pt -85.68 -19.99 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 73.409999999999997 111.102 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.64 -36.31 78.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 71.25 110.905 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.698 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.11 -56.58 34.63 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.613 0.72 . . . . 72.420000000000002 111.068 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.698 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 53.7 Cg_endo -69.78 -29.34 23.92 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.687 2.258 . . . . 60.32 112.313 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -80.4 -17.28 52.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.221 -0.445 . . . . 74.230000000000004 110.922 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.593 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.95 -54.75 52.27 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.634 0.731 . . . . 72.349999999999994 110.851 -179.918 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.8 Cg_endo -69.78 -27.71 26.07 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.741 2.294 . . . . 61.240000000000002 112.33 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.3 m -82.19 -17.99 44.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 60.5 110.844 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.635 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.2 OUTLIER -57.78 -52.62 73.08 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.68 0.752 . . . . 73.25 110.842 -179.838 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.635 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.7 Cg_endo -69.75 -23.85 30.39 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.73 2.287 . . . . 72.409999999999997 112.341 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.7 -41.99 22.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 64.109999999999999 111.153 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 15.4 tt -74.76 -34.33 33.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 71.519999999999996 111.125 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.66 -32.73 60.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 60.420000000000002 110.893 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.24 -28.52 40.31 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.792 -0.718 . . . . 73.150000000000006 112.434 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.432 ' HA ' HG22 ' A' ' 22' ' ' THR . 4.0 mtpm? -80.2 -30.84 38.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.74 0.305 . . . . 64.200000000000003 110.873 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.634 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -68.34 -33.69 74.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 60.530000000000001 111.134 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.636 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -71.88 -40.37 68.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 71.0 111.099 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.432 HG22 ' HA ' ' A' ' 19' ' ' LYS . 9.3 t -80.65 -23.4 39.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 72.150000000000006 111.188 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -75.18 -37.82 61.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 74.25 110.881 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 20' ' ' ALA . 85.7 t -72.77 -35.7 50.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.228 -0.442 . . . . 63.450000000000003 111.125 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 21' ' ' ALA . 95.9 t -70.17 -37.3 71.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 61.340000000000003 111.137 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.23 -30.57 38.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 74.209999999999994 111.073 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 60.240000000000002 111.104 179.944 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.058 0 CA-C-O 120.81 0.338 . . . . 75.340000000000003 110.878 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.42 -35.89 90.78 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.688 -0.768 . . . . 70.420000000000002 112.537 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.3 mtt180 -67.15 -40.11 86.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.853 0.359 . . . . 64.519999999999996 110.891 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.407 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 10.7 tp -85.55 -19.81 8.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 73.530000000000001 111.167 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -68.55 -36.43 78.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 74.420000000000002 110.86 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.71 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.06 -56.62 34.32 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.581 0.705 . . . . 73.25 111.089 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.71 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 53.3 Cg_endo -69.74 -29.27 24.22 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.696 2.264 . . . . 64.010000000000005 112.326 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -80.54 -17.32 51.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 74.519999999999996 110.806 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.59 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.93 -54.67 53.02 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.696 0.76 . . . . 72.329999999999998 110.866 -179.884 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.8 Cg_endo -69.69 -27.71 26.45 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.705 2.27 . . . . 71.129999999999995 112.386 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m -82.16 -18.34 43.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.46 . . . . 71.010000000000005 110.872 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.633 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -57.2 -52.55 73.32 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.667 0.746 . . . . 75.209999999999994 110.88 -179.823 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.633 ' HD2' ' N ' ' A' ' 13' ' ' SER . 54.0 Cg_endo -69.76 -23.48 30.77 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.659 2.24 . . . . 74.340000000000003 112.3 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.56 -41.67 23.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.26 -0.427 . . . . 63.549999999999997 111.091 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 33.6 mm -72.41 -40.07 63.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.462 . . . . 71.129999999999995 111.16 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -71.83 -31.87 66.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 44.100000000000001 110.911 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.61 -28.93 41.21 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.715 -0.755 . . . . 54.25 112.534 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.8 mtpp -80.05 -32.17 39.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.731 0.301 . . . . 72.25 110.881 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.67 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -66.83 -36.64 82.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 55.549999999999997 111.134 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.655 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -70.42 -39.09 74.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 64.400000000000006 111.122 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.9 m -80.31 -24.11 40.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 65.319999999999993 111.163 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -75.38 -38.94 59.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 74.329999999999998 110.802 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.67 HG23 ' O ' ' A' ' 20' ' ' ALA . 92.6 t -70.35 -35.02 60.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 75.409999999999997 111.167 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 21' ' ' ALA . 96.7 t -69.94 -36.7 70.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 63.310000000000002 111.123 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.21 -32.81 38.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.481 . . . . 52.130000000000003 111.093 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.271 -0.422 . . . . 72.239999999999995 111.105 179.946 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.789 0.328 . . . . 74.5 110.882 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -67.37 -34.34 84.74 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.725 -0.75 . . . . 64.319999999999993 112.508 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -69.99 -37.59 75.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.815 0.34 . . . . 71.120000000000005 110.826 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.6 tt -87.09 -19.88 7.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 73.510000000000005 111.149 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -69.47 -36.57 76.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 51.549999999999997 110.854 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.688 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.09 -56.2 38.6 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.557 0.694 . . . . 61.340000000000003 111.068 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.688 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 53.8 Cg_endo -69.76 -29.56 23.66 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.69 2.26 . . . . 70.409999999999997 112.346 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -80.4 -17.31 52.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 74.349999999999994 110.896 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.599 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -57.83 -54.81 51.51 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.648 0.737 . . . . 75.109999999999999 110.876 -179.901 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 54.2 Cg_endo -69.71 -27.76 26.3 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.73 2.287 . . . . 73.430000000000007 112.324 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.1 -18.04 44.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 65.430000000000007 110.856 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.635 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -57.75 -52.59 73.23 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.657 0.741 . . . . 55.25 110.869 -179.832 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.635 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.5 Cg_endo -69.8 -23.79 30.21 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.664 2.243 . . . . 53.310000000000002 112.351 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.75 -41.98 22.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.227 -0.442 . . . . 62.439999999999998 111.086 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 11.2 tp -74.82 -34.24 32.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 72.120000000000005 111.113 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.3 tp -75.86 -32.6 59.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 74.239999999999995 110.925 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.21 -28.43 40.8 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.708 -0.758 . . . . 74.239999999999995 112.526 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.3 mttt -80.0 -31.36 39.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.823 0.344 . . . . 63.399999999999999 110.938 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.662 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -67.05 -36.65 82.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 73.450000000000003 111.089 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.654 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -70.29 -39.4 74.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.244 -0.434 . . . . 54.409999999999997 111.081 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.4 m -80.27 -24.0 40.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 51.329999999999998 111.14 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -75.39 -38.63 59.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.438 . . . . 65.310000000000002 110.857 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 20' ' ' ALA . 92.8 t -70.83 -35.14 58.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.202 -0.454 . . . . 53.32 111.142 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 21' ' ' ALA . 96.2 t -69.87 -36.67 70.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 70.219999999999999 111.141 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.17 -32.91 38.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.465 . . . . 74.219999999999999 111.111 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 75.420000000000002 111.087 179.972 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.823 0.344 . . . . 73.129999999999995 110.876 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.29 -35.94 91.0 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.742 -0.742 . . . . 73.430000000000007 112.51 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 44.5 mmm-85 -67.19 -40.16 86.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.777 0.323 . . . . 73.299999999999997 110.866 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.411 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 0.8 OUTLIER -85.52 -19.75 8.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.46 . . . . 53.310000000000002 111.107 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -68.77 -36.17 77.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.46 . . . . 72.019999999999996 110.831 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.704 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.16 -56.52 35.25 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.607 0.718 . . . . 71.299999999999997 111.083 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.704 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 53.4 Cg_endo -69.78 -29.46 23.72 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.665 2.243 . . . . 73.129999999999995 112.345 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -80.36 -17.34 52.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 71.129999999999995 110.864 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.594 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.89 -54.72 52.52 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.668 0.747 . . . . 72.510000000000005 110.883 -179.866 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.6 Cg_endo -69.79 -27.77 25.92 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.732 2.288 . . . . 71.010000000000005 112.298 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.1 -18.0 44.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.272 -0.422 . . . . 72.349999999999994 110.9 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.628 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -57.85 -52.58 73.34 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.638 0.732 . . . . 73.340000000000003 110.811 -179.806 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.628 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.9 Cg_endo -69.75 -23.79 30.46 Favored 'Trans proline' 0 C--N 1.341 0.132 0 C-N-CA 122.682 2.255 . . . . 75.099999999999994 112.367 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.78 -41.98 22.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 74.129999999999995 111.095 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.1 tp -74.82 -34.25 32.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.431 . . . . 73.409999999999997 111.111 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.7 tp -75.74 -32.7 60.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.461 . . . . 60.240000000000002 110.933 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.22 -28.49 40.5 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.746 -0.74 . . . . 54.119999999999997 112.481 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -80.04 -31.1 39.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.841 0.353 . . . . 73.010000000000005 110.931 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.691 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -66.95 -40.08 87.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 72.409999999999997 111.07 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.48 -37.44 77.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 70.219999999999999 111.131 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.6 m -80.46 -23.27 40.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 74.230000000000004 111.166 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -77.92 -38.86 44.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 74.400000000000006 110.905 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 20' ' ' ALA . 99.3 t -66.19 -40.31 86.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 74.310000000000002 111.133 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.5 m -68.92 -31.91 52.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 73.25 111.094 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.48 -34.18 36.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 50.130000000000003 111.105 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 71.010000000000005 111.081 179.956 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.839 0.352 . . . . 61.109999999999999 110.906 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.46 -35.98 90.87 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.726 -0.749 . . . . 75.140000000000001 112.459 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.7 mmt-85 -67.05 -40.14 87.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.773 0.321 . . . . 65.5 110.915 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.411 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 1.1 tt -85.55 -19.73 8.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 63.200000000000003 111.084 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -68.74 -36.15 78.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.207 -0.451 . . . . 65.420000000000002 110.86 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.695 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.23 -56.47 35.7 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.572 0.701 . . . . 63.140000000000001 111.126 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.695 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 54.0 Cg_endo -69.75 -29.4 24.0 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.705 2.27 . . . . 45.140000000000001 112.342 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -80.54 -17.26 52.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.242 -0.436 . . . . 70.140000000000001 110.866 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.601 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.98 -54.44 55.52 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.646 0.736 . . . . 75.230000000000004 110.941 -179.928 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.8 Cg_endo -69.77 -27.31 26.56 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.661 2.241 . . . . 65.109999999999999 112.342 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.46 -19.11 39.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 72.540000000000006 110.802 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.643 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.2 OUTLIER -55.99 -52.14 74.91 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.689 0.757 . . . . 73.209999999999994 110.874 -179.83 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.643 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.6 Cg_endo -69.79 -20.58 34.49 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.687 2.258 . . . . 70.340000000000003 112.302 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.42 -42.38 20.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.283 -0.417 . . . . 71.430000000000007 111.08 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.1 pt -75.73 -35.17 30.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 62.210000000000001 111.115 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.482 HD13 ' O ' ' A' ' 17' ' ' LEU . 0.2 OUTLIER -76.55 -30.57 57.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 45.350000000000001 110.947 179.89 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.54 -29.78 35.04 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.706 -0.759 . . . . 71.200000000000003 112.467 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.439 ' HA ' HG22 ' A' ' 22' ' ' THR . 0.0 OUTLIER -80.9 -31.28 35.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.786 0.327 . . . . 72.030000000000001 110.884 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.657 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -68.12 -33.75 75.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 64.340000000000003 111.081 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.648 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -71.86 -40.37 69.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 74.230000000000004 111.117 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.439 HG22 ' HA ' ' A' ' 19' ' ' LYS . 9.2 t -80.77 -23.33 39.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.215 -0.448 . . . . 60.43 111.121 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -74.7 -38.51 62.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.24 -0.436 . . . . 65.420000000000002 110.863 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 20' ' ' ALA . 93.1 t -72.02 -35.06 52.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 72.319999999999993 111.121 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 21' ' ' ALA . 95.9 t -69.82 -36.85 71.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.46 . . . . 64.219999999999999 111.157 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.19 -32.95 38.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 72.420000000000002 111.11 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 73.120000000000005 111.112 179.927 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 16.8 m . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.904 0.383 . . . . 53.520000000000003 111.101 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.13 -19.46 47.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 74.420000000000002 110.874 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.42 -35.88 90.77 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.762 -0.732 . . . . 74.530000000000001 112.543 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.15 -40.17 86.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.767 0.318 . . . . 72.329999999999998 110.844 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.407 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 1.6 tt -85.52 -19.74 8.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 71.25 111.126 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -68.77 -36.15 77.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.143 -0.481 . . . . 70.019999999999996 110.872 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.708 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.2 -56.41 36.3 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.644 0.735 . . . . 73.150000000000006 111.144 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.708 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 53.5 Cg_endo -69.82 -29.48 23.51 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.663 2.242 . . . . 62.310000000000002 112.316 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -80.43 -17.24 52.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.435 . . . . 73.0 110.862 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.586 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.87 -54.8 51.68 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.632 0.729 . . . . 60.109999999999999 110.894 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.9 Cg_endo -69.75 -27.78 26.08 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.695 2.263 . . . . 71.120000000000005 112.344 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.03 -18.0 44.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.441 . . . . 73.329999999999998 110.879 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.62 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -57.79 -52.72 72.35 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.696 0.76 . . . . 75.209999999999994 110.861 -179.823 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.62 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.6 Cg_endo -69.76 -24.5 29.6 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.691 2.261 . . . . 70.129999999999995 112.344 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.32 -40.85 25.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 74.530000000000001 111.068 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 23.9 mm -72.19 -40.44 65.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 75.519999999999996 111.132 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.4 mt -71.9 -30.23 65.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.469 . . . . 74.439999999999998 110.923 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.44 -30.29 37.34 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.712 -0.756 . . . . 51.439999999999998 112.493 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.438 ' HA ' HG22 ' A' ' 22' ' ' THR . 0.0 OUTLIER -80.09 -32.65 39.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.811 0.338 . . . . 72.409999999999997 110.882 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.655 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -67.65 -33.19 74.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.251 -0.432 . . . . 54.450000000000003 111.113 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.647 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -72.18 -40.49 67.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 72.540000000000006 111.122 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.438 HG22 ' HA ' ' A' ' 19' ' ' LYS . 9.1 t -80.79 -23.3 39.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 61.119999999999997 111.154 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -74.63 -38.55 62.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 75.349999999999994 110.911 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 20' ' ' ALA . 94.4 t -71.99 -35.1 52.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 74.340000000000003 111.159 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 21' ' ' ALA . 96.5 t -69.85 -36.88 71.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 74.430000000000007 111.091 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.23 -32.92 38.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 64.030000000000001 111.105 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.91 -19.97 54.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 61.350000000000001 111.115 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -59.94 -25.97 65.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.206 -0.452 . . . . 71.109999999999999 110.902 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.7 ptmm? -73.64 -32.57 64.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 73.439999999999998 110.884 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.0 m . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 65.340000000000003 110.806 -179.87 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 6.7 m . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.886 0.374 . . . . 72.420000000000002 111.102 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.12 -19.43 47.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 75.230000000000004 110.91 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.42 -35.86 90.74 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.784 -0.722 . . . . 72.140000000000001 112.474 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -67.27 -40.08 86.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.759 0.314 . . . . 74.129999999999995 110.875 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.408 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 4.0 tt -85.61 -19.62 8.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.2 -0.454 . . . . 71.510000000000005 111.105 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -68.76 -36.4 78.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 74.049999999999997 110.85 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.706 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.14 -56.49 35.53 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.567 0.699 . . . . 74.540000000000006 111.077 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.706 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 53.9 Cg_endo -69.75 -29.35 24.04 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.715 2.277 . . . . 61.32 112.34 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -80.44 -17.35 52.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.258 -0.428 . . . . 72.519999999999996 110.894 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.594 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.93 -54.67 53.1 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.628 0.728 . . . . 75.239999999999995 110.902 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.8 Cg_endo -69.74 -27.9 26.01 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.705 2.27 . . . . 64.129999999999995 112.357 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.96 -18.09 44.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.436 . . . . 71.420000000000002 110.84 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.625 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -57.73 -52.83 71.49 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.66 0.743 . . . . 74.109999999999999 110.794 -179.755 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.625 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.6 Cg_endo -69.73 -24.39 29.88 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.717 2.278 . . . . 74.150000000000006 112.336 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.22 -40.53 26.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 51.299999999999997 111.085 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 54.8 mt -73.25 -39.88 56.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 64.420000000000002 111.122 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.23 -29.65 62.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 41.340000000000003 110.921 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.84 -30.46 35.4 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.763 -0.732 . . . . 75.150000000000006 112.473 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.439 ' HA ' HG22 ' A' ' 22' ' ' THR . 50.8 pttt -80.8 -31.9 35.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.797 0.332 . . . . 73.019999999999996 110.916 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.65 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -67.89 -33.44 74.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 73.140000000000001 111.141 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.649 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -72.05 -40.43 68.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 74.040000000000006 111.063 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.439 HG22 ' HA ' ' A' ' 19' ' ' LYS . 9.0 t -80.78 -23.34 39.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 74.439999999999998 111.104 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -74.68 -38.51 62.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 73.140000000000001 110.874 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 20' ' ' ALA . 93.6 t -72.03 -35.12 52.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 75.519999999999996 111.123 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 21' ' ' ALA . 95.2 t -69.81 -36.86 71.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 70.439999999999998 111.11 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.17 -32.96 38.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 73.439999999999998 111.111 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.92 -20.03 55.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 71.209999999999994 111.085 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -59.87 -25.94 65.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.201 -0.454 . . . . 74.099999999999994 110.923 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.62 -32.62 64.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 73.099999999999994 110.844 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 36.6 t . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.289 -0.414 . . . . 75.129999999999995 110.899 -179.919 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.41 HG12 ' O ' ' A' ' 1' ' ' VAL . 14.5 t . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.884 0.374 . . . . 72.319999999999993 111.11 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.06 -19.45 47.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 74.099999999999994 110.923 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.42 -35.89 90.77 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.761 -0.733 . . . . 60.509999999999998 112.499 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 11.6 mtm180 -67.24 -40.09 86.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.788 0.328 . . . . 71.549999999999997 110.903 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.402 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 4.7 tt -85.59 -19.65 8.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 74.340000000000003 111.087 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -68.7 -36.47 78.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 73.329999999999998 110.88 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.706 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.06 -56.48 35.73 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.567 0.699 . . . . 62.549999999999997 111.124 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.706 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 53.5 Cg_endo -69.83 -29.33 23.71 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.653 2.235 . . . . 55.049999999999997 112.319 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -80.46 -17.31 52.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 74.340000000000003 110.805 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.586 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.91 -54.76 52.06 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.664 0.745 . . . . 64.219999999999999 110.862 -179.87 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.8 Cg_endo -69.71 -27.82 26.23 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.71 2.273 . . . . 71.040000000000006 112.363 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.9 m -82.01 -18.03 44.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 74.349999999999994 110.857 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.629 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -57.84 -52.69 72.54 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.617 0.722 . . . . 55.140000000000001 110.848 -179.769 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.629 ' HD2' ' N ' ' A' ' 13' ' ' SER . 54.4 Cg_endo -69.75 -24.54 29.61 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.624 2.216 . . . . 75.430000000000007 112.378 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.26 -40.63 26.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 71.340000000000003 111.092 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 24.1 mm -72.53 -40.24 62.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 65.109999999999999 111.151 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.9 tp -71.47 -32.12 67.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.21 -0.45 . . . . 72.209999999999994 110.916 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.56 -28.97 41.27 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.712 -0.756 . . . . 52.030000000000001 112.458 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.433 ' HA ' HG22 ' A' ' 22' ' ' THR . 26.0 mttm -80.17 -31.53 38.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.774 0.321 . . . . 74.219999999999999 110.886 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.647 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -68.11 -33.42 74.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 75.219999999999999 111.116 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.653 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -72.09 -40.4 68.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 64.510000000000005 111.064 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.433 HG22 ' HA ' ' A' ' 19' ' ' LYS . 9.2 t -80.77 -23.28 39.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.209 -0.451 . . . . 72.120000000000005 111.181 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -74.98 -38.07 61.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 62.409999999999997 110.899 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 20' ' ' ALA . 85.2 t -72.36 -35.14 51.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 71.5 111.164 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 21' ' ' ALA . 94.8 t -69.83 -36.83 71.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 64.340000000000003 111.14 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.24 -32.84 38.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 54.030000000000001 111.102 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -80.11 -19.92 46.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 54.43 111.119 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.424 ' HD1' HG12 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -59.97 -34.01 72.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.476 . . . . 72.120000000000005 110.897 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -71.03 -32.3 69.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.272 -0.422 . . . . 55.43 110.94 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.6 t . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 74.319999999999993 110.838 -179.901 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.1 m . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.92 0.39 . . . . 71.530000000000001 111.112 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.22 -19.23 47.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.133 -0.485 . . . . 74.129999999999995 110.914 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -65.34 -35.66 91.74 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.74 -0.743 . . . . 72.109999999999999 112.491 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.2 mmm-85 -67.32 -40.21 85.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.777 0.322 . . . . 61.100000000000001 110.882 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.406 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 1.3 tt -85.68 -19.64 8.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 54.020000000000003 111.125 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -68.69 -36.34 78.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 72.239999999999995 110.882 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.71 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.23 -56.47 35.72 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.589 0.709 . . . . 70.340000000000003 111.099 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.71 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 54.5 Cg_endo -69.72 -29.4 24.13 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.691 2.26 . . . . 61.32 112.35 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -80.48 -17.27 52.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 74.040000000000006 110.87 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.59 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.91 -54.75 52.18 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.622 0.725 . . . . 64.209999999999994 110.864 -179.919 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 54.3 Cg_endo -69.74 -27.8 26.13 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.677 2.251 . . . . 74.329999999999998 112.361 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.7 m -82.05 -18.0 44.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 52.240000000000002 110.828 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.619 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -57.79 -52.69 72.56 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.69 0.757 . . . . 74.140000000000001 110.871 -179.816 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.7 Cg_endo -69.8 -24.56 29.34 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.697 2.265 . . . . 63.009999999999998 112.313 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.24 -40.66 26.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 72.299999999999997 111.124 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 15.8 mt -72.51 -40.27 63.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 54.119999999999997 111.134 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.6 tt -71.41 -32.15 68.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 63.329999999999998 110.989 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.55 -28.93 41.43 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.72 -0.752 . . . . 73.319999999999993 112.508 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.436 ' HA ' HG22 ' A' ' 22' ' ' THR . 9.2 mttm -80.16 -31.53 38.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.835 0.35 . . . . 74.030000000000001 110.889 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.654 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -68.07 -33.57 74.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.44 . . . . 71.530000000000001 111.083 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.651 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -71.95 -40.42 68.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.438 . . . . 51.43 111.061 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.436 HG22 ' HA ' ' A' ' 19' ' ' LYS . 9.2 t -80.76 -23.33 39.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.264 -0.425 . . . . 74.129999999999995 111.126 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.68 -38.56 62.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.461 . . . . 75.430000000000007 110.879 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 20' ' ' ALA . 94.2 t -71.96 -35.19 53.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.174 -0.467 . . . . 73.129999999999995 111.146 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 21' ' ' ALA . 95.8 t -69.78 -36.84 71.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.485 . . . . 62.109999999999999 111.119 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.22 -33.0 38.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 75.5 111.079 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.95 -20.0 55.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.434 . . . . 53.340000000000003 111.125 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -59.93 -25.95 65.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 54.32 110.9 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.49 -32.63 64.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.253 -0.431 . . . . 62.43 110.929 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 75.349999999999994 110.827 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.46 HG22 ' HD2' ' A' ' 4' ' ' ARG . 35.6 m . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.925 0.393 . . . . 53.109999999999999 111.132 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.13 -19.43 47.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 71.420000000000002 110.884 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.44 -35.87 90.74 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.77 -0.729 . . . . 62.210000000000001 112.47 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.46 ' HD2' HG22 ' A' ' 1' ' ' VAL . 1.1 mtt180 -67.22 -40.18 86.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.847 0.356 . . . . 70.430000000000007 110.859 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.402 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 4.7 tt -85.54 -19.68 8.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 65.150000000000006 111.125 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -68.6 -36.5 78.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 75.030000000000001 110.868 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.703 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.1 -56.48 35.7 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.606 0.717 . . . . 72.409999999999997 111.114 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.703 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 54.2 Cg_endo -69.74 -29.39 24.03 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.679 2.253 . . . . 73.439999999999998 112.334 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -80.38 -17.37 52.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 61.119999999999997 110.91 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.585 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.86 -54.75 52.2 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.655 0.74 . . . . 71.540000000000006 110.891 -179.919 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 54.0 Cg_endo -69.7 -27.53 26.66 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.691 2.26 . . . . 65.209999999999994 112.324 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.23 -18.33 42.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 75.010000000000005 110.898 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.635 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -57.84 -52.34 75.14 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.659 0.742 . . . . 71.230000000000004 110.827 -179.827 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.635 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.5 Cg_endo -69.69 -24.81 29.56 Favored 'Trans proline' 0 N--CA 1.465 -0.178 0 C-N-CA 122.723 2.282 . . . . 73.430000000000007 112.365 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.23 -40.55 26.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 72.239999999999995 111.158 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.6 mt -72.43 -40.23 63.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 72.299999999999997 111.132 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.54 -32.06 67.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 74.129999999999995 110.915 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.54 -28.89 41.67 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.74 -0.743 . . . . 55.149999999999999 112.509 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.2 mttm -80.06 -31.94 39.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.825 0.345 . . . . 64.349999999999994 110.951 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.666 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -66.87 -36.74 83.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 71.340000000000003 111.11 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.644 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -70.41 -39.0 74.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 53.299999999999997 111.147 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.8 m -80.37 -24.06 40.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.237 -0.438 . . . . 64.540000000000006 111.144 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -75.5 -38.67 59.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 75.340000000000003 110.842 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 20' ' ' ALA . 93.2 t -70.94 -35.46 59.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.194 -0.457 . . . . 33.329999999999998 111.127 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 21' ' ' ALA . 96.3 t -70.7 -38.57 73.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 72.420000000000002 111.112 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.25 -27.44 38.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 23.52 111.129 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -80.49 -34.66 35.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 72.340000000000003 111.092 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 62.6 t-105 -69.93 -40.17 75.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.232 -0.44 . . . . 73.040000000000006 110.917 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.05 -27.99 60.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 73.200000000000003 110.915 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.197 -0.456 . . . . 41.409999999999997 110.844 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 24.5 m . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.873 0.368 . . . . 62.109999999999999 111.161 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.06 -19.44 47.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 74.310000000000002 110.877 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.42 -35.9 90.81 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.787 -0.72 . . . . 70.400000000000006 112.474 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 32.3 mmt-85 -67.19 -40.17 86.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.819 0.343 . . . . 72.329999999999998 110.888 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.408 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 6.5 tt -85.53 -19.65 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 74.519999999999996 111.176 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -68.68 -36.49 78.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 75.230000000000004 110.846 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.704 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.05 -56.53 35.19 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.565 0.697 . . . . 71.019999999999996 111.074 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.704 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 53.7 Cg_endo -69.75 -29.34 24.08 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.709 2.273 . . . . 72.140000000000001 112.337 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -80.49 -17.35 51.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 74.329999999999998 110.825 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.597 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -57.92 -54.71 52.62 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.666 0.746 . . . . 73.510000000000005 110.909 -179.909 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.8 Cg_endo -69.75 -27.73 26.18 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.676 2.251 . . . . 63.240000000000002 112.398 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.4 t -82.11 -18.03 44.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 33.520000000000003 110.871 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.631 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -57.75 -52.63 72.95 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.673 0.749 . . . . 50.109999999999999 110.88 -179.838 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 13' ' ' SER . 54.1 Cg_endo -69.72 -23.82 30.56 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.686 2.257 . . . . 73.120000000000005 112.382 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.68 -42.09 22.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 64.409999999999997 111.129 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 10.2 tp -74.75 -34.25 33.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 70.239999999999995 111.12 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.79 -32.74 60.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 74.239999999999995 110.9 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.11 -28.57 40.62 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.771 -0.728 . . . . 50.119999999999997 112.535 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.44 ' HA ' HG22 ' A' ' 22' ' ' THR . 30.4 mmtt -80.12 -30.82 39.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.783 0.325 . . . . 75.310000000000002 110.922 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.647 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -68.3 -33.79 74.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 72.340000000000003 111.098 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.648 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -71.85 -40.34 69.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 54.210000000000001 111.079 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.44 HG22 ' HA ' ' A' ' 19' ' ' LYS . 9.2 t -80.7 -23.43 39.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.254 -0.43 . . . . 70.439999999999998 111.114 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -74.69 -38.48 62.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 71.450000000000003 110.859 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 20' ' ' ALA . 93.0 t -72.1 -35.1 52.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 63.409999999999997 111.108 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 21' ' ' ALA . 95.4 t -69.79 -36.89 71.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 75.109999999999999 111.14 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.17 -32.93 38.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 63.130000000000003 111.12 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.03 -19.79 54.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 33.009999999999998 111.119 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -59.74 -20.94 59.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.215 -0.448 . . . . 74.239999999999995 110.913 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.91 -33.41 73.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 73.040000000000006 110.878 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 73.030000000000001 110.858 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.8 m . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.843 0.354 . . . . 62.030000000000001 111.139 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.07 -19.44 47.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.469 . . . . 75.230000000000004 110.928 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.42 -35.93 90.83 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.747 -0.74 . . . . 55.32 112.47 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -67.23 -40.11 86.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.764 0.316 . . . . 74.319999999999993 110.847 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.406 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 1.2 tt -85.51 -19.67 8.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 70.299999999999997 111.151 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -68.69 -36.48 78.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 72.049999999999997 110.869 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.703 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.1 -56.53 35.17 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.534 0.683 . . . . 73.340000000000003 111.075 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.703 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 53.9 Cg_endo -69.69 -29.39 24.26 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.657 2.238 . . . . 74.239999999999995 112.385 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -80.4 -17.36 52.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 65.0 110.859 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.587 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.87 -54.73 52.38 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.683 0.754 . . . . 72.25 110.901 -179.917 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 54.0 Cg_endo -69.81 -27.72 25.91 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.668 2.245 . . . . 62.329999999999998 112.348 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.4 m -82.09 -18.04 44.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 74.25 110.828 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.629 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -57.75 -52.61 73.07 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.649 0.737 . . . . 73.400000000000006 110.869 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.629 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.5 Cg_endo -69.75 -23.85 30.4 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.693 2.262 . . . . 71.420000000000002 112.345 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.68 -42.08 22.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 44.509999999999998 111.125 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 11.2 tp -74.8 -34.25 33.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.435 . . . . 65.120000000000005 111.117 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.513 HD12 ' O ' ' A' ' 13' ' ' SER . 3.7 mt -75.62 -32.82 60.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 74.109999999999999 110.956 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.17 -28.54 40.5 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.744 -0.741 . . . . 64.540000000000006 112.484 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.436 ' HA ' HG22 ' A' ' 22' ' ' THR . 84.6 mttt -80.12 -30.83 39.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.803 0.335 . . . . 75.430000000000007 110.943 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.655 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -68.32 -33.77 74.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 74.129999999999995 111.075 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.594 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -71.83 -40.38 69.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.263 -0.426 . . . . 62.43 111.076 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.436 HG22 ' HA ' ' A' ' 19' ' ' LYS . 9.2 t -80.77 -23.26 39.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 62.32 111.136 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -74.78 -38.53 62.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 71.230000000000004 110.831 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 20' ' ' ALA . 93.2 t -71.81 -35.8 56.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 71.099999999999994 111.129 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 21' ' ' ALA . 90.5 t -70.22 -36.96 69.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 63.25 111.11 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.17 -30.83 38.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 45.210000000000001 111.107 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -80.4 -36.49 33.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.216 -0.447 . . . . 65.439999999999998 111.083 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 90.0 t90 -68.05 -40.09 82.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 71.299999999999997 110.968 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.92 -29.36 63.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 71.329999999999998 110.902 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.4 t . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 62.299999999999997 110.888 -179.894 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 6.9 m . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.864 0.364 . . . . 74.25 111.103 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.19 -19.38 47.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.148 -0.478 . . . . 75.430000000000007 110.839 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.44 -35.88 90.75 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.779 -0.724 . . . . 72.420000000000002 112.503 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 13.0 mmt85 -67.24 -40.16 86.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.817 0.341 . . . . 70.420000000000002 110.853 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.407 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 2.4 tt -85.57 -19.61 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.452 . . . . 64.310000000000002 111.133 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -68.67 -36.41 78.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 64.409999999999997 110.898 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.7 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.12 -56.49 35.59 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.63 0.729 . . . . 72.25 111.121 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.7 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 53.5 Cg_endo -69.77 -29.37 23.94 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.659 2.24 . . . . 70.530000000000001 112.338 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -80.39 -17.39 52.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 71.219999999999999 110.851 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.588 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -57.81 -54.77 51.86 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.679 0.752 . . . . 70.109999999999999 110.88 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.588 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.4 Cg_endo -69.77 -27.42 26.45 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.67 2.247 . . . . 74.230000000000004 112.341 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.0 m -82.25 -18.33 42.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 55.030000000000001 110.92 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.636 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -57.84 -52.25 75.82 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.683 0.754 . . . . 72.549999999999997 110.837 -179.812 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.8 Cg_endo -69.76 -23.97 30.18 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.674 2.249 . . . . 74.319999999999993 112.378 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.73 -42.04 22.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 45.299999999999997 111.068 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.7 tp -74.61 -34.22 34.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 64.420000000000002 111.189 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.3 tt -75.84 -32.67 59.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 73.310000000000002 110.919 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.19 -28.42 40.92 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.719 -0.753 . . . . 72.540000000000006 112.506 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.1 mmtp -80.08 -31.28 39.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.78 0.324 . . . . 62.409999999999997 110.879 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.666 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -67.04 -36.93 83.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 40.149999999999999 111.097 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.647 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -70.24 -39.16 75.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 73.109999999999999 111.101 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 85.8 m -80.25 -24.15 40.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.439 . . . . 71.230000000000004 111.134 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -75.44 -38.68 59.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 73.219999999999999 110.832 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 20' ' ' ALA . 93.7 t -70.9 -35.42 59.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 73.430000000000007 111.151 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 21' ' ' ALA . 94.9 t -70.37 -37.06 69.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 62.329999999999998 111.165 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.24 -30.73 38.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 55.130000000000003 111.072 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -80.34 -36.62 33.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 73.409999999999997 111.116 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 86.9 t90 -67.98 -40.15 83.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.183 -0.462 . . . . 75.140000000000001 110.908 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.92 -29.33 63.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 64.530000000000001 110.858 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.432 . . . . 72.230000000000004 110.845 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 31.4 m . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.894 0.378 . . . . 73.430000000000007 111.137 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.15 -19.62 46.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 72.219999999999999 110.88 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -65.0 -34.34 89.63 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.734 -0.746 . . . . 72.430000000000007 112.482 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.51 -39.73 81.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.779 0.323 . . . . 73.209999999999994 110.873 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.407 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 1.1 tt -85.7 -20.02 8.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 65.319999999999993 111.15 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.58 -36.4 78.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 51.509999999999998 110.87 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.709 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.1 -56.58 34.71 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.557 0.694 . . . . 73.310000000000002 111.077 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.709 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 54.2 Cg_endo -69.7 -29.39 24.21 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.704 2.269 . . . . 73.030000000000001 112.327 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -80.37 -17.35 52.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.229 -0.441 . . . . 62.420000000000002 110.893 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.591 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.92 -54.72 52.49 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.664 0.745 . . . . 74.239999999999995 110.9 -179.897 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.6 Cg_endo -69.74 -27.74 26.22 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.656 2.237 . . . . 61.299999999999997 112.367 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.15 -18.07 44.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 61.130000000000003 110.821 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.621 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -57.67 -52.65 72.81 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.635 0.731 . . . . 62.329999999999998 110.847 -179.831 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.6 Cg_endo -69.75 -23.23 31.07 Favored 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.724 2.283 . . . . 73.200000000000003 112.351 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.06 -42.13 21.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 42.039999999999999 111.102 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.8 tp -74.43 -34.86 37.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 63.329999999999998 111.127 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.542 HD13 ' O ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -75.43 -32.71 60.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 65.420000000000002 110.924 179.892 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.06 -28.4 41.5 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.735 -0.745 . . . . 63.329999999999998 112.492 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.8 mtpt -80.08 -31.53 39.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.728 0.299 . . . . 65.519999999999996 110.847 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.668 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -66.95 -36.74 82.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.257 -0.429 . . . . 61.539999999999999 111.139 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.655 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -70.29 -39.29 74.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 61.229999999999997 111.098 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 93.1 m -80.22 -24.16 40.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 65.349999999999994 111.129 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -75.37 -38.63 59.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 73.549999999999997 110.904 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 20' ' ' ALA . 92.4 t -70.66 -34.88 58.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.469 . . . . 70.019999999999996 111.104 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 21' ' ' ALA . 98.3 t -69.98 -36.81 70.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 60.5 111.097 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.12 -32.96 38.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 65.340000000000003 111.093 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.97 -20.03 55.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 75.219999999999999 111.05 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -59.84 -25.97 65.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.251 -0.431 . . . . 63.229999999999997 110.961 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -73.62 -32.59 64.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 72.439999999999998 110.878 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 28.5 t . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 45.240000000000002 110.85 -179.879 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 18.1 m . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.929 0.395 . . . . 74.010000000000005 111.137 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.09 -19.42 47.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.475 . . . . 54.450000000000003 110.938 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.39 -35.91 90.85 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.73 -0.748 . . . . 43.119999999999997 112.517 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 -67.19 -40.14 86.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.803 0.335 . . . . 73.019999999999996 110.876 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.411 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 20.2 pt -85.55 -19.72 8.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 75.329999999999998 111.154 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -68.75 -36.17 78.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 72.010000000000005 110.909 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.707 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.17 -56.44 36.05 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.563 0.697 . . . . 60.030000000000001 111.124 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.707 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 53.6 Cg_endo -69.78 -29.56 23.56 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.676 2.251 . . . . 64.109999999999999 112.347 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -80.29 -17.41 52.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.46 . . . . 71.299999999999997 110.817 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.587 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.79 -54.89 50.63 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.624 0.725 . . . . 74.0 110.898 -179.869 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 54.2 Cg_endo -69.78 -26.2 27.75 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.658 2.239 . . . . 75.519999999999996 112.338 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.79 -19.16 38.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 62.140000000000001 110.859 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.631 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 1.9 t -57.64 -52.14 76.51 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.688 0.756 . . . . 72.239999999999995 110.851 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 13' ' ' SER . 54.3 Cg_endo -69.64 -24.81 29.79 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.7 2.267 . . . . 71.329999999999998 112.364 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.3 -40.62 26.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 72.25 111.091 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 70.4 mt -72.31 -40.25 64.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 75.299999999999997 111.186 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.1 tt -71.47 -32.21 68.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 61.210000000000001 110.931 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.46 -28.87 42.09 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.706 -0.759 . . . . 74.239999999999995 112.524 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -80.05 -31.92 39.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.845 0.355 . . . . 71.409999999999997 110.94 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.668 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -66.92 -36.59 82.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.447 . . . . 71.400000000000006 111.091 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.654 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -70.47 -39.13 74.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 70.420000000000002 111.1 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.9 m -80.26 -24.13 40.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 73.140000000000001 111.185 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -75.39 -38.72 59.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 72.010000000000005 110.853 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 20' ' ' ALA . 91.7 t -70.63 -35.11 59.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 54.149999999999999 111.099 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 21' ' ' ALA . 96.9 t -69.86 -36.73 70.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 53.5 111.135 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.18 -32.93 38.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 71.409999999999997 111.083 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.94 -20.0 54.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 75.219999999999999 111.141 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -59.88 -26.03 65.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 71.310000000000002 110.914 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.36 -32.7 64.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.254 -0.43 . . . . 73.5 110.942 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.8 t . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 74.239999999999995 110.907 -179.953 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.8 m . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.889 0.376 . . . . 54.32 111.142 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.06 -19.5 47.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 63.210000000000001 110.874 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.4 -35.89 90.81 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.712 -0.756 . . . . 64.540000000000006 112.521 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.2 mmm180 -67.2 -40.16 86.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.787 0.327 . . . . 75.209999999999994 110.856 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.409 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 19.9 pt -85.49 -19.74 8.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 71.099999999999994 111.129 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -68.81 -36.1 77.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 55.549999999999997 110.874 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.703 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.2 -56.46 35.81 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.582 0.706 . . . . 71.0 111.097 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.703 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 53.7 Cg_endo -69.74 -29.58 23.71 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.705 2.27 . . . . 73.030000000000001 112.333 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -80.27 -17.3 52.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 74.239999999999995 110.941 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.586 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.83 -54.94 50.18 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.69 0.757 . . . . 72.430000000000007 110.882 -179.901 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 54.1 Cg_endo -69.75 -26.14 27.92 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.655 2.237 . . . . 53.439999999999998 112.369 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.1 m -82.82 -19.22 38.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.461 . . . . 52.140000000000001 110.862 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.631 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 1.9 t -57.57 -52.09 76.91 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.673 0.749 . . . . 55.329999999999998 110.889 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.9 Cg_endo -69.83 -24.67 29.09 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.663 2.242 . . . . 63.399999999999999 112.336 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.32 -40.59 26.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.28 -0.418 . . . . 72.439999999999998 111.081 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 24.0 mm -72.32 -40.3 64.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 71.430000000000007 111.173 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.7 tt -71.44 -32.19 68.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 71.129999999999995 110.909 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.54 -28.83 41.91 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.753 -0.737 . . . . 70.219999999999999 112.472 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.8 mttm -80.08 -31.99 39.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.866 0.365 . . . . 71.230000000000004 110.905 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.667 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -66.86 -36.67 82.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 62.539999999999999 111.066 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.647 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -70.44 -39.11 74.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 72.430000000000007 111.101 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.3 m -80.33 -24.09 40.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.204 -0.453 . . . . 65.400000000000006 111.143 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -75.47 -38.63 59.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 54.119999999999997 110.88 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 20' ' ' ALA . 92.6 t -70.93 -35.53 60.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 61.530000000000001 111.122 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 21' ' ' ALA . 97.5 t -70.34 -37.0 69.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 75.219999999999999 111.13 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.22 -30.74 38.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 72.349999999999994 111.082 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -80.4 -36.53 33.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 53.509999999999998 111.132 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 68.2 t-105 -68.02 -40.13 83.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.451 . . . . 75.329999999999998 110.954 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.92 -29.37 63.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 74.040000000000006 110.895 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 64.310000000000002 110.834 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.7 m . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.888 0.375 . . . . 75.310000000000002 111.179 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.18 -19.21 47.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.453 . . . . 74.219999999999999 110.916 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -65.36 -35.64 91.7 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.77 -0.729 . . . . 52.020000000000003 112.473 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 9.4 mmm-85 -67.36 -40.23 85.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.766 0.317 . . . . 75.200000000000003 110.862 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.408 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 9.1 tt -85.66 -19.64 8.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 61.399999999999999 111.144 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -68.71 -36.31 78.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 72.129999999999995 110.876 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.697 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.17 -56.51 35.31 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.615 0.721 . . . . 51.340000000000003 111.108 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.697 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 53.3 Cg_endo -69.82 -29.3 23.77 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.632 2.221 . . . . 71.540000000000006 112.339 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -80.43 -17.34 52.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 53.409999999999997 110.871 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.591 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.92 -54.74 52.36 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.605 0.717 . . . . 73.239999999999995 110.855 -179.877 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.8 Cg_endo -69.74 -27.41 26.61 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.714 2.276 . . . . 63.25 112.318 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.6 t -82.3 -18.43 42.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.43 . . . . 60.109999999999999 110.877 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.636 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -57.79 -52.24 75.82 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.662 0.744 . . . . 72.129999999999995 110.858 -179.819 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.8 Cg_endo -69.73 -24.03 30.26 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.661 2.241 . . . . 54.039999999999999 112.321 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.7 -42.02 22.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 75.510000000000005 111.092 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.6 tp -74.58 -34.29 34.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 73.239999999999995 111.162 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 30.6 mt -75.75 -32.77 60.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.12 -0.491 . . . . 72.200000000000003 110.902 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.1 -28.46 41.08 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.747 -0.739 . . . . 73.319999999999993 112.518 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.4 mttp -80.07 -31.24 39.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.809 0.338 . . . . 73.239999999999995 110.91 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.664 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -67.16 -36.64 82.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 70.450000000000003 111.104 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.645 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -70.37 -39.22 74.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.434 . . . . 64.019999999999996 111.08 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.1 m -80.3 -24.04 40.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 75.25 111.131 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -75.43 -38.58 59.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 71.540000000000006 110.853 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 20' ' ' ALA . 92.7 t -71.1 -35.44 58.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.446 . . . . 64.530000000000001 111.106 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 21' ' ' ALA . 95.9 t -70.37 -37.12 69.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 74.150000000000006 111.11 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.17 -30.69 38.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 62.219999999999999 111.1 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -80.39 -36.69 33.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 64.099999999999994 111.042 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 50.4 t90 -68.0 -40.06 83.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.434 . . . . 74.140000000000001 110.919 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.99 -29.26 62.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.285 -0.416 . . . . 71.450000000000003 110.849 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 10.6 t . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.248 -0.433 . . . . 62.32 110.833 -179.871 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.413 HG12 ' O ' ' A' ' 1' ' ' VAL . 14.5 t . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.861 0.363 . . . . 71.430000000000007 111.096 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.14 -19.59 46.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.457 . . . . 73.340000000000003 110.92 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -65.06 -34.2 89.17 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.706 -0.759 . . . . 74.340000000000003 112.545 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -68.53 -39.81 81.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.82 0.343 . . . . 64.519999999999996 110.876 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.409 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 28.9 pt -85.65 -19.99 8.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 75.549999999999997 111.164 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.6 -36.4 78.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.189 -0.46 . . . . 75.430000000000007 110.878 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.709 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.09 -56.53 35.22 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.587 0.708 . . . . 61.350000000000001 111.108 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.709 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 53.9 Cg_endo -69.79 -29.27 23.98 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.661 2.241 . . . . 65.450000000000003 112.389 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -80.45 -17.38 51.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 73.439999999999998 110.859 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.594 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.91 -54.71 52.64 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.664 0.745 . . . . 74.450000000000003 110.918 -179.916 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.4 Cg_endo -69.79 -27.77 25.93 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.69 2.26 . . . . 63.409999999999997 112.332 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.04 -18.09 44.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 74.019999999999996 110.836 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.627 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -57.75 -52.56 73.47 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.676 0.75 . . . . 71.219999999999999 110.885 -179.804 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.7 Cg_endo -69.76 -23.85 30.34 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.713 2.275 . . . . 74.219999999999999 112.33 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.69 -42.07 22.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 74.420000000000002 111.114 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.6 tp -74.76 -34.3 33.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 73.510000000000005 111.111 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 51.1 tp -75.66 -32.71 60.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 65.319999999999993 110.958 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.22 -28.54 40.3 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.757 -0.735 . . . . 62.140000000000001 112.419 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.441 ' HA ' HG22 ' A' ' 22' ' ' THR . 4.9 mtpp -80.12 -30.83 39.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.752 0.31 . . . . 61.020000000000003 110.889 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.653 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -68.28 -33.83 75.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.283 -0.417 . . . . 62.5 111.071 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.648 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -71.81 -40.41 69.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 63.229999999999997 111.048 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.441 HG22 ' HA ' ' A' ' 19' ' ' LYS . 9.2 t -80.71 -23.38 39.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 70.310000000000002 111.111 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -74.72 -38.49 62.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 62.299999999999997 110.87 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 20' ' ' ALA . 94.2 t -71.94 -35.12 53.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 62.140000000000001 111.151 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 21' ' ' ALA . 96.1 t -69.79 -36.86 71.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 73.340000000000003 111.125 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.22 -32.9 38.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 71.409999999999997 111.128 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.01 -19.83 54.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 72.230000000000004 111.127 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -59.67 -20.99 59.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 73.430000000000007 110.922 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.95 -33.3 73.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 64.129999999999995 110.907 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 74.349999999999994 110.844 -179.916 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.9 m . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.854 0.359 . . . . 73.409999999999997 111.155 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.07 -19.48 47.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 71.439999999999998 110.902 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.4 -35.95 90.9 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.794 -0.717 . . . . 35.130000000000003 112.473 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 79.8 mtt180 -67.16 -40.15 86.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.758 0.313 . . . . 74.349999999999994 110.853 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.411 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 14.7 tt -85.49 -19.75 8.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 75.540000000000006 111.138 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -68.75 -36.15 78.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 73.420000000000002 110.823 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.706 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.24 -56.47 35.74 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.604 0.716 . . . . 64.239999999999995 111.101 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.706 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 53.9 Cg_endo -69.75 -29.39 24.01 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.676 2.25 . . . . 53.119999999999997 112.371 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -80.54 -17.22 52.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 74.109999999999999 110.89 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.595 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -58.02 -54.45 55.46 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.659 0.742 . . . . 62.109999999999999 110.887 -179.883 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.8 Cg_endo -69.74 -27.35 26.69 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.7 2.266 . . . . 73.209999999999994 112.321 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.42 -19.1 39.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 71.340000000000003 110.865 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.644 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -56.09 -52.07 75.66 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.633 0.73 . . . . 72.329999999999998 110.83 -179.778 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.644 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.5 Cg_endo -69.78 -20.24 35.0 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.675 2.25 . . . . 70.409999999999997 112.36 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.9 -42.54 19.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.434 . . . . 75.530000000000001 111.089 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.449 HG13 HD22 ' A' ' 17' ' ' LEU . 22.2 pt -74.29 -35.91 41.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 65.409999999999997 111.099 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.449 HD22 HG13 ' A' ' 16' ' ' ILE . 2.7 mm? -74.32 -32.81 62.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 72.219999999999999 110.901 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.04 -28.64 40.66 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.743 -0.741 . . . . 72.040000000000006 112.489 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.456 ' HA ' HG22 ' A' ' 22' ' ' THR . 10.0 mtpt -80.19 -30.44 38.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.762 0.315 . . . . 70.420000000000002 110.838 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.679 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -68.49 -34.48 75.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.284 -0.416 . . . . 72.540000000000006 111.089 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.61 -40.24 69.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 64.209999999999994 111.073 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.456 HG22 ' HA ' ' A' ' 19' ' ' LYS . 9.3 t -80.75 -22.59 40.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 52.229999999999997 111.148 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -75.76 -38.53 58.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 72.230000000000004 110.903 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 20' ' ' ALA . 96.3 t -67.83 -40.34 83.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 73.030000000000001 111.146 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.2 p -69.56 -34.28 60.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 74.329999999999998 111.171 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.25 -29.13 38.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.126 -0.488 . . . . 53.030000000000001 111.133 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.98 -19.94 54.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 54.140000000000001 111.109 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 13.0 t-105 -59.95 -28.52 67.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 62.420000000000002 110.934 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.1 ptmt -70.1 -32.57 70.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 75.340000000000003 110.958 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.1 t . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 54.020000000000003 110.864 -179.892 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 31.6 m . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.898 0.38 . . . . 71.219999999999999 111.112 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.14 -19.44 47.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.141 -0.481 . . . . 73.340000000000003 110.895 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.42 -35.89 90.78 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.705 -0.759 . . . . 64.450000000000003 112.499 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 26.4 mmt85 -67.17 -40.2 86.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.813 0.339 . . . . 73.510000000000005 110.84 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.41 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 31.4 pt -85.5 -19.69 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 52.399999999999999 111.137 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -68.81 -36.12 77.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.458 . . . . 62.310000000000002 110.887 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.703 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.21 -56.47 35.72 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.599 0.714 . . . . 73.540000000000006 111.113 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.703 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 54.4 Cg_endo -69.71 -29.56 23.92 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.714 2.276 . . . . 73.349999999999994 112.395 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -80.34 -17.3 52.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 52.530000000000001 110.897 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.593 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.82 -54.95 50.07 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.632 0.73 . . . . 72.230000000000004 110.884 -179.906 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.7 Cg_endo -69.7 -26.17 28.11 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.716 2.277 . . . . 73.239999999999995 112.363 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.7 t -82.88 -19.14 37.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 62.109999999999999 110.857 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.634 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 2.0 t -57.63 -51.96 77.88 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.665 0.745 . . . . 74.109999999999999 110.886 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.634 ' HD2' ' N ' ' A' ' 13' ' ' SER . 54.0 Cg_endo -69.77 -24.08 30.03 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.693 2.262 . . . . 63.32 112.387 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.67 -42.02 22.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 64.0 111.101 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 12.4 tt -74.62 -34.29 34.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 62.119999999999997 111.083 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.9 tp -75.74 -32.75 60.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 73.129999999999995 110.899 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.19 -28.36 41.11 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.695 -0.764 . . . . 45.450000000000003 112.462 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.8 mttt -80.11 -31.29 39.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.752 0.311 . . . . 75.400000000000006 110.882 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.661 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -66.76 -39.97 88.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 63.450000000000003 111.133 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.24 -37.07 77.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 63.130000000000003 111.084 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.0 m -80.32 -24.74 39.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.25 -0.432 . . . . 33.039999999999999 111.161 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -77.39 -37.49 51.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 72.040000000000006 110.882 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 20' ' ' ALA . 91.5 t -71.08 -40.1 75.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.448 . . . . 51.43 111.184 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.0 p -68.67 -33.82 61.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 71.0 111.105 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.29 -32.56 38.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 74.140000000000001 111.028 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.01 -19.94 55.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 42.439999999999998 111.051 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -59.95 -30.72 69.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.245 -0.434 . . . . 70.120000000000005 110.905 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.5 ptmm? -67.36 -32.64 73.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 63.340000000000003 110.921 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.4 p . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.223 -0.444 . . . . 64.340000000000003 110.889 -179.917 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.422 HG12 ' O ' ' A' ' 1' ' ' VAL . 14.4 t . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.902 0.382 . . . . 74.109999999999999 111.117 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.8 pptp? -80.18 -19.61 46.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.459 . . . . 75.099999999999994 110.891 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -65.02 -34.36 89.65 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.719 -0.753 . . . . 74.340000000000003 112.472 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 -68.48 -39.76 81.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.766 0.317 . . . . 72.109999999999999 110.866 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.408 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 29.4 pt -85.68 -19.99 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 73.409999999999997 111.102 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.64 -36.31 78.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 71.25 110.905 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.698 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.11 -56.58 34.63 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.613 0.72 . . . . 72.420000000000002 111.068 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.698 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 53.7 Cg_endo -69.78 -29.34 23.92 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.687 2.258 . . . . 60.32 112.313 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -80.4 -17.28 52.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.221 -0.445 . . . . 74.230000000000004 110.922 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.593 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.95 -54.75 52.27 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.634 0.731 . . . . 72.349999999999994 110.851 -179.918 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.8 Cg_endo -69.78 -27.71 26.07 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.741 2.294 . . . . 61.240000000000002 112.33 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.3 m -82.19 -17.99 44.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 60.5 110.844 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.635 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.2 OUTLIER -57.78 -52.62 73.08 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.68 0.752 . . . . 73.25 110.842 -179.838 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.635 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.7 Cg_endo -69.75 -23.85 30.39 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.73 2.287 . . . . 72.409999999999997 112.341 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.7 -41.99 22.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 64.109999999999999 111.153 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 15.4 tt -74.76 -34.33 33.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 71.519999999999996 111.125 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.66 -32.73 60.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 60.420000000000002 110.893 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.24 -28.52 40.31 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.792 -0.718 . . . . 73.150000000000006 112.434 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.432 ' HA ' HG22 ' A' ' 22' ' ' THR . 4.0 mtpm? -80.2 -30.84 38.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.74 0.305 . . . . 64.200000000000003 110.873 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.634 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -68.34 -33.69 74.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 60.530000000000001 111.134 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.636 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -71.88 -40.37 68.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 71.0 111.099 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.432 HG22 ' HA ' ' A' ' 19' ' ' LYS . 9.3 t -80.65 -23.4 39.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 72.150000000000006 111.188 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -75.18 -37.82 61.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 74.25 110.881 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 20' ' ' ALA . 85.7 t -72.77 -35.7 50.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.228 -0.442 . . . . 63.450000000000003 111.125 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 21' ' ' ALA . 95.9 t -70.17 -37.3 71.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 61.340000000000003 111.137 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.23 -30.57 38.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 74.209999999999994 111.073 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -80.36 -36.79 33.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 60.240000000000002 111.104 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 30.2 t90 -67.91 -40.13 83.44 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.196 -0.456 . . . . 71.519999999999996 110.938 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.89 -29.3 63.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 74.450000000000003 110.92 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.5 m . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.236 -0.438 . . . . 74.310000000000002 110.87 -179.915 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 18.4 m . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.886 0.374 . . . . 55.329999999999998 111.137 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.07 -19.48 47.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 75.340000000000003 110.878 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.42 -35.89 90.78 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.688 -0.768 . . . . 70.420000000000002 112.537 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.3 mtt180 -67.15 -40.11 86.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.853 0.359 . . . . 64.519999999999996 110.891 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.407 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 10.7 tp -85.55 -19.81 8.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 73.530000000000001 111.167 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -68.55 -36.43 78.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 74.420000000000002 110.86 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.71 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.06 -56.62 34.32 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.581 0.705 . . . . 73.25 111.089 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.71 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 53.3 Cg_endo -69.74 -29.27 24.22 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.696 2.264 . . . . 64.010000000000005 112.326 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -80.54 -17.32 51.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 74.519999999999996 110.806 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.59 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.93 -54.67 53.02 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.696 0.76 . . . . 72.329999999999998 110.866 -179.884 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.8 Cg_endo -69.69 -27.71 26.45 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.705 2.27 . . . . 71.129999999999995 112.386 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m -82.16 -18.34 43.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.46 . . . . 71.010000000000005 110.872 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.633 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -57.2 -52.55 73.32 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.667 0.746 . . . . 75.209999999999994 110.88 -179.823 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.633 ' HD2' ' N ' ' A' ' 13' ' ' SER . 54.0 Cg_endo -69.76 -23.48 30.77 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.659 2.24 . . . . 74.340000000000003 112.3 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.56 -41.67 23.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.26 -0.427 . . . . 63.549999999999997 111.091 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 33.6 mm -72.41 -40.07 63.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.462 . . . . 71.129999999999995 111.16 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -71.83 -31.87 66.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 44.100000000000001 110.911 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -81.61 -28.93 41.21 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.715 -0.755 . . . . 54.25 112.534 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.8 mtpp -80.05 -32.17 39.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.731 0.301 . . . . 72.25 110.881 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.67 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -66.83 -36.64 82.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 55.549999999999997 111.134 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.655 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -70.42 -39.09 74.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 64.400000000000006 111.122 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.9 m -80.31 -24.11 40.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 65.319999999999993 111.163 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -75.38 -38.94 59.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 74.329999999999998 110.802 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.67 HG23 ' O ' ' A' ' 20' ' ' ALA . 92.6 t -70.35 -35.02 60.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 75.409999999999997 111.167 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 21' ' ' ALA . 96.7 t -69.94 -36.7 70.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 63.310000000000002 111.123 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.21 -32.81 38.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.481 . . . . 52.130000000000003 111.093 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.03 -19.96 55.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.271 -0.422 . . . . 72.239999999999995 111.105 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 9.9 t90 -59.93 -27.59 66.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.457 . . . . 64.129999999999995 110.932 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.32 -32.61 68.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 64.140000000000001 110.922 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.9 t . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.445 . . . . 73.340000000000003 110.883 -179.917 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 31.1 m . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.865 0.364 . . . . 74.209999999999994 111.168 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.09 -18.72 45.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 74.5 110.882 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -67.37 -34.34 84.74 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.725 -0.75 . . . . 64.319999999999993 112.508 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -69.99 -37.59 75.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.815 0.34 . . . . 71.120000000000005 110.826 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.6 tt -87.09 -19.88 7.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 73.510000000000005 111.149 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -69.47 -36.57 76.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 51.549999999999997 110.854 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.688 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.09 -56.2 38.6 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.557 0.694 . . . . 61.340000000000003 111.068 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.688 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 53.8 Cg_endo -69.76 -29.56 23.66 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.69 2.26 . . . . 70.409999999999997 112.346 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -80.4 -17.31 52.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 74.349999999999994 110.896 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.599 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -57.83 -54.81 51.51 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.648 0.737 . . . . 75.109999999999999 110.876 -179.901 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 54.2 Cg_endo -69.71 -27.76 26.3 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.73 2.287 . . . . 73.430000000000007 112.324 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.1 -18.04 44.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 65.430000000000007 110.856 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.635 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -57.75 -52.59 73.23 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.657 0.741 . . . . 55.25 110.869 -179.832 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.635 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.5 Cg_endo -69.8 -23.79 30.21 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.664 2.243 . . . . 53.310000000000002 112.351 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.75 -41.98 22.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.227 -0.442 . . . . 62.439999999999998 111.086 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 11.2 tp -74.82 -34.24 32.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 72.120000000000005 111.113 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.3 tp -75.86 -32.6 59.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 74.239999999999995 110.925 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.21 -28.43 40.8 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.708 -0.758 . . . . 74.239999999999995 112.526 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.3 mttt -80.0 -31.36 39.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.823 0.344 . . . . 63.399999999999999 110.938 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.662 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -67.05 -36.65 82.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 73.450000000000003 111.089 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.654 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -70.29 -39.4 74.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.244 -0.434 . . . . 54.409999999999997 111.081 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.4 m -80.27 -24.0 40.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 51.329999999999998 111.14 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -75.39 -38.63 59.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.438 . . . . 65.310000000000002 110.857 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 20' ' ' ALA . 92.8 t -70.83 -35.14 58.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.202 -0.454 . . . . 53.32 111.142 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 21' ' ' ALA . 96.2 t -69.87 -36.67 70.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 70.219999999999999 111.141 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.17 -32.91 38.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.465 . . . . 74.219999999999999 111.111 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -80.12 -19.82 46.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 75.420000000000002 111.087 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -59.77 -22.94 62.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 74.040000000000006 110.917 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.34 -33.23 74.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 73.209999999999994 110.922 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 73.510000000000005 110.844 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.75 HG12 ' H ' ' A' ' 3' ' ' GLY . 11.8 t . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.9 0.381 . . . . 73.510000000000005 111.114 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.15 -19.61 46.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 73.129999999999995 110.876 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.75 ' H ' HG12 ' A' ' 1' ' ' VAL . . . -66.29 -35.94 91.0 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.742 -0.742 . . . . 73.430000000000007 112.51 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 44.5 mmm-85 -67.19 -40.16 86.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.777 0.323 . . . . 73.299999999999997 110.866 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.411 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 0.8 OUTLIER -85.52 -19.75 8.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.46 . . . . 53.310000000000002 111.107 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -68.77 -36.17 77.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.46 . . . . 72.019999999999996 110.831 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.704 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.16 -56.52 35.25 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.607 0.718 . . . . 71.299999999999997 111.083 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.704 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 53.4 Cg_endo -69.78 -29.46 23.72 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.665 2.243 . . . . 73.129999999999995 112.345 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -80.36 -17.34 52.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 71.129999999999995 110.864 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.594 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.89 -54.72 52.52 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.668 0.747 . . . . 72.510000000000005 110.883 -179.866 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.6 Cg_endo -69.79 -27.77 25.92 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.732 2.288 . . . . 71.010000000000005 112.298 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.1 -18.0 44.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.272 -0.422 . . . . 72.349999999999994 110.9 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.628 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -57.85 -52.58 73.34 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.638 0.732 . . . . 73.340000000000003 110.811 -179.806 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.628 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.9 Cg_endo -69.75 -23.79 30.46 Favored 'Trans proline' 0 C--N 1.341 0.132 0 C-N-CA 122.682 2.255 . . . . 75.099999999999994 112.367 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.78 -41.98 22.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 74.129999999999995 111.095 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.1 tp -74.82 -34.25 32.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.431 . . . . 73.409999999999997 111.111 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.7 tp -75.74 -32.7 60.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.461 . . . . 60.240000000000002 110.933 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.22 -28.49 40.5 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.746 -0.74 . . . . 54.119999999999997 112.481 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -80.04 -31.1 39.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.841 0.353 . . . . 73.010000000000005 110.931 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.691 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -66.95 -40.08 87.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 72.409999999999997 111.07 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.48 -37.44 77.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 70.219999999999999 111.131 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.6 m -80.46 -23.27 40.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 74.230000000000004 111.166 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -77.92 -38.86 44.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 74.400000000000006 110.905 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 20' ' ' ALA . 99.3 t -66.19 -40.31 86.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 74.310000000000002 111.133 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.5 m -68.92 -31.91 52.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 73.25 111.094 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.48 -34.18 36.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 50.130000000000003 111.105 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.0 -19.96 55.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 71.010000000000005 111.081 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -59.9 -25.65 65.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.244 -0.434 . . . . 72.219999999999999 110.907 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.46 -32.82 74.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.252 -0.431 . . . . 61.340000000000003 110.88 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.9 t . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 63.020000000000003 110.833 -179.897 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.422 HG12 ' O ' ' A' ' 1' ' ' VAL . 14.3 t . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.875 0.369 . . . . 62.43 111.139 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.09 -19.44 47.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 61.109999999999999 110.906 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.46 -35.98 90.87 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.726 -0.749 . . . . 75.140000000000001 112.459 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.7 mmt-85 -67.05 -40.14 87.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.773 0.321 . . . . 65.5 110.915 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.411 ' C ' ' HD2' ' A' ' 8' ' ' PRO . 1.1 tt -85.55 -19.73 8.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 63.200000000000003 111.084 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -68.74 -36.15 78.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.207 -0.451 . . . . 65.420000000000002 110.86 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.695 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . . . -59.23 -56.47 35.7 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.572 0.701 . . . . 63.140000000000001 111.126 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.695 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 54.0 Cg_endo -69.75 -29.4 24.0 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.705 2.27 . . . . 45.140000000000001 112.342 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -80.54 -17.26 52.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.242 -0.436 . . . . 70.140000000000001 110.866 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.601 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -57.98 -54.44 55.52 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.646 0.736 . . . . 75.230000000000004 110.941 -179.928 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 10' ' ' PHE . 53.8 Cg_endo -69.77 -27.31 26.56 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.661 2.241 . . . . 65.109999999999999 112.342 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.46 -19.11 39.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 72.540000000000006 110.802 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.643 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.2 OUTLIER -55.99 -52.14 74.91 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.689 0.757 . . . . 73.209999999999994 110.874 -179.83 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.643 ' HD2' ' N ' ' A' ' 13' ' ' SER . 53.6 Cg_endo -69.79 -20.58 34.49 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.687 2.258 . . . . 70.340000000000003 112.302 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.42 -42.38 20.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.283 -0.417 . . . . 71.430000000000007 111.08 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.1 pt -75.73 -35.17 30.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 62.210000000000001 111.115 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.482 HD13 ' O ' ' A' ' 17' ' ' LEU . 0.2 OUTLIER -76.55 -30.57 57.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 45.350000000000001 110.947 179.89 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -82.54 -29.78 35.04 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.706 -0.759 . . . . 71.200000000000003 112.467 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.439 ' HA ' HG22 ' A' ' 22' ' ' THR . 0.0 OUTLIER -80.9 -31.28 35.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.786 0.327 . . . . 72.030000000000001 110.884 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.657 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -68.12 -33.75 75.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 64.340000000000003 111.081 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.648 ' O ' HG23 ' A' ' 25' ' ' VAL . . . -71.86 -40.37 69.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 74.230000000000004 111.117 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.439 HG22 ' HA ' ' A' ' 19' ' ' LYS . 9.2 t -80.77 -23.33 39.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.215 -0.448 . . . . 60.43 111.121 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -74.7 -38.51 62.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.24 -0.436 . . . . 65.420000000000002 110.863 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 20' ' ' ALA . 93.1 t -72.02 -35.06 52.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 72.319999999999993 111.121 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 21' ' ' ALA . 95.9 t -69.82 -36.85 71.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.46 . . . . 64.219999999999999 111.157 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.19 -32.95 38.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 72.420000000000002 111.11 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.98 -19.94 54.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 73.120000000000005 111.112 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 27.0 t90 -59.95 -26.11 65.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.205 -0.452 . . . . 73.219999999999999 110.885 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.2 ptmt -73.32 -32.62 64.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.279 -0.419 . . . . 65.219999999999999 110.914 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.9 t . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 72.430000000000007 110.862 -179.886 . . . . . . . . 0 0 . 1 stop_ save_